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                            SYNOPSIS 
 
Persistent systemic inflammatory response syndrome is a serious health condition that may 
lead to multiple organ dysfunction, organ failure, and ultimately death. It leads to both 
acute inflammation, caused by either infective (microbes or lipopolysaccharide [LPS]) or 
non-infective (chemicals) sources, and sepsis, an infection caused by a lethal dose of LPS 
(endotoxemia). These conditions have similar inflammatory mediators such as cytokines, 
nitric oxide (NO), high-mobility group box-1 (HMGB1), and heme oxygenase-1 (HO-1), 
suggesting that they may result from similar pathogenic mechanisms. Previous studies have 
investigated the applications of natural products in targeting these inflammatory mediators. 
Honey, for example, is used to treat inflammation and heal wounds. Gelam honey is most 
commonly in Malaysia. The floral source of Gelam honey is Melaleuca cajuputi Powell, 
traditional Melaleuca cajuputi Powell has been used to treat many diseases and it has 
medicinal antiseptic, antibacterial, anti-inflammatory, and anodyne properties. However, it 
is currently unknown whether Gelam honey has a protective effect against systemic 
inflammatory response during acute inflammation and sepsis. We first investigated the 
effects of honey, honey methanol extract (HME), and honey ethyl acetate extract (HEAE) 
on acute inflammation, using animal models. These products inhibited edema and pain, in 
correlation with their potent inhibitory activities against NO and prostaglandin E2 (PGE2) 
in all models. Phenolic compounds have been implicated in these inhibitory activities. We 
also evaluated the anti-inflammatory activity of Gelam honey extracts using High-
Performance Liquid Chromatography (HPLC) and liquid chromatography–mass 
spectrometry (LC-MS). Subsequently, HME and HEAE were tested in vitro for their effect 
on NO production in stimulated macrophages, as well as for their effects on tumor necrosis 
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factor-α (TNF-α) cytotoxicity in L929 cells. These extracts protected cells against TNF 
cytotoxicity and inhibited NO production, with HEAE exhibiting greater activity. 
Moreover, we investigated the effect of the intravenous injection of honey in rats with LPS-
induced endotoxemia. We found that cytokines (TNF-α, IL-1β, and IL-10), HMGB1, and 
NO levels decreased, and HO-1 levels increased significantly in the honey-treated groups. 
We also found that Gelam honey protects organs from lethal doses of LPS, as evidenced by 
improved blood parameters, reduced neutrophil infiltration, and decreased myeloperoxidase 
activity, as well as reduced mortality in honey-treated groups compared with untreated 
groups. We also examined the ability of Gelam honey to scavenge peroxynitrite during 
immune responses mounted by the murine macrophage cell line RAW 264.7. Significantly, 
improved viability of LPS/IFN-γ-treated RAW 264.7 cells and significant inhibition of NO 
production were observed, similar to those observed with an inhibitor of inducible NOS. In 
addition, Gelam honey inhibited peroxynitrite production from the synthetic substrate SIN-
1 as well as peroxynitrite synthesis in LPS-treated rats (endotoxemia). Thus, by suppressing 
the production of cytotoxic molecules such as NO and peroxynitrite, honey may attenuate 
the inflammatory responses that lead to cell damage and, potentially, to cell death. The 
results therefore suggest that honey has therapeutic uses for a wide range of inflammatory 
disorders. 
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SINOPSIS 
 
Sindrom tindak balas keradangan sistemik berterusan merupakan keadaan kesihatan 
yang serius yang boleh menyebabkan disfungsi organ berganda, kegagalan organ, dan 
akhirnya kematian. Ia boleh membawa kepada kedua-dua keradangan akut, yang 
disebabkan oleh sama ada sumber berjangkit (mikrob atau lipopolysaccharide yang [LPS]) 
atau tidak berjangkit (kimia) ,sepsis, dan jangkitan yang disebabkan oleh dos maut LPS 
(endotoxemia). Syarat-syarat ini mempunyai radang mediator yang sama seperti sitokin, 
nitrik oksida (NO), kumpulan kotak tinggi mobiliti-1 (HMGB1), dan heme oxygenase-1 
(HO-1), mencadangkan bahawa mereka mungkin diakibatkan oleh mekanisma patogenic 
yang sama. Kajian sebelumnya telah menyiasat aplikasi produk semulajadi dalam 
mensasarkan mediator radang. Madu, contohnya, digunakan untuk merawat keradangan 
dan menyembuhkan luka. Madu Gelam yang paling biasa digunakan di Malaysia (sumber 
bunga:. tradisional Melaleuca cajuputi Powell, telah digunakan untuk merawat pelbagai 
jenis penyakit dan ia mempunyai ubat antiseptik, antibakteria, anti-radang, dan hartanah 
anodyne. Walau bagaimanapun, buat masa ini tidak diketahui sama ada produk semula jadi 
ini (Gelam madu) mempunyai kesan perlindungan terhadap tindak balas radang sistemik 
semasa keradangan akut dan sepsis. Kami mula menyiasat kesan madu, madu ekstrak 
metanol (HME), dan ekstrak madu etil asetat (HEAE) pada keradangan akut, menggunakan 
model haiwan. Produk-produk ini menghalang bengkak dan kesakitan, dan ini berhubungan 
dengan aktiviti perencatan mujarab mereka terhadap NO dan PGE2 dalam semua model. 
Sebatian fenolik telah terbabit dalam aktiviti perencatan. Kami juga menilai aktiviti anti-
radang ekstrak madu Gelam menggunakan HPLC dan LC -MS. Selepas itu, HME dan 
HEAE telah diuji secara in vitro untuk kesan mereka ke atas pengeluaran NO dalam 
makrofaj dirangsang, serta kesannya terhadap nekrosis tumor faktor-α (TNF-α) sitotoksiti 
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dalam sel-sel L929 . Ekstrak ini melindungi sel daripada sitotoksiti TNF dan menghalang 
pengeluaran NO, dengan HEAE ia mempamerkan aktiviti yang lebih besar. Lebih-lebih 
lagi, kami juga menyiasat kesan suntikan intravena madu dalam tikus dengan endotoxemia 
akibat LPS. Kami mendapati bahawa tahap cytokine (TNF-α, IL-1β, dan IL-10) , HMGB1, 
dan NO menurun, dan tahap HO-1 meningkat dengan ketara dalam kumpulan yang dirawat 
dengan madu . Kami juga mendapati bahawa madu Gelam melindungi organ daripada dos 
maut LPS, seperti yang dibuktikan oleh parameter darah yang lebih baik, penyusupan 
neutrophil dikurangkan, dan myeloperoxidase menurun aktivitinya, serta kematian 
dikurangkan dalam kumpulan yang dirawat dengan madu berbanding dengan kumpulan-
kumpulan yang tidak dirawat. Kami juga mengkaji keupayaan madu Gelam untuk mencari 
peroxynitrite semasa tindakbalas imun yang dipasang oleh garis sel macrophage murine 
yang RAW 264,7 daya maju Ketara bertambah baik LPS / IFN-γ dirawat RAW 264,7 sel-
sel dan perencatan dengan pengeluaran NO yang ketara diperhatikan, sama seperti yang 
diperhatikan dengan perencat NOS inducible. Di samping itu, madu Gelam menghalang 
pengeluaran peroxynitrite dari sintetik substrat SIN-1 serta sintesis peroxynitrite dalam 
tikus yang dirawat dengan LPS (endotoxemia). Oleh itu, dengan pengeluaran pembenteras 
molekul sitotoksik seperti NO dan peroxynitrite, madu boleh melemahkan tindak balas 
keradangan yang menyebabkan kerosakan sel dan berpotensi menyebabkan kematian sel. 
Satu lagi komponen aktif madu, caffeic asid phenethyl ester, mempamerkan ciri-ciri 
antioksidan, antimitogenic, anticarcinogenic, aktiviti anti-radang, dan immunomodulateri. 
Apabila diuji dalam LPS / IFN-γ-sel dirawat 264,7 RAW dan-tikus yang dirawat di LPS, 
keputusan yang diperolehi adalah serupa dengan apa yang diperolehi dengan madu Gelam, 
dan ini menyediakan bukti untuk potensi terapeutik yang serupa.  
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CHAPTER 1. INTRODUCTION 
 
1.1. General overview 
 Sepsis is defined as a type of systemic inflammatory response syndrome (SIRS) 
caused by microbial infection (Kibe et al., 2011; Matsuda N, 2006). Sepsis has systemic 
effects, including hemodynamic and cardiovascular instability, decreased ejection 
fraction, and reduced systemic vascular resistance, which are indistinguishable from the 
signs of acute inflammation (Wilson et al., 1998; Yoon, 2012). Inflammation is an 
immune response that occurs in the tissue. It is a nonspecific reaction to any cell-
injuring agent, either physical (such as heat or cold), chemical (such as a concentrated 
acid or alkali or any other caustic chemical), or microbiological.  It has a rich history 
intimately linked to war wounds and infections (Goris, 1996; Seth et al., 2012). 
Although the complex pathophysiology of acute and chronic inflammation is gradually 
becoming better understood, in modern hospitals, acute inflammation continues to be a 
main threat to patient health. Local inflammation is tightly regulated by the immune and 
nervous systems, combating invading pathogens and removing injured cells. If the local 
inflammatory response fails to contain the insults, systemic inflammation may occur. In 
general, SIRS is an entire normal response to injury or infection. It may lead to 
excessive leukocyte activation, multiple organ dysfunction syndromes (MODSs), organ 
failure, and ultimately death. At the late irreversible stage, even the removal of initial 
local inflammatory stimulus may have no effect on the progression of organ failure and 
mortality (Fernandes et al., 2012; Latifi SQ, 2002; Milam et al., 2010). Moreover, acute 
inflammation and sepsis share many inflammatory mediators (Kuper et al., 2012; 
MacGarvey et al., 2012; Seija et al., 2012; Setoguchi et al., 2012). Neutrophil 
infiltration and activation is a hallmark of SIRS. Neutrophils play an important role in 
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host defense by releasing many proteolytic enzymes and producing free radicals such as 
reactive oxygen species (ROS) to degrade internalized pathogens. However, excessive 
production of these lytic factors by overwhelming numbers of activated neutrophils may 
correlate with host tissue damage and organ failure during sepsis. The incidence of 
sepsis and the number of sepsis-related deaths are increasing; previous studies have 
confirmed that there are more than 750,000 cases of severe sepsis per year in the United 
States, resulting in an annual national hospital cost of $16.7 billion (Angus et al., 2001). 
Therefore, new immune-modulating therapeutic approaches for sepsis are needed to 
control neutrophil migration and infiltration during sepsis; reduce systemic cytokines, 
NO, and HMBG1; induce HO-1 activation and thus increase the survival rate. 
The aim of the present study is to validate the hypothesis that modulation of immune 
response during sepsis with natural products such as honey can protect against systemic 
inflammatory response, using animal models of inflammation and sepsis. Moreover, our 
study also aims to reveal some underlying activities of these natural products in vitro 
and in vivo through monitoring their effects on cytokines, HMGB1, NO, HO-1, 
myeloperoxidase, and on peroxynitrite scavenging, as well as on systemic inflammatory 
response during sepsis development and, consequently, on the survival rate of animals. 
 This study looked into the extraction of Gelam honey and evaluation of the anti-
inflammatory activity of these extracts. Honey extracts were analyzed using liquid 
chromatography-mass spectrometry (LC-MS) to identify phenolic compounds and then 
the extracts were also tested for their effects on tumor necrosis factor alpha (TNF) 
cytotoxicity in L929 cells and nitric oxide in RAW 264.7. The major phenolics in the 
extracts were ellagic, gallic, and ferulic acids, myricetin, chlorogenic acid, and caffeic 
acid. Other compounds found in lower concentrations were hesperetin, p-coumaric acid, 
chrysin, quercetin, luteolin and kaempferol. Honey and its extracts inhibited NO during 
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immune response and   protection from TNF cytotoxicity. Rats’ paws induced with 
carrageenan in the non-immune inflammatory and nociceptive model, and 
lipopolysaccharide (LPS) in the immune inflammatory model inhibited edema and pain 
in inflammatory tissues as well as showing potent inhibitory activities against NO and 
PGE2 in both models. The decrease in edema and pain correlates with the inhibition of 
NO and PGE2. Phenolic compounds have been implicated in the inhibitory activities. 
However, local immune response is not like systemic inflammatory response syndrome 
such as sepsis so we have to confirm if Gelam honey can protect from sepsis. We 
investigated the effect of the intravenous injection of honey in rats with LPS-induced 
sepsis. The results showed that after 4 h of treatment, honey reduced cytokine (tumor 
necrosis factor-α, interleukins 1β, and 10) and NO levels and increased heme 
oxygenase-1 levels. After 24 h, a decrease in cytokines and NO and an increase in HO-1 
were seen in all groups, whereas a reduction in HMGB1 occurred only in the honey-
treated groups as well as Honey-treated rats which showed reduced mortality after 
sepsis compared with untreated rats. We then investigated the role of Gelam honey 
against sepsis-induced organ failure. Treatment with honey showed protective effects on 
organs through the improvement of organ blood parameters, reduced infiltration of 
neutrophils, and decreased myeloperoxidase activity. Honey-treated rabbits also showed 
reduced mortality after sepsis compared with untreated rabbits. Honey may have a 
therapeutic effect in protecting organs during sepsis. During immune response and 
sepsis cell produces a high toxic and oxidant molecules that lead to cell death and 
tissues damage. Peroxynitrite is a short-lived oxidant and a potent inducer of cell death.  
It induces lipid, protein and DNA damage and the potential biological targets of 
peroxynitrite include membrane as well as cytosolic and nuclear receptors. Conditions 
in which the reaction products of peroxynitrite have been detected and in which 
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pharmacological inhibition of its formation or its decomposition have been shown to be 
of benefit include sepsis, vascular diseases, ischaemia–reperfusion injury, inflammation, 
pain and neurodegeneration, therefore  we further showed the ability of Gelam honey to 
scavenge peroxynitrite
 
during sepsis and immune responses mounted in the murine 
macrophage cell line RAW 264.7 when stimulated with lipopolysaccharide/interferon-γ 
(LPS/IFN-γ) and in LPS-treated rats and also significantly improved the viability of 
LPS/IFN-γ–treated RAW 264.7 cells and inhibited nitric oxide production—similar to 
the effects observed with an inhibitor of inducible nitric oxide synthase. Furthermore, 
honey inhibited peroxynitrite production from the synthetic substrate 3-
morpholinosydnonimine (SIN-1) and prevented the peroxynitrite-mediated conversion 
of dihydrorhodamine 123 to its fluorescent oxidation product rhodamine 123. Honey 
inhibited peroxynitrite
 
synthesis in LPS-treated rats and thus, honey may attenuate 
inflammatory responses that lead to cell damage and death, suggesting its therapeutic 
uses for the pharmacological strategies to attenuate the toxic effects of peroxynitrite in 
immune response and sepsis.   
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CHAPTER 2. LITERATURE REVIEW 
2.1. Sepsis 
The word “sepsis” is derived from the Latin origin sepsios, meaning musty; it is 
a condition that is not accepted passively by living organisms. The discovery of 
microbes in 1674 by Antony van Leeuwenhoek was the main event that helped 
elucidate the origin of sepsis. The determination of the body’s systemic responses to 
defend itself against microbial pathogens and their toxins took several hundred years of 
rigorous studies (Hoffmann et al., 1999). Sepsis is a systemic inflammatory process 
caused by infection. It develops from SIRS, and severe sepsis then leads to MODS. An 
epidemiological study has reported that more than 750,000 patients develop sepsis 
annually in the United States alone (Angus et al., 2001), with an estimated cost per year 
for treatment of $18 billion. The mortality rate of sepsis high, i.e., from 30% to 50% 
(Riedemann et al., 2003). It affects the whole body, with the most common sites of 
infection being the lungs, abdominal cavity, urinary tract, and primary infections of the 
bloodstream (Agnello et al., 2002). Invading pathogens, including gram-negative and 
gram-positive bacteria, viruses, parasites, and fungi, may be the initial cause of sepsis. 
The immune response starts in the innate immune system, which employs special 
receptors to recognize the highly conserved components of these pathogens, i.e., 
pathogen-associated molecular patterns (PAMPs). The Toll-like receptors (TLRs) are 
the most important of these receptors. They consist of many members, most of which 
are expressed in human neutrophils (Hayashi, 2003). TLR4 acts as the central receptors 
for LPS, whereas TLR2 acts as the main receptor for gram-positive cell wall 
components, yeast cell wall zymosan, and mycobacterial cell wall components 
(Hildebrand et al., 2012; Underhill, 1999). After the TLRs are activated by their ligands, 
MyD88 is associated with TLR complex as the adaptor molecule, which leads to the 
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formation of the TNF-associated factor 6 (TRAF6)/IL-1 receptor associated kinase 4 
(IRAK4)/IRAK-1 complex (Ye, 2002). This complex interacts with another complex 
comprising transforming growth factor-beta-activated kinase 1 (TAK1), TAK1-binding 
protein 1 (TAB1), and TAB2 (Shibuya, 1996; Takaesu et al., 2000). TAK1 is 
subsequently activated in the cytoplasm, leading to the activation of I kappa B kinase 
kinases (IKKs) (Shibuya, 1996). IKK activation leads to phosphorylation and 
degradation of I kappa B, translocation of NF-κB into the nucleus, and upregulation of 
inflammatory cytokines. TLRs activate many cells such as neutrophils, macrophages, 
and epithelial and endothelial cells to produce inflammatory mediators including 
cytokines (TNF-α, IL-1β, etc.) and NO. The expression of adhesion molecules on 
endothelial cells is induced either directly by TLR activation or indirectly through the 
proinflammatory cytokines TNF-and IL-1 (Parker et al., 2005) . These events promote 
neutrophil migration to the site of inflammation during sepsis. 
2.2. Immune response to sepsis 
Neutrophils have a key regulatory role in vascular inflammation. The hallmark of 
MODS or acute respiratory distress syndrome (ARDS) is infiltration of neutrophils into 
the microvasculature of the organ involved, such as the lung (Phillipson & Kubes, 2011; 
Shah et al., 2010). Sepsis causes endothelial injury and neutrophil infiltration into 
tissues, leading to local injury, disturbed capillary blood flow and enhanced 
microvascular permeability, disseminated intravascular coagulation, circulatory 
collapse, hypoxia and, ultimately, multiple organ failure (Cohen, 2002). Sepsis-induced 
acute lung injury (ALI) remains a major clinical problem with significant morbidity and 
mortality (Razavi et al., 2004). A pathological hallmark of acute lung injury is 
subsequent tissue infiltration of neutrophils and pulmonary microvascular sequestration 
(Kindt et al., 1991; Tate & Repine, 1983). Enhanced pulmonary neutrophil 
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sequestration and infiltration during sepsis changes the neutrophil profile by increasing 
neutrophil surface expression and activating cell-cell adhesion molecules, and 
enhancing the release of soluble mediators, production of cytokines, and generation of 
reactive oxygen species, NO, and ONOO
−  
(Brown et al., 1995; Goode & Webster, 
1993; Novelli, 1997; Skoutelis et al., 2000). Neutrophils express adhesion molecules 
that enable them to adhere to the microvascular endothelium and sequester in vital 
organs. Various proinflammatory mediators released during the sepsis response are 
supposed to increase and activate the expression of adhesion molecules on the surface 
of both neutrophils and endothelial cells, such as intracellular adhesion molecule-1 
(ICAM-1) and β1-integrins CD11/CD18 (Alves-Filho et al., 2006). The toxicity of 
PMNs stems not only from their adhesive and migratory properties but also from their 
ability to generate ROS. The mechanism of ROS generation is assumed to involve 
nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) stimulation of 
neutrophils with TNF-α, IL-1β, and LPS, which results in the assembly of the NADPH 
complex and the production of the superoxide radical (AW, 2006). NADPH is a 
membrane-bound enzyme that catalyzes the formation of superoxide anion from 
molecular oxygen. Superoxide is subsequently converted to hypochlorous acid and 
hydrogen peroxide, which are both unstable and highly reactive oxygen species. ROS 
produced by neutrophils are capable of direct DNA damage, lipid peroxidation, and 
interference with actin metabolism, leading to changes in cellular function and organ 
damage. NADPH inhibition by apocyanin has been shown to decrease lung injury in 
guinea pigs (Deng et al., 2012; Grommes & Soehnlein, 2011). The NO synthase (NOS) 
pathway is another pathway that may also be involved in the generation of free radicals 
by neutrophils. NO knockout mice have been shown to have decreased lung injury when 
injected with LPS. Phenolic compounds reduce sepsis-induced remote organ injury, at 
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least in part, through their ability to balance oxidant-antioxidant status, to inhibit 
neutrophil infiltration and to regulate the release of inflammatory mediators (Kolgazi et 
al., 2006). Cells of the monocyte/macrophage family are the basis of the innate immune 
system; they play a vital role in the immune response against microorganisms. 
Monocytes derived from bone marrow circulate in the blood for less than 48 hours and 
enter tissues to differentiate into macrophages. Macrophages perform different 
biological activities depending on the type of the tissue microenvironment. 
Macrophages have a longer life span and more heterogeneous functions than monocytes 
(Wu et al., 2005). Although the role of an innate immune reaction is to eradicate the 
invading microorganisms, a hyperinflammatory monocyte system contributes to the 
etiology and progression of SIRS. Macrophages are critical in recognizing LPS, 
lipoteichoic acid (LTA), or other bacterial components through various pattern 
recognition cellular receptors such as the Toll receptors. The interaction between 
macrophages and pathogens results in the beginning of inflammatory mediators and 
coagulation cascades. These pathways produce many soluble mediators that function in 
autocrine or paracrine loops and further activate the proinflammatory cascades (Panda 
et al., 2012). Macrophages can release a series of inflammatory mediators, including IL-
1, IL-6, TNF-α, platelet activating factor (PAF), eicosanoids, NO, and ROS, when 
stimulated with bacterial products (Bergenfelz et al., 2012; Kleiman et al., 2012; Risco 
et al., 2012; Vandevyver et al., 2012). They are also a source of intracellular superoxide 
and hydrogen peroxide (H2O2), responsible for killing phagocytosed microorganisms. 
During sepsis, macrophages exist in an overactive state and can release some 
inflammatory mediators and ROS that contribute to tissue damage (Van Amersfoort et 
al., 2003) . Further, activated macrophages increase their expression of CD40 and TNF-
α receptors, and secrete TNF-α. This autocrine stimulus synergizes with interferon-γ 
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(IFN-γ) secreted by T helper 1 (TH1) cells to increase the antimicrobial action of the 
macrophage, in particular by inducing the production of NO and ROS (Van Amersfoort 
et al., 2003). Previous studies showed that natural product such as flavonoids, phenolic 
acid and polyphonic inhibit the activation of macrophage through NF-κB activity or 
DNA binding, IKK, COX2, iNOS and cytokines inhibition (Cho et al., 2003; Jeong & 
Jeong, 2010; Joo et al., 2012; Kanters et al., 2003; Sgambato et al., 2001). 
TNF-α is produced by monocytes and macrophages after inflammation; it is a 
pivotal cytokine in the pathogenesis of inflammatory diseases. It is the major early 
mediator of sepsis and has been reported to have role in the development of MODS in 
sepsis (Mira et al., 1999; Qiu et al., 2011). Two hours after exposure to LPS, TNF-α 
will be in its highest level in serum where it can activate many cell types; initiate the 
proinflammatory cascade with up-regulation of adhesion molecules on neutrophils; and 
stimulate the release of IL-1, IL-6, eicosanoids, and PAF, among others (Agnello et al., 
2002), thus initiating inflammatory cell migration into tissues. TNF-α upregulates 
phospholipase A2, cyclooxygenase, and NOS (Bhatia & Moochhala, 2004) . It is a 
potent activator of NF-κB. and TNF-α antibodies and soluble TNF-α receptors have 
been used in humans . Furthermore, it has been confirmed that neutralized monoclonal 
antibodies against TNF‐α can diminish the production of some inflammatory mediators 
and other proinflammatory cytokines (Brennan FM, 1989). Reactive oxygen species 
(ROS) play a critical role in mediating TNF-α-induced cytotoxicity (Kunnumakkara et 
al., 2008). It was shown that such cytotoxicity can be blocked by specific free radical 
scavengers (Goossens et al., 1995). Previous research has reported that Malaysian 
honey has free radical scavenging activity (Aljadi & Kamaruddin, 2004). Therefore, it is 
believed that the free radical scavenging capacity of flavonoids identified in the honey 
extracts may play a role in protecting cells from this cytotoxicity (Middleton et al., 
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2000). In fact, Habtemariam (Habtemariam, 2000)  reported that phenolics, such as 
caffeic acid, effectively inhibit TNF-induced cytotoxicity in L929 cells. It also inhibits 
TNF in vivo and reducing the mortality in sepsis (Fidan et al., 2007). 
 IL-1β is a proinflammatory cytokine produced by many cell types, such as 
monocytes/macrophages, fibroblasts, and endothelial cells, and is involved in 
inflammatory and immunological processes (Dinarello, 2011b) . It has a vital role in 
endotoxemia and also contributes to the development of severe sepsis and MODS, and 
induces the production of other cytokines and inflammatory mediators involved in 
sepsis (CA, 2000; Dinarello, 2011a; Yoza & McCall, 2011). Further, an IL-1 receptor 
antagonist (IL-1ra) has been characterized to be structurally related to IL-1, and in vitro 
has been demonstrated to protect against endotoxin-induced lung injury in rats and to 
improve survival rate after lethal endotoxemia in mice (Dinarello, 2011a; Tsuchiya et 
al., 2012). There are some  natural product such as ethanol extract of propolis , 
mushroom and  Epigallocatechin-3-gallate, a Green Tea-Derived Polyphenol, ellagic 
acid  have been shown a potent inhibiting of IL-1 β (Blonska et al., 2004; Jedinak et al., 
2011; Wheeler et al., 2004; Yu et al., 2007). 
IL-6 is a pro- and anti-inflammatory cytokine. It is produced by 
macrophages/monocytes, endothelial cells, and smooth muscle cells, and its expression 
increases in response to endotoxin, TNF-α, and IL-1β (Agnello et al., 2002). IL-6 is an 
important cytokine that is up-regulated during sepsis (Gouel-Cheron et al., 2012; 
Kruttgen & Rose-John, 2012). It has been demonstrated to increase in post-burn injuries 
and after surgery (Nijsten et al., 1991) . It mediates the synthesis of acute phase 
proteins, including C-reactive protein (CRP) (Castell JV, 1989). Serum IL-6 level is a 
biomarker that can be used in identifying patients at risk of progression to sepsis, severe 
sepsis, septic shock, and MODS early in the infective and inflammatory processes (Qiu 
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et al., 2012).  Natural product such as green tea , propolis ,some phenolic compounds 
from plant such as (-)-epigallocatechin-3-gallate, chrysin, quercetin and resveratrol  
have shown a potent inhibition of IL-6 and protect from sepsis (Cernada et al., 2012; 
Lin et al., 2010; Liu et al., 2005; Woo et al., 2005; Zhong et al., 1999). 
IL-10 is anti-inflammatory cytokine produced mainly by monocytes/macrophages 
and, to a lesser degree, by lymphocytes. It plays an important role in sepsis (Howard, 
1993; Standiford, 1995). It has been identified as a vital modulator of the lethal 
excessive production of inflammatory cytokines. It inhibits the in vitro synthesis of IL-
1α, IL-1β, TNF-α, and IL-6 (de Vries, 1995; Fiorentino et al., 1991). It is an important 
mediator of endotoxemia-induced immunosuppression, and is a critical mediator of 
macrophage and leukocyte deactivation during LPS desensitization and endotoxemia 
(Pils et al., 2010; Steinhauser et al., 1999; Urbonas et al., 2012). Administration of 
recombinant IL-10 has been shown to significantly protect animals from sepsis (Gerard, 
1993; Hickey et al., 1998; Standiford, 1995). IL-10 is a potent suppressor of 
macrophage production of important activating and/or chemotactic cytokines 
(Cassatella, 1993; Kasama, 1994; Rolph, 1992). Furthermore, in vitro, IL-10 cytokine 
directly inhibits neutrophil and macrophage bactericidal activity and phagocytosis 
(Laichalk, 1996; Ocuin et al., 2011; Oswald, 1992). Both in humans and in animal 
models, the period that follows septic events has been shown to result in the preferential 
expression of anti-inflammatory cytokines, particularly IL-10 (O’Sullivan, 1995). IL-10 
administration in animal models of SIRS has been shown to protect from organ injury; 
no animal studies are available to date (Mittal et al., 2010) . HMGB1 is a ubiquitous 
nuclear factor released by activated immune cells such as neutrophils and macrophages; 
it mediates organ damage in severe sepsis and is released by necrotic cells (Wang, 1999; 
Yang, 2004). HMGB1 has been implicated in some diseases such as 
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ischemia/reperfusion injury of the lung and liver (Wang H, 1999). It is capable of 
stimulating the release of proinflammatory cytokines, such as TNF, and upregulating 
endothelial adhesion (Andersson et al., 2000). It also contributes to activation of 
NADPH oxidase via a TLR4 signaling pathway in PMNs (Fan et al., 2007) . HMGB1 is 
a necessary and sufficient mediator of organ damage in severe sepsis (Chavan et al., 
2012). It has been shown that administration of HMGB1 to experimental animals causes 
epithelial cell dysfunction and lethal organ damage (Wang, 1999; Yang, 2004). In 
contrast, administration of anti-HMGB1 antibodies prevents epithelial dysfunction and 
organ damage during sepsis in mice (Chavan et al., 2012). Previous studies showed that 
polyphenolic compounds (-)-epigallocatechin-3-gallate  from green tea, oleanolic acid 
inhibited HMGB and protect from sepsis (Kawahara et al., 2009; Li et al., 2007). 
Hemeoxygenase (HO) is an enzyme that catalyzes the degradation of heme to 
produce biliverdin, iron, and carbon monoxide. HO consists of constitutive and 
inducible isozymes (HO-1, HO-2) (Ryter et al., 2006). HO-1, which is released during 
endotoxemia, is a protein associated with oxidative stress protection. HO-1 is regulated 
by apoptotic stimuli, including heme, TNF-α, and apoptotic compounds. It has 
antiapoptotic, antioxidant, and immunomodulatory functions (MacGarvey et al., 2012; 
Ryter et al., 2006). Upregulation of HO-1 inhibits the release of cytokines, HMGB1, 
and NO, which may have a protective effect against the effects of endotoxemia in rats. 
HO-1 protects against severe inflammation, and its upregulation has been shown to 
inhibit the release of cytokines (e.g., TNF-α and IL-1β), HMGB1, and NO, which may 
have a protective effect against endotoxemia in animals (Bortscher et al., 2012; Yu & 
Yao, 2008). HO-1 also inhibits NF-B, thereby modulating cytokine release and 
inhibiting inducible NOS, with a subsequent decrease in NO (Bellezza et al., 2012; 
Brouard et al., 2002; Carchman et al., 2011). Flavonoids were shown to induce HO-1 
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gene expression (Scapagnini et al., 2002). Similarly, potent HO-1-inducing abilities 
were identified in other natural products (such as (-)-epigallocatechin-3-gallate 
(EGCG)); moreover, these natural products include immunomodulators of LPS-induced 
HMGB1 release, and their administration increases the survival of HO-1-deficient mice 
(Li et al., 2007; Takamiya et al., 2009). 
Prostaglandin is a very important mediator of all types of inflammation. It is 
synthesized by the enzyme cyclooxygenase (COX) which is stimulated in the 
inflammatory phase by pro-inflammatory mediators, such as cytokines, LPS and 
carrageenan. Previous studies have shown that COX-2 is responsible for increased 
prostaglandin production in inflamed tissue (DeWitt, 1991). Previous studies have 
shown that phenolic compounds inhibited COX-2 such as phenolic acid and flavonoids 
(Yang et al., 2009). Honey has been proven to have a potent activity against gastritis 
and stomach ulcers (Kandil  et al., 1987b). Specific inhibition of COX-2 expression at 
the transcriptional level is a potent mechanism in the treatment of inflammatory disease 
(O'Banion et al., 1992). It is possible that honey and its extracts are selective inhibitors 
of COX-2 because honey has no side effects on the gastrointestinal system. In relation 
with the above results, the inhibition of PGE2 by honey extracts is more pronounced. 
Ellagic acid has an inhibitory effect on PGE2 release from monocytes and other 
phenolic compounds in such as quercetin, chrysin and luteolin which have been 
demonstrated to have  inhibitory effects on interleukin, 1β, and cyclooxygenase-2 
(COX-2) expression, prostaglandin E2 (PGE2) synthesis and NF-κB (Gutierrez-Venegas 
et al., 2007; Romier et al., 2008). Nitric oxide (NO) is a pleiotropic mediator of 
inflammation and was first discovered as a factor released from endothelial cells that 
causes vasodilatation by relaxing vascular smooth muscle (Furchgott, 1980). It has a 
short half-life (5–10 seconds), is derived from L-arginine, and is rapidly converted to 
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nitrate and nitrite after being secreted (Boveris A, 2002). NO is synthesized by the NOS 
family of enzymes, which includes the calcium-independent, inducible isoforms and the 
calcium-dependent, constitutive (cNOS) isoforms (Wang et al., 2012). It plays a 
controversial role in sepsis and septic shock. It has vasodilatory effects in sepsis 
(Landry & Oliver, 2001) ; has pro- and anti-inflammatory as well as antioxidant and 
oxidant properties (Enkhbaatar et al., 2009; Wink et al., 2001); and acts as a “vital 
poison” in the immune and inflammatory network (Dugas et al., 1995) . NO also causes 
increased leukocyte adhesion in the liver and lungs, as well as inhibits acute-phase 
protein production. The late phase of hypotension, cellular suffocation, apoptosis, 
vasoplegia, lactic acidosis, and multi-organ failure in endotoxic shock or severe sepsis is 
implicated with the levels of NO and its derivatives such as (ONOO-) (C, 2003). LPS 
was found to increase endothelial NO release, further suggesting that NO may be 
responsible for induction of hypotension in severe sepsis. NO is therefore a key 
contributory mediator of tissue damage in SIRS (Ishikawa et al., 2012; Iskit & Guc, 
2003). An understanding of the biological, pharmacological, and pathological activity of 
NO during inflammatory diseases and sepsis has provided a new strategy for identifying 
therapeutic targets in the management of sepsis (Anderson, 2012). Nitric oxide (NO) is 
known to be an important mediator of inflammation (Misko et al., 1993). Inducible 
nitric oxide synthase (iNOS) is the enzyme responsible for NO production in the 
inflammatory response. Aminoguanidine, a highly selective inhibitor of iNOS (Romier 
et al., 2008), totally inhibited NO production in activated macrophages at 1mM. 
Similarly, HME and HEAE dose-dependently inhibited the production of NO without 
affecting the viability of RAW 264.7 cells. Some flavonoids, including hesperetin, and 
naringin; induce HO-1 and can inhibit LPS-induced NO production. Moreover, 
genistein, kaempferol, quercetin, and daidzein inhibit the activation of the signal 
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transducer and activator of transcription 1 (STAT-1), another important transcription 
factor for iNOS (Hamalainen et al., 2007). Additionally, quercetin, caffeic acid, chrysin, 
ellagic acid and various polyphenolic compounds are known for their down-regulation 
of NF-κB (Del Boccio & Rotilio, 2004), this in turn reduces biosynthesis of iNOS, and 
ultimately inhibits the production of nitric oxide. Most of the phenolic compounds 
mentioned above were identified in this study; it can therefore be assumed that the 
inhibition of nitric oxide production by the honey extracts was due to these compounds. 
Although the concentrations of the phenolics identified were higher in HME, the in vitro 
anti-inflammatory activity seemed to be better for HEAE. It was reported that ethyl 
acetate extracts will contain a higher concentration of bioactive compounds; an example 
being the anti-inflammatory compound caffeic acid phenethyl ester (CAPE) (Del 
Boccio & Rotilio, 2004; Habtemariam, 2000; Song et al., 2002). This supports the 
observation that HEAE showed better activity. Peroxynitrite (ONOO
-
) is produced by 
the reaction of superoxide and nitric oxide; it is a short-lived and highly oxidant 
molecule. Its decomposition to nitrate and nitrite is intimately coupled with the redox 
biochemistry of this species. It is a very active molecule and targets all parts of the cell 
from the membrane to the nucleus. Peroxynitrite levels increase during inflammation, 
which leads to the inactivation of interleukins and decrease in inducible NOS activity 
(Freels, 2002; Lanone, 2002; Zouki, 2001). Also, peroxynitrite enhances nuclear factor-
κB (NFκB)-mediated proinflammatory activity (Seija et al., 2012; Shacka, 2006). It is a 
potent inducer of cell death through different pathways such as MLK/p38/JNK, and 
stimulates the release of apoptosis-inducing factor (AIF) from the mitochondria, which 
subsequently triggers DNA fragmentation processes (Hao et al., 2011; Shacka, 2006; 
Zhang, 2002). Some physiological inhibitors of peroxynitrite, such as uric acid, have 
been used in many studies and showed valuable effects in animal models of 
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inflammation, sepsis and reperfusion injury (Kooy, 1994; Lanone, 2002; Nin et al., 
2011; Robinson, 2004; Scott, 2002, 2005; Seija et al., 2012; Soriano et al., 2011; 
Whiteman, 2002). Recent studies show that peroxynitrite stimulates the release of the 
mitochondrial apoptosis-inducing factor, which subsequently triggers DNA 
fragmentation (Zhang et al., 2002), release of mitochondrial pro-apoptotic factors, and 
cytochrome c-dependent apoptosis in the cytosol through peroxynitrite-dependent 
oxidation of the mitochondrial permeability transition pore. The key role of 
peroxynitrite in promoting mitochondrial dysfunction is clearly exemplified in 
experimental sepsis, in which peroxynitrite production results in the inhibition of 
mitochondrial respiration in the diaphragm in a process associated with mitochondrial 
protein nitration. The latter is prevented by NO synthase inhibitors and Mn-porphyrin 
therapy (Nin et al., 2004). Peroxynitrite-induced activation of the MLK/p38/JNK 
pathway also plays a crucial role in apoptosis (Dubuisson et al., 2004; Rhee et al., 2005; 
Trujillo et al., 2004). Earlier studies showed that inhibit NO production, and thus 
peroxynitrite formation, thereby reducing the effects of these cytotoxic compounds both 
in vitro and in vivo. Moreover, scavengers of peroxynitrite are known to be protective 
against tissue damage (Szabo et al., 2007). Some scavengers of peroxynitrite, such as 
uric acid, ebselen, mercaptoalkylguanidines, N-acetylcysteine, and dihydrolipoic acid, 
and some chemicals that work as decomposition catalysts of peroxynitrite, such as 
metalloporphyrins of iron and manganese, can attenuate the toxic effects of 
peroxynitritein vitro and in vivo (Daiber et al., 2000; Hooper et al., 1998; Klotz & Sies, 
2003; Lancel et al., 2004; Noiri et al., 2001; Ploner et al., 2001; Scott et al., 2005; 
Spitsin et al., 2000; Szabo, 2003; Szabo et al., 1997). These compounds can reduce 3-
nitrotyrosine immunoreactivity in various pathophysiological conditions and have 
beneficial effects in animal models of inflammation, sepsis, and reperfusion injury 
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(Beckman, 1996; Briviba et al., 1996; Brodsky et al., 2004; Crow, 2000, 2006; Nin et 
al., 2004; Noiri et al., 2001; Tabuchi et al., 1995; Wang et al., 2003). Many phenolic 
compounds such as gallicacid, caffeic acid, kaempferol, ferulic acid, p-coumaric, and 
quercetin have been shown to inhibit peroxynitrite. Monohydroxylated phenolic 
compounds, such as ferulic acid and p-coumaric acid, act as peroxynitrite scavengers by 
nitration. On the other hand, compounds with a catechol moiety, such as caffeic acid 
and chlorogenic acid, reduce peroxynitrite by electron donation (Klotz & Sies, 2003; 
Pannala et al., 1998).  
2.3. Multiple Organ Dysfunction Syndromes (MODSs) 
MODSs arise because of uncontrolled immune-inflammatory response and is 
characterized by generalized and persistant inflammation. This process results in 
cellular damage at the level of the endothelium, decreasing the endothelial permeability 
to fluid, proteins, and cells, as well as to gut bacteria. Cytokine and coagulation 
cascades are promoted, resulting in microvascular thrombosis and infiltration of organs 
with various leukocytes. Cellular death occurs in local and regional environments 
secondary to hypoxia, causing further release of toxic oxygen species and inflammatory 
mediators (Emura & Usuda, 2010; Luo et al., 2009). Thus, both hemorrhagic as well as 
septic shock have been recognized as the leading causes of MODS. In the 1980s, 
however, MODS was thought to arise secondarily to an overwhelming infectious 
process. Approximately 90% of multiple organ failure MOF in these patients was due to 
a septic source (Emura & Usuda, 2010). To date, several studies have concluded that 
MODS after a trauma represents the bridge from mild organ dysfunction to death; 
however, the process itself begins as early as within 24 hours of the original insult. 
Coagulopathy ensues, as well as hyperglycemia, dysfunction of the gut, and adrenal 
insufficiency, followed by CNS dysfunction and eventually death (de Montmollin & 
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Annane, 2011). Septic shock is the main cause of MODS in intensive care units, and the 
intensity of MODS is correlated directly to mortality (Carrillo Esper et al., 2011; de 
Montmollin & Annane, 2011). Former studies showed that phenolic compounds such as 
Caffeic acid phenethyl ester and thymoquinone protect organs from sepsis-induced 
injury (Alkharfy et al., 2011; Fidan et al., 2007). 
2.4. Animal models of inflammation and sepsis 
Many animal models are used to study acute and chronic inflammation. In acute 
inflammation, the most common models are paw and ear edema induced with various 
chemicals such as carrageenan (Kumar & Kuttan, 2009; Murta & Ferrari, 2012; Nikota 
& Stampfli, 2012; Ogino et al., 2009; Tweedie et al., 2012), acetic acid (Whittle, 1964), 
xylene (Kou et al., 2005), phorbolmyristate acetate (Griswold et al., 1998), formalin 
(Wheeler-Aceto et al., 1990), and oxazolone (Beaulieu et al., 2007); some enzymes and 
fatty acids; histamine (Amann et al., 1995) and arachidonic acid (Romay et al., 1998); 
and components of bacterial cell wall such as LPS. In chronic inflammation, the most 
commonly used model is cotton pellet-induced granuloma (Shahavi & Desai, 2008). 
Sepsis models can be divided into exogenous administration of a toxin (such as LPS or 
endotoxins), a viable pathogen such as bacteria, or by alteration of the animal’s 
endogenous protective barrier (inducing colonic permeability, allowing bacterial 
translocation) (Buras et al., 2005; Li et al., 2011; Orman et al., 2011, 2012; Sadowitz et 
al., 2011). LPS is a major constituent of gram-negative bacterial cell walls. It typically 
consists of lipid A and O-antigen. LPS is found both on the surface of phagocytic cells 
and as soluble proteins in the bloodstream. It is scavenged by neutrophils and 
macrophages through complex mechanisms and is transported by LPS-binding protein 
as well as membrane-bound or soluble CD14, enabling its interaction with TLRs on the 
phagocyte membrane. CD14 is a receptor of LPS in mice and in humans. The prototype 
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model for innate immune responses is leukocyte activation by LPS. Gram-negative 
bacterial infection accounts for approximately 60% of cases of sepsis in humans , and it 
causes sepsis in animal models (Brudecki et al., 2012). LPS has an important role in the 
pathogenesis of sepsis, and it is a highly stable and toxic molecule. It can activate 
numerous cells of the immune system to produce proinflammatory cytokines (e.g., 
TNF-α, IL-1, IL-6, IL-8, IL-12, and IFN) and ROS. Understanding the physiological 
effects of LPS on the cellular and molecular levels holds the key to understanding the 
responses of innate immunity (Merrill et al., 2011; Yamanishi et al., 2012). Cecal 
ligation and puncture (CLP) belongs to the endogenous category and is considered the 
best standard for sepsis research (Parker & Watkins, 2001). The CLP model was 
designed to simulate ruptured appendicitis or perforated diverticulitis in humans (Jung 
et al., 2012). The technique involves midline laparotomy, exteriorization of the cecum, 
ligation of the cecum distal to the ileocecal valve, and puncture of the ligated cecum. 
This procedure generates bowel perforations with leakage of fecal contents into the 
peritoneum, which establishes an infection with mixed bacterial flora and provides an 
inflammatory source of necrotic tissue. The CLP technique has achieved popularity 
because of its ease of use, general reproducibility, and similarity to human disease 
progression. Most markedly, the CLP model recreates the hemodynamic and metabolic 
phases of human sepsis (Dejager et al., 2011). Moreover, apoptosis of selected cell 
types and host immune responses seem to mimic the course of human disease, adding 
further clinical validity to this model (Ayala & Chaudry, 1996; Hotchkiss & Karl, 
2003). One comparison study has shown that LPS causes a rapid induction of cytokines, 
followed by an early decline in mice, whereas CLP induces a slower sustained increase 
of cytokines in both the plasma and peritoneum, which mimic the responses in sepsis 
patients (Dejager et al., 2011). 
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2.5. Natural product 
Throughout human history, herbal medicine has formed the basis of folk 
remedies for various inflammatory ailments. The use of willow bark extract to reduce 
pain and fever was documented by a Greek physician (Hippocrates) in the 5
th
 century 
BC, and the subsequent discovery of salicylic acid as its pain/fever-relief active 
component gave rise to the first synthetic anti-inflammatory drug, aspirin, and the birth 
of the pharmaceutical industry (Yang & Landau, 2000). Honey is a sweet and viscous 
fluid produced by bees from floral nectars. It includes over 400 different chemical 
compounds, more than 95% of which mainly consist of sugars and water. Its major 
components are carbohydrates (glucose and fructose, as well as disaccharides such as 
maltose and sucrose, and trisaccharides such as melezitose (Lazaridou et al., 2004). 
Proteins, enzymes, organic acids, mineral salts, vitamins, phenolic acids, flavonoids, 
free amino acids, and volatile compounds constitute the minor components of honey 
(Alissandrakis, 2005). The moisture content in honey usually amounts to 20%, reaching, 
in some exceptional cases, almost 23% in heather honey. The characteristics of the 
moisture content depend on the water activity in the honey. In liquid honeys, water 
activity reaches values from aw = 0.53 for 15.8% of water content to aw = 0.69 for 
22.20% of water content (Sanz S., 1994). 
Honey is alluded to in the ancient Sumerian and Babylonian cuneiform writings, 
the Hittite code, the sacred writings of India (Vedas), and in the ancient writings of the 
ancient Egyptians, Chinese, Greeks, and Romans (Jackson, 1995). Muslim physicians 
use honey to heal a variety of human diseases. In the Qur’an and many Prophetic 
narrations, honey is described as a universal healing agent. “And your Lord inspired 
the bee, saying: ‘Take you habitations in the mountains and in the trees and in 
what they erect. Then, eat of all fruits and follow the ways of your Lord made easy 
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for you.’ There comes forth from their bellies a drink of varying color wherein is 
healing for mankind. Verily, in this is indeed a sign for people who think.” (Al-
Qur’an 16:68-69).The Muslim traditionalist Abu Sa’id al-Khudri related that a man 
came to the Prophet (peace and the blessings of Allah upon him) and said: “My brother 
has some abdominal trouble.” The Prophet (peace and the blessings of Allah upon him) 
said to him “Let him drink honey.” The man returned to the Prophet (peace and the 
blessings of Allah upon him) and said, “O Messenger of Allah! I let him drink honey 
but it caused him more pain.” The Prophet (peace and the blessings of Allah upon him) 
said to him, “Go and let him drink honey!” The man went and let his brother drink 
honey, then returned  back and said, “O Messenger of Allah, it did not cause him except 
more pains.” The Prophet (peace and the blessings of Allah upon him) then said, “Allah 
has said the truth, but your brother's abdomen has told a lie. Let him drink honey.” So 
he made him drink honey and he was healed (Compiled by Bukhari (a).Narrated by Ibn 
‘Abbas). The Prophet (peace and the blessings of Allah upon him) said, “Healing is in 
three things: cupping, a gulp of honey or cauterization, (branding with fire) but I forbid 
my followers to use cauterization (branding with fire).” (Bukhari (b), Muslim). It is also 
reported that the Prophet (peace and the blessings of Allah upon him) said, “Make use 
of the two remedies: honey and the Qur’an”. 
 Honey is a naturally sweet viscous fluid produced by bees from floral 
nectar. To date, more than 400 different chemical compounds have been identified in 
many varieties of honey (Lazaridou et al., 2004), including proteins, enzymes, organic 
acids, mineral salts, vitamins, phenolic acids, flavonoids, free amino acids, fatty acids 
and small quantities of volatile compounds (Gheldof et al., 2003; Weston & 
Brocklebank, 1999). Carbohydrates are the major components in honey, which are 
mainly monosaccharides such as glucose (30.31%) and fructose (38.38%). The next 
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major components are the disaccharides such as sucrose, maltose, turanose, isomaltose, 
and maltulose. In addition, honey also contains oligosaccharides (Rizelio et al., 2012; 
Sereia et al., 2011; White, 1980). Many organic acids have been discovered in honey 
including formic, butyric, gluconic, acetic, citric, maleic, oxalic, lactic, succinic, and 
pyroglutamic acids (White, 1978a), in addition to glycolic, pyruvic, α-ketoglutaric, 2- or 
3-phosphoglyceric, and tartaric acids; glucose-6-phosphate; and α- or β-
glycerophosphate. Many amino acids are also present in honey, proline being the most 
dominant (Daniele et al., 2012; White, 1978b). Some antibiotic peptides (e.g., 
lysozymes, apidaecin, and abaecin) were found in the body fluid of bees that had been 
injured and infected by bacteria, showing that honey has a nonperoxide antibacterial 
activity (Casteels, 1993; Fujiwara, 1990; Hultmark, 1996; Weston, 2000). Enzymes are 
another important constituent of honey; they play important roles in the production of 
honey from the nectar of the plant. Additionally, enzymes are heat sensitive and their 
activities are decreased during storage, which can be used as indicators of the freshness 
of honey (Crane, 1979). The enzymes in honey are known to have antioxidant 
properties. Glucose oxidase is a highly specific enzyme, the nonenzymatic hydrolysis of 
which using molecular oxygen spontaneously releases hydrogen peroxide from gluconic 
acid (Chaplin, 1990; Uhlig, 1998). Invertase (α-glucosidase) is added to the nectar by 
the bees during the process of harvesting and ripening of honey. Amylase (α- and β) 
(diastase) break down starch. Catalase breaks down hydrogen peroxide, which is 
responsible for antimicrobial activity. Moreover, acid phosphatase has been detected in 
nectar, but the activity of this enzyme in honey is not yet known. Honey contains 
several essential vitamins, particularly B, C, and E (Crane, 1979). It also contains 
several minerals including calcium, chlorine, potassium, sulfur, sodium, phosphorus, 
magnesium, silica, iron, manganese, and copper (White, 1980). The interest in phenolic 
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compounds in honey has only recently increased due to their potential roles in 
biological activity and as biochemical markers for authenticating the geographical 
(Martos, 2000b; Tomás-Barberán, 1993a) or botanical origins of honeys (Andrade, 
1997b, 1997a; Tomás-Barberán, 1989, 2001) or both (Anklam, 1998; Anklam, 2001; 
Martos, 2000b, 1997). Many groups of phenolic compounds, such as flavonoids, 
phenolic acid, and other polyphenolic compounds, are found in honey. Flavonoids are a 
group of phenolic compounds that are relatively lipophilic and act as antioxidants 
(Shahidi, 1992). Flavonoids in honey can originate from nectar, propolis, or pollen 
(Ferreres, 1992). In general, the flavonoid concentration in honey is approximately 20 
mg/kg (Ferreres, 1994c). The concentration of flavonoid in honey is much lower than in 
propolis (Bogdanov, 1989; Ferreres, 1991). More than 30 flavonoids have been 
identified in honey, such as chrysin, quercetin, luteolin, kaempferol, and apigenin 
(Boudourova-Krasteva, 1997). Many flavonoids are used to treat diseases such as 
inflammation and cancer (Jang et al., 1997). Phenolic acids act as potent antioxidants. 
Over 70 other phenolics have been identified from honey and propolis (Andrade, 1997b, 
1997a; Bankova, 1987; Joerg, 1996; Joerg, 1992, 1993; Sabatier, 1992b; Tazawa, 1999). 
The most common phenolic acids found in honeys are benzoic acids and cinnamic 
acids, and their esters such as caffeic acid and its ester caffeic acid phenyl ester 
(Sabatier, 1992a). Like flavonoids, many phenolic compounds are also used to treat 
diseases such as inflammation and cancer (Jang et al., 1997). The antimicrobial activity 
of honey has been proven by many studies. The active factors identified concerning this 
antimicrobial activity include hydrogen peroxide, phenolic compounds, and other 
chemical compounds, which are responsible for the acidity and osmolality of honey 
(White, 1963). Hydrogen peroxide was the first and the major antimicrobial factor 
discovered in honey. It has been shown to confer good protection against some harmful 
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microorganisms (White, 1963). The Malaysian Gelam honey, for example, has been 
reported to have antimicrobial activities (Aljadi A. M.  , 2003). Besides its many 
beneficial properties as discussed above, the viscosity of honey provides protection in 
the affected area, allows absorption of edema fluids, and accelerates the formation of 
new granulation tissues (Bulman, 1953). Honey is a popular wound healing dressing 
owing to its anti-inflammatory, antioxidant, and antimicrobial activities. It is also 
known to reduce pain, is nontoxic, is self-sterile, and is nutritive. Honey has been shown 
to promote wound healing in ulcer, gangrene, and skin graft (Postmes, 1997; S.E, 1993). 
Malaysian honey has been proven to stimulate fibroblast cells, activate epithelization, 
and accelerate the healing process (Aljadi A. M.  , 2003). Infections of the intestinal 
tract are extremely common. It affects humans of all ages worldwide. Honey has a 
bactericidal activity against many enteropathogenic organisms, including Shigella and 
Salmonella species and E. coli (Jeddar, 1985). Previous studies showed that a 20% 
solution of honey inhibited Helicobacter pylori in vitro. In contrast, H. pylori exhibited 
resistance to other antimicrobial agents (AT, 1991). Honey has been used to treat 
patients with gastritis, duodenitis, and duodenal ulcers. After recovery following 
treatment, it was found that the hemoglobin levels of most patients had increased and 
that fecal blood loss had decreased (Salem, 1982). Previous animal and clinical studies 
have also shown that honey reduces the secretion of gastric acid. Additionally, gastric 
ulcers have been successfully treated by the use of honey as a dietary supplement 
(Kandil  et al., 1987a). Topical application of honey has been reported to reduce 
inflammation (Subrahmanyam, 1998), edema, and exudation (Subrahmanyam, 1996). 
Honey has also been shown to reduce the number of inflammatory cells infiltrating the 
wound area (Postmes, 1997), and has been demonstrated to show anti-inflammatory 
activity . Honey  antioxidant activity is one of the most important properties of honey 
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due to the diversity of its components that can act as antioxidants (Tonks et al., 2003). 
The antioxidant sources and, consequently, the activity of these antioxidants depend on 
the flora of honey (Gheldof, 2002b). The sources of antioxidant in honey are phenolic 
compounds (e.g., flavonoids, phenolic acid, and polyphenolic acid), vitamins (e.g., 
vitamin C and E), enzymes (e.g., glucose oxidase, catalase), organic acid, carotenoid-
like substances, and Maillard reaction products (Frankel, 1998; Gheldof, 2002a; 
Gheldof, 2002c). Many studies have implicated antioxidant activity with protection 
from many diseases such as cancer and cardiovascular, autoimmune, and inflammatory 
diseases (Briviba et al., 1996; Brodsky et al., 2004; Grimble, 1994; Nuttall et al., 1999; 
Taylor et al., 1994). 
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CHAPTER 3.  RESULTS 
 
 Results are presented as compilation of all papers. 
 
3.1  Ellagic acid, phenolic acids, and flavonoids in Malaysian honey extracts 
 demonstrate in vitro anti-inflammatory activity 
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doi:10.1016/j.nutres.2This study looked into the extraction of Malaysian honey and the evaluation of the anti-
inflammatory activity of these extracts. It was hypothesized that honey extracts contain varying
amounts of phenolic compounds and that they possess different in vitro anti-inflammatory activities.
Honey extracts were analyzed using liquid chromatography–mass spectrometry to identify and
compare phenolic compounds, whereas high-performance liquid chromatography was used for their
quantification. Subsequently, honey methanol extract (HME) and honey ethyl acetate extract
(HEAE) were tested in vitro for their effect on nitric oxide production in stimulated macrophages.
The extracts were also tested for their effects on tumor necrosis factor–α (TNF) cytotoxicity in
L929 cells. The major phenolics in the extracts were ellagic, gallic, and ferulic acids; myricetin;
chlorogenic acid; and caffeic acid. Other compounds found in lower concentrations were hesperetin,
p-coumaric acid, chrysin, quercetin, luteolin, and kaempferol. Ellagic acid was the most abundant of
the phenolic compounds recorded, with mean concentrations of 3295.83 and 626.74 μg/100 g of
honey in HME and HEAE, respectively. The median maximal effective concentrations for in vitro
nitric oxide inhibition by HEAE and HME were calculated to be 37.5 and 271.7 μg/mL,
respectively. The median maximal effective concentrations for protection from TNF cytotoxicity by
HEAE and HME were 168.1 and 235.4 μg/mL, respectively. In conclusion, HEAE exhibited
greater activity in vitro, whereas HME contained a higher concentration of phenolic compounds per
100 g of honey.
© 2010 Elsevier Inc. All rights reserved.Keywords: Honey extracts; Chromatography, High-performance liquid chromatography (HPLC); Electrospray ionization
mass spectrometry (ESI mass spectrometry); Tumor necrosis factor–α (TNF); Nitric oxide (NO); Reactive oxygen
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inducible nitric oxide synthase; LC-MS, liquid chromatography–mass spectrometry; LPS, lipopolysaccharide;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MW, molecular weight; NO, nitric oxide;
OD, optical density; TNF-α/TNF, tumor necrosis factor–α.author. Tel.: +603 79492077; fax: +603 79568841.
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010.08.0081. Introduction
Honey, which is consumed worldwide, is increasingly
being used as a substitute for granulated sugar [1]. In
651M. Kassim et al. / Nutrition Research 30 (2010) 650–659addition to its sweetening properties and lower glycemic
load [2]; honey is an important natural source of antioxidants
and has potential therapeutic value in the treatment of heart
disease, cancer, cataracts, and several inflammatory diseases
[3]. The therapeutic actions of honey include antioxidant
capacity and antimicrobial properties, as well as wound-
healing and anti-inflammatory activities [4,5].
Of particular interest in this study is honey's anti-
inflammatory activity. Inflammation is a nonspecific re-
sponse of mammalian tissues to a variety of hostile agents
[6]. There are many mediators of inflammation, examples of
which are some cytokines and nitric oxide (NO). Tumor
necrosis factor–α (TNF-α) is a pleiotropic cytokine that
induces a wide range of biological effects, including
production of inflammatory cytokines, cell proliferation,
differentiation, and death [7]. Nitric oxide is known to be an
important mediator of acute and chronic inflammation [8].
Although the anti-inflammatory activity of honey has been
studied previously [9], this is the first time, to the best of our
knowledge, that the effects of Malaysian honey extracts on
TNF activity and NO inhibition have been evaluated in vitro.
Natural products present in our daily diet were revealed to be
potential chemopreventive compounds due to their ability to
adjust and modify cellular responses to abnormal proinflam-
matory stimuli [10]. In fact, flavonoids, such as those found
in many plants and honey, show various cytoprotective
effects [11,12]. It is hoped that, via empirical evidence of its
benefits, more individuals will turn to incorporating honey, a
highly nutritious and healing food, into their daily diet as a
prophylaxis for inflammation.
There are various components in honey; and its
antioxidant activity can be attributed to the following
elements: flavonoids, phenolic acids, ascorbic acid, catalase,
peroxidase, carotenoids, and products of the Maillard
reaction [13]. The quantity of these components varies
widely according to the floral and geographical origin of the
honey [14]. Phenolic compounds are one of the important
groups of compounds that occur in plants. These compounds
are reported to exhibit anticarcinogenic, anti-inflammatory,
antiatherogenic, antithrombotic, immune-modulating, and
analgesic activities, among others, and exert these functions
as antioxidants [15-17].
Because of the presence of various phenolic compounds
in honey [18], it is hypothesized that different extraction
methods and solvents will yield extracts containing differing
phenolic concentrations. Furthermore, because honey has
been used for various therapeutic purposes, we also propose
that the extracts will exhibit anti-inflammatory effects in
vitro. In addition, as it has been demonstrated that the
phenolic content of honey correlates with various biological
activities [3,19], it is then assumed that the extracts and their
differing phenolic contents will have distinctive anti-
inflammatory activities. The objectives of this study were
to identify and quantify phenolic compounds in honey, most
of which are bioactive flavonoids, subsequent to the
extraction of honey with 2 different solvents, namely,methanol and ethyl acetate. Liquid chromatography–mass
spectrometry (LC-MS) and high-performance liquid chro-
matography (HPLC) were used for the identification and
quantification of these compounds, respectively. Honey
methanol extract (HME) and honey ethyl acetate extract
(HEAE) were tested on 2 in vitro models of inflammation
with the specific aim of evaluating the extracts' ability both
to inhibit NO production by stimulated macrophages and to
protect L929 cells from TNF-mediated cytotoxicity.2. Methods and materials
2.1. Materials
Fresh Malaysian honey (Gelam, collected by Apis
mellifera; Brix value = 21%) was obtained from the National
Apiary, Department of Agriculture, Parit Botak, Johor;
Malaysia. The physical characteristics of honey were a
smooth, amber liquid appearance with a strong penetrating
odor and a solubility of 99.9% in warm water. All chemicals
and reagents used were of analytical grade.
2.2. Extraction of phenolic compounds from honey by
XAD-2 resin
The honey extract was prepared as described in previous
studies [14,20] with some modifications. Liquefied honey
(100 g) was thoroughly mixed with acidified deionized water
(500 mL), adjusted with concentrated hydrochloric acid to
pH 2 for 60 minutes (with no heating), until completely
dissolved. The resulting solution was filtered by vacuum
suction to remove particles. The filtrate was mixed with 150
g of clean, swelled XAD-2 resin and stirred slowly with a
magnetic stirrer for 60 minutes. The XAD-2 resin/honey
solution slurry was poured into a glass column (42 × 3.2 cm);
and the resin was washed at a rate of 10 mL/min with
acidified water (300 mL, pH 2), followed by rinsing with
deionized water (500 mL at 10 mL/min) to remove all sugars
and other polar constituents of honey.
The phenolic compounds adsorbed onto the column were
eluted with methanol (1000 mL, adjusted to pH 7). The
extract was concentrated to dryness on a rotary evaporator at
40°C under reduced pressure. The extract was divided into 2
portions: one was redissolved in 1 mL methanol (HPLC
grade) and filtered through a 0.45-μmmembrane filter before
HPLC analysis, whereas the other was redissolved in
deionized water (5 mL) and extracted with ethyl acetate (5
mL × 3) instead of diethyl ether [14]. It can be presumed that
ethyl acetate can extract more flavonoids and other phenolic
compounds than diethyl ether, as the former is a more polar
solvent [14]. Methanol and honey ethyl acetate extracts and
standard phenolic compounds prepared at a concentration of
100 μg/mL were evaporated to dryness by flushing with
nitrogen while being warmed on a hot plate. The dried
residues were redissolved in 1 mL methanol. The solutions
were filtered through a 0.45-μm membrane filter before LC-
MS analysis.
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Twenty microliters of each sample was injected into the
HPLC machine. The phenolic compounds were detected
using UV absorption spectra monitored at 290 and 340 nm;
the majority of honey flavonoids and phenolic acids
demonstrate their UV absorption maximum at these 2
wavelengths [14]. The column used was a reversed-phase
C18 column, Agilent ZORBAX Eclipse XDC18 (3 × 250
mm; particle size, 5 μm) (Agilent Technologies, Santa
Clara, Calif). The mobile phase constituted of 0.25% formic
acid and 2% methanol in water (solvent A) and methanol
(solvent B) at a constant solvent flow rate of 1 mL/min. The
following gradient was used according to the previously
mentioned method with minor modifications: there was an
isocratic flow through the column with 10% solvent (B) and
90% solvent (A) for 15 minutes, before increasing to 40%,
45%, 60%, 80%, and 90% at 20, 30, 50, 52, and 60 minutes,
respectively. Isocratic elution followed with 90% methanol
(B) from the 60th to 65th minute. Finally, the gradient was
changed to 10% methanol from the 65th to 68th minute; and
the composition was held until the 73rd minute. A
calibration curve of caffeic acid at 290 nm was used to
calculate phenolic acids concentrations, whereas calibration
curves of quercetin and ellagic acid at 340 nm were used for
flavonoids and other polyphenolics, respectively. This is
because the different phenolic compounds are absorbed
better at these wavelengths [14]. The calibration curves of
the standards were used to determine the concentrations of
the phenolic compounds in the extracts [21].
2.4. LC-MS condition
Analyses of phenolic compounds by LC–electrospray
ionization (ESI)–MSwere carried out using a Thermo Finnigan
LCQ ion trap mass spectrometer (Thermo Finnigan Co, San
Jose, CA) equipped with an electrospray interface. Liquid
chromatography separation was performed on a reversed-phase
Zorbax SB-C18 column (250 × 4.6 mm; particle size, 5 μm;
Agilent Technologies) at 25°C. The conditions of LC-MS were
the same as HPLC, although solvent A was replaced with 1%
acetic acid in water in the mobile phase. The UV detector was
set to an absorbance wavelength of 280 to 340 nm. The ESI
parameters were as follows (optimized depending on com-
pounds): nebulizer, 30 psi; dry gas (nitrogen) flow, 10 μL/min;
and dry gas temperature, 325°C. The ion trap mass
spectrometer was operated in negative and positive ion
modes with a scanning range of m/z 50 to 800.
2.5. Activity of honey extracts in vitro
2.5.1. Cell culture
Murine fibrosarcoma cell line L929 was purchased from
American Type Culture Collection (Manassas, VA). Murine
macrophage cell line RAW264.7 was obtained from the
Department of Biotechnology, University Putra Malaysia.
Cells were maintained in high glucose Dulbecco modified
Eagle medium (DMEM) with 10% fetal bovine serum and noantibiotics, undergoing passage every 2 to 3 days with
standard aseptic techniques. Cells from 70% to 90%
confluent flasks with greater than 90% viability were seeded
in 96-well culture plates by dispensing 100 μL per well. Cell
density was 1 × 105 (L929) or 1 × 106 (RAW264.7) cells per
milliliter of culture medium. The plates were incubated for
24 hours (L929) or 2 hours (RAW264.7) at 37°C, after which
they were treated with honey extracts and a combination of
agents, as detailed in “Section 2.5.2.”
2.5.2. Cell viability and cytotoxicity
In both assays, cell viability was assessed with the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) colorimetric assay as described by Mosmann [22]
with some modifications. Following 24-hour incubation of
the cells with the extracts and controls, culture medium was
replaced with 100 μL fresh DMEM and 20 μL of 5 mg/mL
MTT and incubated for 1 hour. Subsequently, the cell
medium was aspirated; and 100 μL of 100% dimethyl
sulfoxide was added to all wells to dissolve the insoluble
purple formazan product into a colored solution, the
absorbance of which was measured at a wavelength of 570
nm using a microplate reader (Hidex Chameleon, Turku,
Finland). The optical density (OD) of the samples was
compared with that of the negative control to obtain the
percentage viability, as follows: cell viability (%) = [(OD570
(sample)/OD570 (negative control)) × 100].
2.5.3. TNF-α cytotoxicity assays
To measure the ability of the extracts to protect against
TNF-α–induced cytotoxicity, 2 methods were used as
described in previous studies [23-25] with some modifica-
tions. In the first method, L929 cells seeded in 96-well plates
were pretreated with various concentrations of the honey
extracts (50-250 μg/mL) and actinomycin D (1 μg/mL) for 30
minutes. Tumor necrosis factor–α was added to the treated
wells at a final concentration of 1 ng/mL [23]. The same
method was applied for the second assay, but excluded
actinomycin D [25,26]. Cells treated with anti–TNF-α were
used as a positive control in both assays. The plates were
incubated for another 24 hours, after which viability was
assessed by microscope examination and the MTT colorimet-
ric assay. The viability of cells in treated wells was compared
with that of the dimethyl sulfoxide–treated negative control.
2.5.4. NO inhibition assay
Tests were prepared as described in previous studies [27,28]
with some changes. Murine macrophage RAW264.7 cells were
seeded in 96-well plates with a cell density of 5 × 104 cells per
well and incubated for 2 hours. The cells were stimulated with
interferon-γ (IFN-γ) and lipopolysaccharide (LPS) with final
concentrations of 200 U/mL and 10 μg/mL, respectively, in
DMEMwithout phenol red. Stimulated cells were treated either
with the honey extracts at different concentrations (0, 25, 50,
75, and 100 μg/mL) or with the inducible nitric oxide synthase
(iNOS) inhibitor aminoguanidine at 1 mmol/L as a positive
control; untreated cells were used as negative controls. The final
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for 16 to 20 hours at 37°C, 5% CO2.
Following incubation, NO inhibition was assessed by
quantifying nitrite (NO2
−) released in the culture medium
via the Griess reaction [29]. Fifty microliters of cell
supernatant from treated and untreated wells was mixed
with an equal volume of the Griess reagent. The resulting
color was measured at 550 nm with a microplate reader
(Tecan Sunrise, Grödig, Austria). The absorbance values
were compared with a standard sodium nitrite curve and
converted to corresponding nitrite concentrations (in
micromoles per liter). The percentages of NO inhibition
by the extracts were calculated as follows:
% Inhibition = 100 ×

NO −2
 
control − NO −2
 
sample
 
= NO −2
 
control

2.6. Statistical analyses
The values represent the mean ± standard deviation of 5
replicates for HPLC and LC-MS analyses of the honey
extracts. On the other hand, data were collected from 3
independent experiments for in vitro assays. Data were
expressed as the mean ± standard deviation. Data were
analyzed using either unpaired t test or 1-way analysis of
variance followed by Tukey multiple comparison tests, as
indicated. Graph Pad Prism (version 4; GraphPad Software
Inc., La Jolla, Calif) statistical software was used for the
analysis, and P value b .05 was considered statistically
significant. Post hoc power analysis was conducted using the
software Primer of Biostatistics (version 6.0; McGraw-Hill,
New York, NY); the range of power of the tests conducted
was 0.8 to 0.95, where α = .05.Fig. 1. Absorption chromatogram at 290 nm of honey phenolic acids and flavonoi
minutes = chlorogenic acid, 9.5 minutes = caffeic acid, 13.8 minutes = p-coumaric
myricetin, 27.8 minutes = quercetin, 30.1 minutes = hesperetin, 30.9 minutes = luThe median maximal effective concentrations (EC50) for
the inhibition of NO production in RAW264.7 cells and
inhibition of TNF cytotoxicity in L929 by the honey extracts
were calculated using sigmoidal dose-response (variable
slope) equation under nonlinear regression (curve fit) with
Graph Pad Prism 4.3. Results
One hundred grams of liquefied fresh Malaysian honey
Apis mellifera yielded 52 ± 0.17 and 10 ± 0.13 mg of
methanol and ethyl acetate extracts, respectively. The yield
was significantly different for the 2 extracts when compared
with unpaired t test (P b .001). The yield ratio for HEAE to
HME was ca 1:5 for every 100 g of honey.
3.1. Identification and quantification of phenolic
compounds in Malaysian honey by HPLC and LC-MS
Compared with the methanolic extract, a lower recovery
of gallic acid and ellagic acid was observed in HEAE in
chromatograms recorded at 290 and 340 nm. Fig. 1 shows
the UV absorption chromatogram of Malaysian honey at 290
nm, following isolation by XAD-2 then extraction with ethyl
acetate. Standard compounds eluted from XAD-2 resin
showed the following recovery ranges: 18% to 45% for
phenolic acids, except for gallic acid that had a recovery of
3%. The flavonoids had a recovery of 35% to 90%, and the
polyphenol ellagic acid had a recovery of 4%. The
concentrations of phenolic compounds in Malaysian honey
calculated from peak areas of the compounds found in both
HME and HEAE are summarized in Table 1.
Ellagic acid recorded the highest concentration among the
phenolic compounds in Malaysian honey in both extraction
methods, with a total of 3295.83 μg/100 g of honey in XAD-ds detected in Malaysian honey using HPLC: 2.7 minutes = gallic acid, 8.6
acid, 16.3 minutes = ferulic acid, 22.3 minutes = ellagic acid, 24.1 minutes =
teolin, 34.9 minutes = kaempferol, 45 minutes = chrysin.
Table 1
Concentrations of phenolic compounds detected in Malaysian honey using
HPLC (each value represents the mean ± SD)
Retention
time (min)
μg/100 g honey at
290/340 nm ethyl
acetate extract
μg/100 g honey
at 290/340 nm
methanol extract
Compounds
2.7 35.37 ± 2.8 341.01 ± 28 Gallic acid
8.6 34.84 ± 3.1 153.65 ± 12.5 Chlorogenic acid
9.5 37.36 ± 2.9 158.39 ± 17.4 Caffeic acid
13.8 39.90 ± 3.7 80.68 ± 7.6 p-Coumaric acid
16.3 78.99 ± 9.3 239.08 ± 19.4 Ferulic acid
22.3 626.74 ± 56.2 3295.83 ± 38.6 Ellagic acid
24.1 93.01 ± 12.3 223.57 ± 27.1 Myricetin
27.8 22.63 ± 1.9 66.50 ± 7.2 Quercetin
30.1 46.5 ± 5.6 109.27 ± 13.5 Hesperetin
30.9 8.60 ± 1.1 33.61 ± 4.2 Luteolin
34.9 10.71 ± 1.3 16.12 ± 1.9 Kaempferol
45 8.75 ± 0.9 69.01 ± 8.7 Chrysin
The HEAE and HME were analyzed with HPLC with the UV detector set at
290/340 nm. The unknown concentrations of the phenolic compounds in the
honey extracts were derived by calculating the peak area from the calibration
curves of the standards used. Values represent mean concentration ±
standard deviation of 5 replicates (HME: n = 5, HEAE: n = 5).
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XAD-2 with ethyl acetate extraction. Liquid chromatogra-
phy–MS was used for the identification of some phenolic
compounds. Fig. 2 depicts the peak of chrysin detected in
Malaysian honey using negative ESI-MS. Summarized in
Table 2 are the mass spectra, UV spectra, and fragments of
the identified compounds using positive and negativeFig. 2. Electrospray ionization–mass spectra negative ionization foionization. Some compounds did not ionize under the
conditions used for analysis. In addition, as displayed in
Table 2, negative ESI-MS was more useful for identifying
compounds in the extracts than positive ESI-MS.
Liquid chromatography–MS analysis for the identifica-
tion of the phenolic constituents in honey extracts demon-
strated the presence of phenolic compounds in free form
(aglycones), derivative, as well as conjugated forms (sugar
moieties). As presented in Table 2, the peaks at 8.39 and
11.53 minutes were both identified as ferulic acid (molecular
weight [MW] = 194) [M − H] −193 m/z at 8.39 minutes and
[M − H − H2O] 175 m/z at 11.53 minutes after water loss.
The peak at 23.51 minutes was identified as ellagitannin
(MW = 802) [M + H] +803 m/z, which is in agreement with a
previous study [30].
Some phenolic compounds appeared as a sugar moiety,
such as ellagic 3-O-glucoside, rhamnosyl naringenin, and
quercetin-3-O-glucoside. Hesperetin, ellagic acid, and quer-
cetin have identical MWs of 302 g/mol; however, it has been
reported that the MSn fragmentation pattern can be used to
distinguish between these compounds. Further ionization
produced major fragments at m/z 271, 255, 179, and 151,
which demonstrated the presence of quercetin as an
aglycone, but not ellagic acid [31], whereas further
fragments of hesperetin produced major ions at m/z 286,
188, and 164 [32]. Besides the fragmentation patterns,
retention time and UV spectra are also very important to
differentiate between hesperetin, quercetin, and ellagic acid.
Moreover, some compounds were identified using both
positive and negative ionization such as elenolic acidr chrysin. MW = 254.242 g/mol, ESI-MS [M − H] = 253.28.
Table 2
Phenolic compounds identified in Malaysian honey using LC-MS
Retention time (min) MW MS ESI-MS [M ± H] UV band (nm) Fragment ions Compound names
8.39 194 175 − 296, 324 Ferulic acid
11.53 194 193 − 296, 324 175 Ferulic acid
21.35 299 298 − 242, 172, 158 Kaempferide
21.66 464 463 − 361, 303, 199, 172 Ellagic-glucoside
22.64 242 243 + 235, 260, 350, 385 Elenolic acid
22.43 242 241 − 235, 260, 350, 385 Elenolic acid
23.51 801 803 + 235, 285 161, 261, 303 Ellagitannin
23.64 302 301 − 242, 199, 155 Quercetin
24.63 302 303 + 235, 280, 235 263, 203 Ellagic acid
27.23 302 303 + 270,290 249, 188 Hesperetin
29.35 299 298 − 172, 158 Kaempferide
29.39 299 300 + 172, 158 Kaempferide
33.26 254 253 − 260, 295, 320, 335 178 Chrysin
38.09 229 + — 195, 183 Unknown
55.22 462 463 + 303, 271, 165 Quercetin-3-O-glucoside
59.95 418 272 + 273, 204 Rhamnosyl naringenin
The phenolic compounds above were identified in Malaysian honey using LC-MS. This was achieved by comparing the mass spectrometric data with standards
and literature data. Both positive and negative ionizations were used to detect the MS and fragment ions. Data shown are from a single experiment and are
representative of 3 experiments.
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H] 300 m/z and [M − H] 298 m/z.3.2 Viability and cytotoxicity
3.2.1. Effect of honey extracts on L929 and RAW264.7
cells viability
The effect of the extracts on the viability of cells is
important to distinguish between their toxic and therapeuticFig. 3. The honey extracts did not cause significant toxicity to L929 cells at the tested
did not affect the viability of RAW264.7 cells (B) at the tested doses (P N .05 when
3 independent observations. Stim indicates cells stimulated with LPS + IFN-γ; AGeffects. This is especially important in the NO assay to
indicate that the reduction of NO release is due to the
inhibition of inflammatory pathways rather than cell death,
which will also alter the concentration of NO. As can be seen
in Fig. 3, the honey extracts caused no significant cytotoxicity
at the tested concentrations of (1-250 μg/mL) in L929 cells
and (3.125-100 μg/mL) in RAW264.7 cells. However,
although the differences were not statistically significant
(P N .05), HEAE seemed to cause amild toxicity in L929 cells.doses (P N .05 when compared with cells in DMEM alone) (A). The extracts
compared with stimulated cells in media only. Data shown are means ± SD of
, aminoguanidine.
Fig. 4. Treatment of L929 cells with TNF (1 ng/mL) led to 70% cytotoxicity; this was reversed significantly and dose-dependently with the honey extracts. Data
shown are means ± SD of 3 independent observations (***P b .001 and **P b .005 when compared with cells treated with TNF alone).
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3.2.2.1. Effect of honey extracts on L929 cells treated with
TNF and actinomycin D. In this method, neither HME
nor HEAE caused a significant protective effect (data
not shown).
3.2.2.2. Effect of honey extracts on L929 cells treated with
TNF alone. The cytotoxicity in cells treated with TNF-α
alone was more than 70% as shown in Fig. 4. Both honey
extracts appeared to significantly inhibit TNF cytotoxicity.
At the highest concentration tested (250 μg/mL), HEAE and
HME almost fully reversed the cytotoxic effects of TNF,
with a viability of 94% and 84%, respectively. Moreover, the
extracts showed dose-dependent protective effects. TheFig. 5. Honey ethyl acetate extract dose-dependently reduced the concentration of
doses (3.125-100 μg/mL) of honey extracts with LPS and IFN-γ (10 μg/mL and
medium was measured using Griess reagent and converted to equivalent microm
shown are means ± SD of 2 independent observations. Unstim indicates cells in mcalculated EC50 for protection from TNF cytotoxicity by
HEAE and HME were 168.1 and 235.4 μg/mL, respectively.
3.2.3. Effect of honey extracts on NO production in
RAW264.7 cell induced with LPS and IFN-γ
This test was performed to assess the potential anti-
inflammatory activity by evaluating the effects of honey
extract on NO production in LPS- and IFN-γ–stimulated
macrophages. As seen in Fig. 5 (stimulated cells), there was a
20-fold increase in NO concentration in RAW264.7 cells
supernatant after 16 to 20 hours of LPS and IFN-γ
stimulation. Fig. 5 depicts the inhibition of NO production
in cells treated with honey extracts. The highest inhibition
percentages were 80% (4.3 μmol/L of NO) and 40% (16
μmol/L) for HEAE and HME (100 μg/mL), respectively.NO produced from stimulated RAW264.7. Cells were tested at the indicated
200 U/mL, respectively) for 16 to 20 hours. The NO concentration in the
olar concentrations as compared with a sodium nitrite standard curve. Data
edia alone.
Fig. 6. Both honey extracts (HEAE and HME) significantly inhibited NO production from stimulated RAW264.7 cells when compared with stimulated cells
(Stim = 0% inhibition). The protection was more profound in the ethyl acetate extract when compared with the methanol extract. All data shown are means ± SD
of 3 independent observations (***P b .001, **P b .005, and *P b .05).
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manner in the presence of honey extracts as seen in Fig. 6,
although the inhibition was more profound for HEAE. The
calculated EC50 for NO inhibition by HEAE and HME were
37.5 and 271.7μg/mL, respectively.4. Discussion
The phenolic compounds in honey are bound to sugar
moieties, making them more soluble in water; this could
explain the poor recovery of gallic and ellagic acid in this
study, which is in agreement with a previous report [33]. The
poor recovery can also be attributed to weak binding of these
compounds to XAD-2 resin and their strong solubility in
water. Although HPLC did not provide information about
some compounds and their derivatives and conjugates, the
identification of some phenolic compounds and their
derivatives, such as ellagic acid and ellagitannin and their
conjugates, was possible with LC-MS.
Most phenolic compounds identified from the honey
extracts possess antioxidant activity [12,13,19]. This in turn
lead to exploration of the use of honey extracts as
chemopreventive agents in diseases known to involve free
radicals, such as cancer and inflammation [4]. There is
increasing evidence that dietary phenolic compounds play a
role in preventing cancer [34-36], a disease strongly
associated with chronic inflammation [10]. The inhibition
of inflammatory mediators, such as TNF and NO, which
were explored in this study, is one of the important steps in
controlling inflammation.Reactive oxygen species play a critical role in mediating
TNF-α–induced cytotoxicity [37]. It was shown that such
cytotoxicity can be blocked by specific free radical
scavengers [38]. Our findings show that both types of the
honey extracts had a dose-dependent protective effect in
TNF-α–mediated cytotoxicity. Previous research has
reported that Malaysian honey has free radical scavenging
activity [19]. Therefore, it is believed that the free radical
scavenging capacity of flavonoids identified in the honey
extracts may play a role in protecting cells from this
cytotoxicity [11]. In fact, Habtemariam [39] reported that
phenolics, such as caffeic acid, effectively inhibit TNF-
induced cytotoxicity in L929 cells.
Another mechanism by which phenolics may protect the
cells is by either inducing or acting as a substrate for
cytoprotective enzymes such as heme oxygenase–1 (HO-1).
Flavonoids were shown to induce HO-1 gene expression
[40]. Actinomycin D, a transcription inhibitor used in this
study [41], inhibits de novo protein synthesis such as HO-1
expression [42]. This could explain the reason for the
protective effect of the extracts on cells treated with TNF
alone compared with the absence of significant bioactivity in
L929 cells treated with TNF and actinomycin D. Further-
more, the cytotoxicity mechanisms involved in treatment
with TNF alone or TNF + actinomycin D were shown to be
different [38]. It may be appropriate, therefore, to presume
that the protection of the extracts is due to, at least in part, the
induction of HO-1 and inhibition of reactive oxygen species.
Nitric oxide is known to be an important mediator of
inflammation [43]. Inducible nitric oxide synthase is the
enzyme responsible for NO production in the inflammatory
658 M. Kassim et al. / Nutrition Research 30 (2010) 650–659response. Aminoguanidine, a highly selective inhibitor of
iNOS [44], totally inhibited NO production in activated
macrophages at 1 mmol/L. Similarly, HME and HEAE dose-
dependently inhibited the production of NO without
affecting the viability of RAW264.7 cells.
Some flavonoids, including hesperetin and naringin,
induce HO-1 and can inhibit LPS-induced NO production.
Moreover, genistein, kaempferol, quercetin, and daidzein
inhibit the activation of the signal transducer and activator of
transcription 1, another important transcription factor for
iNOS [45]. In addition, quercetin, caffeic acid, chrysin,
ellagic acid, and various polyphenolic compounds are known
for their down-regulation of nuclear factor–κB [46]; this in
turn reduces biosynthesis of iNOS and ultimately inhibits the
production of NO. Most of the phenolic compounds
mentioned above were identified in this study; therefore, it
can be assumed that the inhibition of NO production by the
honey extracts was due to these compounds.
Although the concentrations of the phenolics identified
were higher in HME, the in vitro anti-inflammatory activity
seemed to be better for HEAE. This could be explained by
the fact that the concentrations were reported for every 100 g
of honey extracted. The dry extract yield ratio of the HEAE
to the HME had been 1:5 for every 100 g of honey, hence
overrepresenting the concentrations of the phenolic com-
pounds in the methanol extract. This introduced a limitation
in this study, as it was not possible to compare between the
extracts' phenolic content (ie, for every milligram of extract).
On the other hand, it was possible to compare the extracts' in
vitro activities because of adequate presentation of their
concentration. It was reported that ethyl acetate extracts will
contain a higher concentration of bioactive compounds, an
example being the anti-inflammatory compound caffeic acid
phenethyl ester [40,47,48]. This supports the observation
that HEAE showed better activity.
In conclusion, we accept the hypothesis for this study
because of the fact that the results of this study indicated that
different extraction methods and solvents will yield different
concentrations of phenolic compounds in honey. In addition,
this study's findings also supported our hypothesis that
Malaysian honey extracts would display varying anti-
inflammatory activities in the 2 in vitro models of
inflammation used. This bioactivity may be attributed, at
least in part, to the phenolic compounds within the extracts.
As such, this study has made a contribution to the elucidation
of the potential therapeutic value of honey and its extracts in
inflammatory conditions, thus highlighting the nutritional
value of this food.Acknowledgment
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Honey is a viscous, liquid, natural product with a complex
chemical composition. It is made up of carbohydrates, free
amino acids, vitamins, trace elements and phenolic com-
pounds [1]. It possesses both antioxidant and antibacterial
activities [2]. Many animal and clinical studies have investi-
gated the activity of honey against various microorganisms.
It has been shown to have a broad-spectrum antimicrobial
activity on gram-negative and gram-positive bacteria [3]. It
is used both in modern medicine to treat infected wounds
[2] and as an important ingredient in traditional alternative
therapies due to its antimicrobial and anti-inﬂammatory prop-
erties. Animal and clinical studies have shown that honey aids
in the healing of gastric ulcers and may even accelerate the
healingprocess comparedwithnonsteroidal anti-inﬂammatory
drugs [4].
Gelam honey has been shown to stimulate ﬁbroblast cells,
activate epithelialization, and accelerate wound healing in an
animalmodel study. It has antibacterial activity against bacteria: +60 3 79674957.
.
All rights reserved.includingMethicilline Resistant Staphylococcus aureus (MRSA),
as well as demonstrating a high antioxidant capacity and free
radical scavenging activities [5]. Inﬂammation is an immuno-
logical and pathophysiological response of tissues. It can be
caused by infectious organisms, cancer, autoimmune diseases,
toxic chemical substances or physical injury and leads to the
local accumulation of plasma ﬂuid and blood cells. Pain, heat,
redness, and swelling are all markers of the natural inﬂamma-
tory processes. Phospholipase A2 then causes arachidonic acid
to be releasedwhen the integrity of a cell'smembrane becomes
compromised. It is then transformed into prostaglandins and
thromboxanes through the action of COX. Nitric oxide (NO) is
a gaseous free radical. It is highly labile with a half-life of less
than 10 seconds in the presence of oxygen. NO is rapidly
metabolized to nitrate and nitrite [6]. It is produced from the
amino acid L-arginine by the enzymatic action of nitric oxide
synthase (NOS). There are three isoforms of NOS, two of which
are constitutive (cNOS: eNOS) and the other which is inducible
NOS (iNOS). Co-factors for NOS include oxygen, NADPH,
tetrahydrobiopterin and ﬂavin adenine nucleotides. The activ-
ity of iNOS is stimulated during inﬂammation by bacterial
endotoxins such as lipopolysaccharide (LPS) and cytokines
such as tumor necrosis factor (TNF) and interleukins. During
1197M. Kassim et al. / Fitoterapia 81 (2010) 1196–1201inﬂammation, the amount of NO produced by iNOS may be
1,000-fold greater than that produced by cNOS [7].
In this study, we investigated the anti-inﬂammatory and
anti-nociceptive activities of Gelam honey and its extracts in
the inﬂammatory tissue of immune and non immune animal
models, focusing on the inﬂammatory mediators, PGE2 and
NO.
2. Materials and methods
2.1. Materials
Fresh Malaysian honey Apis mellifera (Gelam) was ob-
tained from the National Apiary, Department of Agriculture,
Parit Botak, Johor, Malaysia. All chemicals and reagents used
were of analytical grade.
2.2. Methods
2.2.1. Preparation of extraction from honey by solid phase
extraction (SPE)
C18 cartridges of SPE were preconditioned for neutral
ﬂavonoids and phenolics by sequentially passing 8 ml of
methanol and 4 ml of deionized water adjusted to pH 7.0. For
phenolic acids, cartridges were preconditioned by passing
4 ml of 0.01 M HCl instead of deionized water [8]. The honey
was prepared as described by Martos [9] with certain
modiﬁcations. In each condition, the honey (100 mg) was
thoroughly mixed with deionized water for 30 min, 5 times,
until completely dissolved. The resulting honey solution was
then ﬁltered under vacuum to remove any solid particles.
This solution was divided into two parts. The ﬁrst part was
adjusted to pH 7.0 with diluted NaOH solution, loaded onto
the neutral fractionating C18 column, and washed with 10 ml
of pH 7.0 deionized water. The second part was adjusted to
pH 2.0 with 2.0 M HCl, passed through the preconditioned
acidic column and washed with 5 ml of 0.01 M HCl. For the
methanol extract, the adsorbed fractions were eluted with
12 ml of methanol and evaporated using a rotary evaporator
until dry at 40 °C with a water bath. The residues from all
the above conditions were re-dissolved individually in 1 ml of
methanol for HPLC and after that they were dried again. The
dried methanol extract was divided into two portions. One
portion was used as the methanolic fraction and the second
portion was redissolved in deionized water (1 ml) and re-
extracted with ethyl acetate (1 ml×3) [9]. 20 μl of each ex-
tract was then injected into the HPLC system.
2.2.2. HPLC analysis
Samples of a volume of (20 μl) each were injected. The
phenolic compounds were detected using UV absorption
spectra and monitored at 290 nm and 340 nm. The majority
of the honey ﬂavonoids and phenolic acids show their UV
absorption maximum at these two wavelengths [9]. The
column used was a reversed phase C18 column, Agilent
ZORBAX Eclipse XDC-18 (3×250 mm, particle size 5 μm). The
mobile phases were 0.25% formic acid and 2% methanol
in water (solvent A) and methanol (solvent B), at a constant
solvent ﬂow rate of 1 ml/min. The following gradient was
used, according to the method devised by Martos [9], except
for minor modiﬁcations: 10% methanol (B) ﬂowed throughthe column isocratically with 90% solvent A for 15 min which
was then was increased to 40% methanol (B) for 20 min, to
45%methanol (B) for 30 min, to 60%methanol (B) for 50 min,
to 80% methanol (B) for 52 min, to 90% methanol for 60 min,
and then followed by isocratic elution with 90% methanol (B)
for 65 min. Finally, the gradientwas changed to 10%methanol
for 68 min, and this composition was held until 73 min.
2.2.3. Animals
For this study, male Sprague Dawley rats with an average
weight of 200-250 g were kept in individual cages under
standard conditions (Temperature at 22±2 °C 12 h light, 12 h
dark), fed on Purina lab chaw and given water ad libitum. Five
groups (n=6) were used for each model.
2.2.4. Formation and measurement of paw edema
Edema was induced by a sub-plantar injection of carra-
geenan or LPS into the footpad of the right hind paw of all
animals in the study groups in both models. The animals
were pretreated for one hour by injecting 500 μl (i.p.) the
following: Honey (800 mg/kg, 1:1 in H2O); honey methanolic
extract (HME) and honey ethyl acetate extract (HEAE)
(180 mg/kg in 5% DMSO); indomethacin (5 mg/kg in 2%
NaHCO3 solution); and saline with 5% DMSO). All animals
in both models were injected with (200 μl/paw) 1% g/ml
carrageenan (λ-Carrageenan fromEucheumaSpinosa (Sigma))
in saline in thenon-immunemodel; andwith(200 μl/paw)mg/
ml LPS from Escherichia coli (sigma) in saline in the immune
model. The paw volume was then measured every hour from
0 to 9 hours and also at 24 hours employing the volume
displacement technique using a Plethysmometer (Ugo Basile,
Italy). Edemawas calculated as follows: Edema= paw volume
at every hour - the paw volume at zero hours.
2.2.5. Measurement of PGE2 and NO in paw tissue
Twenty-four hours after injecting carrageenan and LPS,
the rats were sacriﬁced and the paw tissues were removed.
The tissues were centrifuged with 100 μl dH2O to extract the
PGE2 and NO products from the muscles and were stored
at -20 °C until analysis. The analysis was done with an ELISA
kit for PGE2, following the manufacturers’ (Cayman Chemi-
cal) guidelines. Nitrate reductase enzyme from E.coliwas used
to measure NO products also following the manufacturers’
(Sigma) guidelines.
2.2.6. Measurement of nociceptive activity
A plantar test was used to assess nociceptive responses
to thermal stimuli according to the method introduced by
Hargreaves [10]. Rats were placed in a transparent plastic
chamber. The rats were allowed to habituate in this envi-
ronment for 20 min prior to testing. After the acclimatization
period, an infra-red (IR) source was positioned under the
glass ﬂoor directly beneath the hind paw and activated. Paw
withdrawal latency in response to radiant heat wasmeasured
using the plantar test apparatus (Ugo Basile, Comerio, Italy).
A digital timer connected to the heat source automatically
recorded the response latency for paw withdrawal to the
nearest tenth of a second. A cut-off time of 22 seconds was
used to prevent tissue damage. The reaction time was mon-
itored at 15 and 30 minutes, and thereafter half- hourly,
the total time of the study being 7 hrs. The paw withdrawal
1198 M. Kassim et al. / Fitoterapia 81 (2010) 1196–1201latency of each rat was measured three times at each test
interval and the median score was recorded.
2.2.7. Statistical analysis
Results are expressed as mean±SD. Statistical analysis of
the results was performed using one- way ANOVA followed
by Tukey's multiple comparison test and the results were
considered signiﬁcant at Pb0. 05.
3. Results
3.1. Phenolic compounds in Gelam honey extracts fractionated
by HPLC
The methanol in both conditions (acidic and neutral) and
ethyl acetate extracts of Gelam honey were applied to SPE
(C18) and HPLC, and similarly with commercial phenolic
compounds. The identiﬁcation of phenolic compounds in
all conditions was compared with commercial standards
depending on retention time and the wavelength of the
phenolic compounds. Most of the phenolic acids appeared at
290 nmwhile most of the ﬂavonoids and other polyphenolics
appeared at 340 nm. All phenolic compounds were present
in both extracts (methanol and ethyl acetate). However,
the quantities of the compounds varied, being higher in the
methanol extraction. In the acidic condition, some ﬂavonoids
and other polyphenolics appeared, while in the neutral con-
dition the phenolic acids were absent. The highest levels of
gallic acid were found in the acidic condition, whilst ellagic
acid was found at the highest levels in neutral conditions as
indicated in Figs. 1 and 2.
3.2. Measurement of paw edema volume
The subplantar injection of carrageenan and LPS to both
models led to a time dependent increase in paw volume
which peaked at 6 hrs for carrageenan, at 3 hrs for LPS and
remained elevated thereafter for 24 hrs. Edema in the paw
was measured by a plethysmometer in both models. HME,
HEAE and honey signiﬁcantly reduced the edema as shown in
Figs. 3 and 4. The. P value was b0.05.
3.3. Measurement of anti-nociceptive activity
The results depict the anti-nociceptive activity measured
through infraredwithdrawal latency in all groups. HME, HEAEFig. 1. Chromatograms of acidic condition of methanolic extracts of Gelam honey by
acid, B=p-Coumaric acid, C=Ferulic acid, D=Ellagic acid, E=Myrectin, F=Qureceand honey signiﬁcantly reduced the pain as shown in Fig. 5.
The P value was b0.05.
3.4. Measurement of NO and PGE2 in paw edema
The concentrations of NO and PGE2 in exudates of paw
tissues in all groups of both models were measured. The
LPS groups had higher concentrations compared with the
carrageenan groups with the exception of the indomethacin
groups (which showed approximately the same quantity).
HME, HEAE and honey signiﬁcantly inhibited the NO and
PGE2 as shown in Figs. 6 and 7. The P values were signiﬁcant
when Pb0.05.
4. Discussion
Our study investigates the anti-inﬂammatory and anti-
nociceptive activities of Gelam honey in vivo and analytical
conclusions about the potential therapeutic use of honey, a
cheap and readily available natural product. To date, research
ﬁndings have been inconclusive in terms of deﬁning the role
of honey in nociceptive activities. To the best of our
knowledge, this is the ﬁrst report on the inhibition of NO
and PGE2 speciﬁcally in inﬂamed paw tissue in immune and
non immune animal models by using honey and its extracts.
Honey and its extracts were found to downgrade inﬂamma-
tory activity by reducing cardinal inﬂammatory signs and
markers of inﬂammation. This was observed through the
inhibition of swelling, the decrease in pain, as well as the
reduction of the mediators of inﬂammation tested (PGE2,
NO). The anti-inﬂammatory activity of honey and its extracts
is attributed to the phenolic compounds present in the honey.
We are able to demonstrate enhanced anti-inﬂammatory
activity in the methanol and ethyl acetate extracts of honey
models as compared to the wholesome honey model.
It has been documented that carrageenan and LPS induced
rat paw edema form a suitable in vivo model to predict
the value of an agent's anti-inﬂammatory activity [11]. The
results of this study (Figs. 3 and 4) indicate that the volume of
edema differed between the two models. The LPS model
showed a faster development of edema, with the largest
edema volume being recorded at 3 hrs. On the other hand, the
carrageenan model induced a larger edema volume, and the
development of edema occurred over a longer period with
the largest edema volume being recorded at 6 hrs. The effects
of honey and its extracts were signiﬁcant in both models butusing SPE (C18) and detected by HPLC-UV absorption at 290 nm. A = Caffeic
tin, G=Hesperetin, H=Luteulin, I=Kaempferol, J=Chrysin, K=Gallic acid.
Fig. 2. Chromatograms of neutral condition of methanolic extortion of Gelam honey by using SPE (C18) and detected by HPLC-UV absorption at 340 nm. A =
Ellagic acid, B = Myrectin, C = Qurecetin,D = Hesperetin,E = Luteulin,F = Kaempferol,G = Chrysin.
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be attributed to the fact that carrageenan is known to destroy
macrophages [12].
The extracts (HME and HEAE) showed higher inhibition of
edema in both of the models compared with honey. This was
indicative of the role of phenolic compounds in the inhibition
of edema, and it appeared that, particularly in HME, it
contains the highest concentrations of phenolic compounds,
speciﬁcally ellagic acid and gallic acid. The role of ellagic acid
will be explained below,while gallic acid has been reported to
inhibit iNOS, COX2, decrease histamine release, and suppress
pro-inﬂammatory cytokine production in macrophage and
P-selectin-mediated inﬂammation both in vitro and in vivo
[13,14]. It is suggested that the mechanism of action of
phenolic compounds may be the inhibition of molecular
vasodilators, such as NO, as well as the inhibition of PGE2.
Pain is a common symptom of injuries and inﬂammatory-
related conditions. The perception of pain, commonly known
as nociception, depends on integrated receptors and molec-
ular pathways. Inﬂammatory mediators are involved in the
genesis, persistence, and severity of pain [15]. The inﬂamma-
tory milieu that usually precedes and accompanies pain is
transcriptionally regulated [16]. The nuclear factor NF-κB
is a transcription factor essentially involved in controlling
the release of inﬂammatory mediators, which may exacer-0
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Fig. 3. The edema volume of the rats’ paws after injection with carrageenan
for all groups. Saline, indomethacin, honey, honeymethanolic extract (HME),
and honey ethyl acetate extract (HEAE), P value is signiﬁcant when Pb0.05.bate pain, hyperalgesia and nociception [17]. Carrageenan
is used in hyperalgesia as a thermal stimulus as indicated
by decreased withdrawal latency [18]. PGE2 and NO were
established as playing a signiﬁcant role in nociceptive
processing [19]. In this model, a decrease in paw withdrawal
latency to radiant heat and withdrawal threshold was ob-
served throughout the 30 min - 7 hrs time period after induc-
tion of the paws by carrageenan. The results in Fig. 5 depict
that honey and its extracts showed potent anti-nociceptive
activity which is caused by the inhibition of PGE2 and NO.
The extracts were more signiﬁcant supporting the above
suggestion for the involvement of phenolic compounds in this
activity.
Nitric oxide (NO) is known to be an important mediator
of acute and chronic inﬂammation. The inducible nitric oxide
synthase (iNOS) is up-regulated in response to inﬂammatory
and pro-inﬂammatory mediators, and their products can
inﬂuence many aspects of the inﬂammatory cascade. Aspirin
(widely used to treat inﬂammation) and indomethacin in-
hibit NF-kB activation [20]. Certain natural products inhibit
NF-kB activation and decrease the level of iNOS and COX-2
expression caused by stimulation with LPS [21]. The results
in Fig. 6 show that honey and it extracts inhibited NO in
inﬂammatory tissues in both models. In the carrageenan
model, the inhibition was more pronounced than that of
the LPS model. The inhibition activity was more signiﬁcant in0
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Fig. 4. The edema volume of the rats’ paws after injection with LPS for all
groups. Saline, indomethacin, honey, honey methanolic extract (HME), and
honey ethyl acetate extract (HEAE), P value is signiﬁcant when Pb0.05.
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Fig. 5. Antinociceptive effect of honey and its extracts on rats’ paws using
infrared light after injection with carrageenan for 7 hrs. Tested honey,
indomethacin, honey methanolic extract (HME) and honey ethyl acetate
extract (HEAE) signiﬁcantly inhibited the nociceptive response; P value is
signiﬁcant when Pb0.05.
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Fig. 7. Effect of honey and its extracts on PGE2 production in paw tissues in
the carrageenan and LPS models. Indomethacin (INDO), honey methanolic
extract (HME), and honey ethyl acetate extract (HEAE), P value is signiﬁcant
when Pb0.05.
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NO inhibition but the mechanism is still unclear. The major
phenolic compounds in the methanol and ethyl acetate
extracts were gallic acid, ellagic acid, caffeic acid, luteolin,
chrysin and quercetin. The anti-inﬂammatory activity corre-
lates positively with the radical-scavenging activity and total
phenolic content [22]. It has been reported that Gelam honey
has potent free radical scavenging activity [5]. Phenolic
compounds showed a clear and strong correlation between
ROS scavenging activity and decreased cytotoxicity. Phenolic
compounds in Gelam honey such as quercetin, caffeic acid,
chrysin and ellagic acid are known for their downregulation
of NF-κB. This, in turn, reduces the biosynthesis of iNOS [23],
and ultimately inhibits the production of nitric oxide. Phe-
nolic compounds in honey and its extracts may be able to
inhibit NO through the inhibition of NF-kB and scavenging
activity of the NO radical.-1
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Fig. 6. Effect of honey and its extracts on NO production in paw tissue in
the carrageenan and LPS models, indomethacin (INDO), honey methanolic
extract (HME), and honey ethyl acetate extract (HEAE), P value is signiﬁcan
when Pb0.05.tProstaglandin is a very important mediator of all types
of inﬂammation. It is synthesized by the enzyme cycloox-
ygenase (COX) which is stimulated in the inﬂammatory
phase by pro-inﬂammatory mediators, such as cytokines, LPS
and carrageenan. Previous studies have shown that COX-2 is
responsible for increased prostaglandin production in in-
ﬂamed tissue [24]. The results shown in Fig. 7 indicate that
honey and its extracts inhibit the PGE2 in inﬂammatory
tissues of both inﬂammation models. Phenolic compounds
have a major role in the inhibition of PGE2 in inﬂammatory
tissues since methanol and ethyl acetate extracts were more
involved in the inhibition of PGE2 production than the whole
honey. Nevertheless, t the mechanism is still unclear. Honey
has been proven to have a potent activity against gastritis
and stomach ulcers [4]. Speciﬁc inhibition of COX-2 expres-
sion at the transcriptional level is a potent mechanism in
the treatment of inﬂammatory disease [25]. It is possible
that honey and its extracts are selective inhibitors of COX-2
because honey has no side effects on the gastrointestinal
system. In relation with the above results, the inhibition of
PGE2 by honey extracts is more pronounced. Ellagic acid, the
major phenolic compound in Gelam honey, has an inhibitory
effect on PGE2 release from monocytes and other phenolic
compounds in Gelam honey such as quercetin, chrysin and
luteolin which have been demonstrated to have inhibitory
effects on interleukin, 1β, and cyclooxygenase-2 (COX-2)
expression, prostaglandin E2 (PGE2) synthesis and NF-κB
[23,26]. These phenolics in Gelam honey and its extracts
may have inhibited PGE2 through the inhibition of COX-2
and NF-kB.
In conclusion, phenolic compounds in Gelam honey and
its extracts do appear to have anti-inﬂammatory effects
against the inﬂammatory mediators NO and PGE2 in tissues.
Effects on NO and PGE2 correspond with the reduction in
paw edema volume and the inhibition of pain. Honey and its
extracts are, therefore, potentially useful for treating inﬂam-
matory conditions.
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Available online 22 May 2012Malaysian Gelam honey has anti-inflammatory and antibacterial properties, a high antioxidant
capacity, and free radical-scavenging activity. Lipopolysaccharide (LPS) stimulates immune
cells to sequentially release early pro- and anti-inflammatory cytokines and induces the
synthesis of several related enzymes. The aim of this study was to investigate the effect of the
intravenous injection of honey in rats with LPS-induced endotoxemia. The results showed that
after 4 h of treatment, honey reduced cytokine (tumor necrosis factor-α, interleukins 1β, and
10) and NO levels and increased heme oxygenase-1 levels. After 24 h, a decrease in cytokines
and NO and an increase in HO-1 were seen in all groups, whereas a reduction in HMGB1
occurred only in the honey-treated groups. These results support the further examination of
honey as a natural compound for the treatment of a wide range of inflammatory diseases.
© 2012 Elsevier B.V. All rights reserved.Keywords:
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Heme oxygenase-11. Introduction
Honey is a naturally sweet viscous fluid produced by bees
from floral nectar. To date, more than 400 different chemical
compounds have been identified in many varieties of honey
[1], including proteins, enzymes, organic acids, mineral salts,
vitamins, phenolic acids, flavonoids, free amino acids, fatty
acids and small quantities of volatile compounds [2,3]. As early
as 5000 BC, honey was used by Egyptians in wound manage-
ment, while the Greeks, Chinese, and Romans exploited its
antiseptic properties as a topical agent for the treatment of sores
and skin ulcers [4]. The ability of honey to induce the activation
and proliferation of peripheral blood cells, including lympho-
cytic and phagocytic activity, is well-established, as its role
in combating infection by stimulating the anti-inflammatory,: +60 3 79553705.
.
All rights reserved.antioxidant, and proliferative activities of the immune system
[5,6]. It was reported in a clinical experiment that when wound
infected with bacteria was treated with honey, infection was
more quickly eradicated [7–9]. Immunomodulatory effects
were demonstrated in vitro by cytokine release from human
peripheral monocytes and the monocytic cell line Mono Mac 6
after incubation with honey [10]. All of these properties have
been determined in Gelam honey. Specifically, Gelam honey
inhibits the release of both nitric oxide (NO) and tumor necrosis
factor (TNF)-α in vitro and in vivo [11]. The floral source of
Gelam honey is Melaleuca cajuputi Powell, it has medicinal
antiseptic, antibacterial, anti-inflammatory and anodyne prop-
erties, and it is used traditionally against pain, burns, colds,
influenza and dyspepsia. Cajeput oil is produced from the M.
cajuputi leaves by steam distillation. It is used for the treatment
of coughs and colds, against stomach cramps, colic, asthma,
relief of neuralgia and rheumatism. It has been approved for
food use by the Food and Drug Administration (FDA) of the
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include ellagic acid, gallic acid ,chrysin, quercetin, caffeic acid
phenethyl ester, luteolin, kaempferol, and hesperetin [11,14],
many of which have anti-inflammatory and immunomodula-
tory properties [15–17]. Gelam honey also antagonizes the
lipopolysaccharide (LPS)-induced immune response in vitro
and in vivo [11,14]. LPS is a cell-wall component of Gram
negative bacteria and a potent inducer of the host immune
system, including the overproduction of numerous pro- and
anti-inflammatory cytokines, an increase in oxidative stress,
and the induction of nitric oxide synthase (iNOS) and heme
oxygenase-1 (HO-1). Together, these events result in severe
tissue injury. Moreover, LPS causes endotoxemia, which is
associated with multiple organ failure and is often lethal
[18,19]. Given the complexity of the immune response to
LPS-induced endotoxemia and the many anti-inflammatory
properties of honey, we examined the ability of Gelam honey
to induce several key immunomodulators (TNF-α, IL-1, IL-6,
IL-10, NO, and HO-1) and HMGB1 in a rat model of LPS-
induced endotoxemia.
2. Materials and methods
2.1. Materials
Fresh Malaysian honey (Gelam, from Apis mellifera) was
obtained from the National Apiary (Department of Agricul-
ture, Parit Botak, Johor, Malaysia) and then sent to the
Malaysian Nuclear Agency for sterilization using a cobalt-60
source (model JS10000). Prior to use, the Gelam honey was
diluted in saline and then filter-sterilized through a 0.20-μm
syringe filter. All chemicals and reagents used were of analy-
tical grade.
2.2. Extraction of phenolic compounds from honey by strong
acid hydrolysis
Extraction and hydrolysis conditions for the honey sam-
ple were performed to obtain their corresponding aglycones
in 50% (v/v) aqueous methanol, containing hydrochloric
acid (6 M) as described in Ref. [20] with a modified. For the
extraction of phenolic compounds of Gelam honey, 5 g was
dissolved in 30 ml 50% (V/V) aqueous methanol with added
HCl. The mixture was stored at 35 °C for 24 h. Then the
extract was evaporated under pressure at 40 °C after that,
the residues were diluted with 5 ml water and 5 ml ethyl
acetate repeated three times. All ethyl acetate extracts were
collected and then flushed with N2; the dry residues were
redissolved in methanol, and then filtrated through a
membrane (45 μml). 20 μml of resultants extract was
injected to Liquid chromatography–mass spectrometry
(LC–MS) to identify the compounds present. The LC–MS
conditions were similar to the previously describe [11]
2.3. Animals
Male Sprague Dawley (SD) rats weighing 300–350 g were
kept in individual cages under standard conditions (12-h
light and 12-h dark conditions). They were fed a diet of
Purina lab chow and given water ad libitum. The study was
carried out in accordance with the University of MalayaAnimal Ethics Committee guidelines for animal experimen-
tation. Approved protocols were followed and a project
license, ANES/14/07/2010/MKAK (R), was obtained.
2.4. Toxicity test
The toxicity of Gelam honey in rats (n=8) was evaluated
for 1 month prior to the study. Four different doses of honey
(10, 60, 300, and 600 mg/kg diluted in 1 ml of saline) were
injected daily through the tail vein. The control group re-
ceived a similar volume of saline. Both the honey- and the
saline-treated rats were observed for 3 h after injection.
Symptoms and mortality were recorded for all groups. At
the end of the study, all of the rats were sacrificed and their
blood and organs collected. Compared with the control
group, the treated groups showed no abnormalities as deter-
mined by biochemical and histopathological analyses of the
liver, lungs, and kidneys (data not shown).
2.5. Induction of endotoxemia in rats by LPS stimulation and
treatment with honey
The rats were divided into six groups (n=6/group) and
were treated as described below. Endotoxemia was induced
in four groups by intravenous injection of 5 mg/kg LPS (B:
0111; Sigma, St. Louis, MO, USA) prepared in saline. One of
the four groups served as the positive control (LPS only),
while the other three received one of three different concen-
trations of honey: 60 mg/kg (H60), 300 mg/kg (H300), and
600 mg/kg (H600), diluted in saline. The fifth group served as
the negative control and was given saline only, while the
sixth group was given honey (600 mg/kg in saline) but no
LPS. All doses were administered in a volume of 1 ml and
were prepared immediately prior to injection.
Five groups of 10 rats were used for survival rate analysis.
Endotoxemia was induced in four groups by intravenous
injection of 5 mg/kg LPS as described above; the fifth group
was left untreated (control). The viability of all 50 rats was
monitored every 12 h for 15 days.
2.6. Quantiﬁcation of cytokines, NO, HO-1, and HMGB1 levels
Blood samples were collected 4 and 24 h after treatment,
after which all of the rats were killed. Samples were collected
after 4 h of treatment and serum levels of TNF-α, IL-1, IL-6,
IL-10, NO, and HO-1 were measured using an enzyme-linked
immunosorbent assay (ELISA; R&D Systems, Minneapolis,
MN, USA). The ELISA was repeated after 24 h. Serum HMGB1
levels were also examined after 24 husing an ELISA (Shino-Test:
326054329, Japan) according to themanufacturer's instructions.
2.7. Statistical analysis
Data are expressed as the mean±standard deviation and
analyzed using a non-parametric one-way analysis of vari-
ance (ANOVA) followed by Tukey's multiple comparison test.
All analyses were carried out using GraphPad Prism 5
statistical software (San Diego, CA, USA). Survival data were
subjected to Kaplan–Meier analysis. Pb0.05 was considered
statistically significant.
1056 M. Kassim et al. / Fitoterapia 83 (2012) 1054–10593. Results
3.1. Identiﬁcation of phenolic compounds in Gelam honey by
LC–MS
LC–MS was used for the identification of some phenolic
compounds. Fig. 1S shows the peaks of gellic acid, ferulic acid,
quercetin, ellagic acid, Hesperetin, and chrysin detected in
Gelam honey using positive and negative ESI-MS. Figs. 2S–6S
show the fragments of the identified compounds using
positive and negative ionization (ESI-MS). Some compounds
did not ionize under the conditions used for analysis. TheTNF-α
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3.2. Effect of honey on cytokines, HMGB1, NO, and HO-1
Cytokine production was lower in rats injected with LPS
and subsequently treated with honey than in rats injected
with LPS alone. A significant reduction in TNF-α level oc-
curred at 4 h, but was no longer apparent at 24 h (Fig. 1).
Honey also showed potent inhibitory activity against IL-1β
and IL-10; however, in contrast to its short-lived effect on
TNF-α level, highly significant differences in the levels ofIL-1β
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Fig. 3. Effect of honey on heme oxygenase-1 (HO-1) levels. Rats were
injected with 5 mg/kg LPS and HO-1 levels were measured 4 h and 24 h
later. The six groups of rats (n=6/group) were the same as those described
in Fig. 1. Data are presented as the mean±standard deviation. (**Pb0.003).
1057M. Kassim et al. / Fitoterapia 83 (2012) 1054–1059these two cytokines between the honey-treated groups and
the LPS-only control group were evident both at 4 h and 24 h
(Fig. 1). The specific immunomodulatory effects of honey
were demonstrated by the observation that IL-6 levels
remained unchanged after honey treatment, and did not
differ from those of the control groups, while serum HMGB1
levels decreased only at 24 h (Fig. 1). Furthermore, honey
induced a significant reduction in NO production at 4 h and
to a lesser extent at 24 h (Fig. 2). Honey was also a potent
inducer of HO-1, with significant differences between the
honey-treated groups and the LPS-only control group evident
at 4 h and at 24 h (Fig. 3).
3.3. Survival
At 12 h after LPS injection, only 70% of the rats in the
H60 group survived; however, all the LPS-injected rats in
the H300 or H600 groups were still alive. At 24 h, survival
in the LPS, H60, H300, and H600 groups decreased to 30%.
By 36 h, all rats in the LPS and H60 groups had died, while
survival in the H300 and H600 groups decreased to 38%. By
contrast, the negative control group, which received saline
only, survived for an average of 15 days. Kaplan–Meier ana-
lysis revealed a significantly shorter time to death in the
LPS-only group than in the H300 and H600 groups (Fig. 4).
4. Discussion
In our study, Gelam honey was injected intravenously, as
this is the fastest route of delivery for the majority of drugs.
The rapid transit of the injected agent through the blood-
stream allows immediate exposure to the blood and immune
cells. In addition, intravenous injection preserves the activity
of the many vitamins, minerals, enzymes, and active com-
pounds present in the honey, whereas the acid environment
of the stomach encountered following oral administration0
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Fig. 2. Effect of honey on nitric oxide (NO). NO production was measured
(as nitrate and nitrite) in rats stimulated with 5 mg/kg LPS 4 h and 24 h after
treatment. The groups of rats were treated as described in Fig. 1. Data are
presented as the mean±standard deviation. (***Pb0.003 and *Pb0.001).would result in their destruction [21–23]. Previous study
reported that no side effects with the use of intravenous
honey in sheep [24]. This study demonstrated that intrave-
nous injection of honey into LPS-treated rats inhibited
cytokine production, including that of TNF-α, IL-1, and
IL-10, as well as HMGB1 and NO release, while at the same
time inducing HO-1. Thus, consistent with in vitro studies
demonstrating the immunomodulatory effects of Gelam honey
on cytokines and NO released in L929 and RAW 264.7 [11],
our results show that Gelam honey inhibits cytokines, NO
and protects rats from endotoxemia. Upregulation of HO-1
inhibits the release of cytokines, HMGB1 and NO. Furthermore,
upregulation of HO-1 may protect rats from the effects of
endotoxemia,whichmay reflect the decrease in systemic levels
of cytokines, HMGB1, and NO. The cytokine levels observed in0 20 40 60
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Fig. 4. Effect of honey on survival. Five groups of rats (n=10/group)
received a 1-ml injection of LPS (5 mg/kg) into the tail vein. The survival rate
of the group injected with LPS alone is depicted by white squares. The
survival rates of the groups treated with LPS plus 60, 300, 600 mg/kg honey
are depicted by white circles, black squares, and black triangles, respectively.
Control rats received saline only (white triangles). Honey was injected daily
for 3 days after LPS treatment. Kaplan–Meier analysis showed a significantly
shorter time to death for the untreated LPS group (LPS) than for the groups
treated with LPS+300 mg/kg honey (LPS+H300) or LPS+600 mg/kg
honey (LPS+H600) (***Pb0.005).
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neutrophils, macrophages, and lymphocytes and their subse-
quent infiltration into the tissues, and to the activation of other
cells such as endothelial in different tissues such as blood,
vessels, lung and liver. In endotoxemia, the levels of cytokines,
HMGB1 and NO, are increased in the blood and tissues due to
activation of nuclear factor (NF)-κB. Inhibition of cytokines, NO,
and HMGB1, and the induction of HO-1 induced in response to
LPS are important for protection against endotoxemia [25]. The
release of cytokines and NO contributes to inflammation-
related pathologies and mortality; therefore, inhibition of
cytokines and NO provides protection from endotoxemia-
induced mortality in both animals and humans [26]. The
mechanism by which honey inhibits both pro-inflammatory
cytokines (such as TNF-α and IL-1β), and NO is unclear, but it
may involve the inhibition of NF-κB. A previous study shows
that NF-κB prevents the release pro-inflammatory cytokines
and inhibits the release of iNOS [27,28]. However, the
inhibitory effect of honey on the anti-inflammatory cytokine,
IL-10, remains a matter for speculation. IL-10 is a potent
anti-inflammatory cytokine that inhibits the synthesis of
TNF-α, IL-1α, IL-1β, and IL-6 in vitro [29–31]. It is also an
importantmediator of endotoxemia-induced immunosuppres-
sion and of macrophage deactivation during LPS desensitiza-
tion and endotoxemia [30,32]. High circulating levels of IL-10
lead to immunoparalysis [31,33], an effect that is compounded
by the presence of secondary factors, including LPS; in such
cases, temporary immunoparalysis can become chronic, with a
concomitantly higher risk of infection [34,35]. The enzyme
HO-1 protects animals from severe inflammation, and a clear
relationship has been determined between HO-1 activation
and decreased HMGB1 levels which, in turn, protects animals
from endotoxemia. In addition, the induction ofHO-1 improves
animal survival during lethal endotoxemia, and inhibits the
production of both NO and cytokines such as TNF-α and IL-1β
[36]. Consistent with our suggestion that honey exerts its
effects, at least in part, via NF-κB, HO-1 also inhibits NF-κB,
thereby modulating cytokine release and inhibiting iNOS, with
a subsequent decrease in NO [37,38]. Our results showed that
honey inhibited HMGB1 while inducing HO-1 and increasing
the survival of LPS-treated rats. Similarly, potentHO-1-inducing
abilities were identified in other natural products (such as (−)-
epigallocatechin-3-gallate (EGCG)); moreover, these natural
products include immunomodulators of LPS-induced HMGB1
release, and their administration increases the survival of HO-
1-deficient mice [19,39].
The active components in honey include phenolic acid,
flavonoids, and polyphenols such as caffeic acid phenethyl
ester and quercetin [40–42], which inhibit HMGB1.
5. Conclusion
In addition to its well-known properties as a natural
sweetener, honey has many anti-inflammatory properties.
These include the ability to stimulate HO-1 production and to
inhibit the release of both pro- and anti-inflammatory
cytokines (TNF-α, IL-1, IL-10), HMGB1, and NO. Together,
these effects suggest a mechanism by which honey is able to
protect animals from the lethal effects of LPS-induced endo-
toxemia. Therefore, honey should be further explored with
respect to its anti-inflammatory and immunomodulatoryproperties for the use in the treatment of inflammatory
diseases.
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Abstract: Gelam honey exerts anti-inflammatory and antioxidant activities and is thought 
to have potent effects in reducing infections and healing wounds. The aim of this study was 
to investigate the effects of intravenously-injected Gelam honey in protecting organs from 
lethal doses of lipopolysaccharide (LPS). Six groups of rabbits (N = 6) were used in this 
study. Two groups acted as controls and received only saline and no LPS injections. For 
the test groups, 1 mL honey (500 mg/kg in saline) was intravenously injected into two 
groups (treated), while saline (1 mL) was injected into the other two groups (untreated); 
after 1 h, all four test groups were intravenously-injected with LPS (0.5 mg/kg). Eight 
hours after the LPS injection, blood and organs were collected from three groups (one from 
each treatment stream) and blood parameters were measured and biochemical tests, 
histopathology, and myeloperoxidase assessment were performed. For survival rate tests, 
rabbits from the remaining three groups were monitored over a 2-week period. Treatment 
with honey showed protective effects on organs through the improvement of organ blood 
parameters, reduced infiltration of neutrophils, and decreased myeloperoxidase activity. 
Honey-treated rabbits also showed reduced mortality after LPS injection compared with 
untreated rabbits. Honey may have a therapeutic effect in protecting organs during 
inflammatory diseases. 
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1. Introduction 
Honey is a natural, sweet and viscous fluid produced by bees from floral nectar, which comprises 
more than 400 different chemical compounds [1], including proteins, enzymes, organic acids, mineral 
salts, vitamins, phenolic acids, flavonoids, free amino acids, and small quantities of volatile 
compounds [2]. Historically, honey has been used as a treatment for a broad spectrum of injuries, 
including wounds, burns and ulcers [3,4]. Honey has also been reported to stimulate the immune 
system (monocytes, neutrophils) [5–7]. It also clears infection by boosting the immune system, 
exerting anti-inflammatory and antioxidant activities, and stimulating cell growth [8]. Gelam honey 
inhibits nitric oxide (NO) and cytokine release both in vitro and in vivo [9,10]. 
Lipopolysaccharide (LPS) stimulates innate immune responses that mediate the cellular release of 
NO and various proinflammatory cytokines and chemokines, as well as inducing macrophage 
migration and contributing to the pathogenesis of sepsis [11]. Injection of animals with high doses of 
LPS causes multiple organ failure, characterized by circulatory failure, systemic hypotension,  
hypo-reactivity to vasoconstrictors, subsequent problems with organ perfusion and the development of 
functional abnormalities [12], which reflect systemic inflammatory response syndrome and septic 
shock, rather than endotoxin-induced failure of lung, liver, and renal tissues [13]. 
Sepsis is the leading cause of death  worldwide, with more than 750,000 cases of sepsis diagnosed 
annually and mortality rates ranging from 30 to 60%; this systemic inflammation accounts for 
approximately 200,000 deaths per year in the US alone [14]. Sepsis causes endothelial injury and 
neutrophil infiltration into tissues, leading to local injury, disturbed capillary blood flow and enhanced 
microvascular permeability, disseminated intravascular coagulation, circulatory collapse, hypoxia and, 
ultimately, multiple organ failure [15]. The aim of the current study was to investigate whether 
intravenous injection of honey can protect organs from lethal doses of LPS that induce sepsis in rabbits. 
2. Results 
2.1. Effect of Gelam Honey on Biochemical and Hematological Tests, Histopathology, and MPO Activity 
Intravenous injection of honey resulted in potent protection against a lethal dose of LPS as 
evidenced by improved liver, kidney, cardiac and lipid profiles. Compared to the untreated group, the 
honey-treated group showed significant reductions in the levels of alanine transaminase (ALT), 
aspartate aminotransferase (AST), γ-glutamyltransferase (γ-GT), alkaline phosphatase (ALP), 
cholesterol, triglycerides, creatine kinase, creatinine, urea and amylase. Moreover, the honey-treated 
group showed higher RBC, WBC and thrombocyte counts than the untreated group (Table 1). Arterial 
blood gases and pH values were determined for all groups (Table 1). The honey-treated group showed 
mild respiratory alkalosis, while in the untreated group, the arterial blood pH was closer to acidosis. 
Blood pCO2 was lowered by LPS injection, but to the same level in the honey-treated group and 
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untreated group, indicating that honey injection did not prevent the reduction in pCO2. Blood HCO3 
and PO2 were higher in the honey-treated group than in the untreated group. There was clear evidence 
of hypoxia in the untreated group, as shown by the reduction in the pO2 value (Table 1). Neutrophil 
infiltration was reduced in the treated group; however, MPO activity in the honey-treated group was 
significantly lower than that in the untreated group (Figure 1). In addition, more histopathological 
changes were observed in the untreated group, as evidenced by cellular infiltration of the lungs  
(Figure 2). Finally, 66.7% of rabbits in the untreated group died compared with 33.3% in the treated 
group (Figure 3). Survival rates were monitored over a 2-week period. 
Figure 1. Effect of honey on neutrophil infiltration into lung tissues induced by a lethal 
dose of lipopolysaccharide (LPS). Myeloperoxidase (MPO) activity was measured in all 
groups (n = 6 per group) 8 h after LPS injection. MPO activity was significantly higher in 
the untreated (saline + LPS 0.5 mg/kg) group than in the treated (honey, 500 mg/kg + LPS 
0.5 mg/kg) group. *** P < 0.002. 
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Figure 2. (A) Immune-cell infiltration and tissue damage in the lungs of rabbits from the 
untreated group 8 h after LPS injection; (B) Immune-cell infiltration and tissue damage in 
the lungs of rabbits from the honey-treated group 8 h after LPS injection; (C) Normal lung 
tissues in rabbits treated with saline. Hematoxylin and eosin staining; magnification 10×; 
scale bar, 30 µm. 
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Figure 3. The effect of honey on the survival of rabbits injected with LPS (0.5 mg/kg). 
Rabbits in all three groups (n = 6 per group) received 1 mL injections of LPS into the ear 
vein. The survival rates in the untreated and honey-treated (60, 300, and 600 mg/kg) 
groups injected with 0.5 mg/kg LPS are shown as black triangles and black squares, 
respectively. Control rabbits received saline only (black circles). Honey was administered 
daily for 3 days after LPS treatment. Kaplan–Meier analysis showed significantly better 
survival rates in the honey-treated group (500 mg/kg + LPS) than in the untreated LPS 
group (LPS). *** P < 0.005.  
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Table 1. Assessment of organ damage in the control group and in honey-treated and 
untreated groups given a single intravenous injection of lipopolysaccharide. 
Parameter Normal Rabbits (N = 6) Untreated (N = 6) Honey-treated (N = 6) 
Urea (mmol/L) 5.85 ± 0.20 55.85 ± 2.5 10.5 ± 0.23 
a
 
Creatinine (mmol/L) 83.71 ± 2.5 154 ± 6.16 72 ± 2.87 
a
 
ALT (IU/L) 54.125 ± 1.8 108.75 ± 3.6 78.75 ± 1.98 
a
 
AST (IU/L) 27.75 ± 0.9 577.33 ± 19.2 231.5 ± 7.6 
a
 
ALP (IU/L) 131.5 ± 4.1 542.75 ± 15.5 308.75 ± 11.4 
a
 
GGT (IU/L) 10 ± 0.32 38.4 ± 0.6 25 ± 1.7 
b
 
Triglyceride (mmol/L) 0.885 ± 0.03 10.434 ± 0.4 2.47 ± 0.13 
a
 
Total cholesterol (mmol/L) 1.1125 ± 0.04 3.16 ± 0.1 1.8 ± 0.08 
c
 
HDL (mmol/L) 0.65 ± 0.03 0.25 ± 0.006 0.545 ± 0.02 
b
 
LDL (mmol/L) 0.202 ± 0.005 0.45 ± 0.01 0.32 ± 0.012 
Creatine kinase (IU/L) 1327.4 ± 5.3 2168.3 ± 34 998.6 ± 26.8 
a
 
pH (KPa) 7.38 ± 0.3 7.36 ± 0.3 7.5 ± 0.27 
b
 
pCO2 (KPa) 4.3 ± 0.17 3 ± 0.12 3 ± 0.12 
pO2 (KPa) 16.21 ± 0.53 7.65 ± 0.23 19.3 ± 0 .77 
b
 
HCO3 (mmol/L) 19 ± 0.71 15 ± 0.51 19 ± 0.54 
a
 
Platelet (10e9/L) 194.3 ± 6.4 144.5 ± 4.3 183.4 ± 7.6 
b
 
Amylase (IU/L) 181.3 ± 7.2 215.5 ± 6.2 180 ± 5.2 
b
 
RBC (10e12/L 9.27 ± 0.31 4.83 ± 0.15 8.3475 ± 0.32 
a
 
WBC (10e9/L) 15 ± 0.6 6.05 ± 0.25 11.65 ± 0.36 
a
 
a
 P < 0.001; significant effect of untreated group vs. honey-treated group; 
b
 P < 0.003; significant 
effect of untreated group vs. honey-treated group; 
c
 P < 0.005; significant effect of untreated group vs. 
honey-treated group. 
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3. Discussion 
Previous studies have shown that honey has antioxidant, antimicrobial, and anti-inflammatory  
properties [16]. This study identified a protective role for honey against systemic damage induced by 
lethal doses of LPS in a rabbit model. These effects were evidenced by decreased blood chemistry 
parameters of organ dysfunction, decreased cellular infiltration into the tissues, and decreased 
mortality. To the best of our knowledge, this is the first study showing that honey can protect organs 
from lethal doses of LPS. The results indicate that honey can counteract the effects of LPS, which is a 
compound that can lead to organ and multi-organ failure. 
When immune responses are insufficient, infections can lead to sepsis [17]. Many studies report 
that sepsis is a complicated pathophysiological and immunological process that causes alterations in 
the structure and characteristics of blood cells and tissues, leading to multi-organ failure. Lethal doses 
of LPS in animals induce a variety of organ and systemic changes that lead to organ failure and, 
ultimately, to death [18,19]. Previous studies have shown that the acute exposure of rabbits to LPS is 
associated with necrosis in organs such as the lungs and liver. The presence of polymorphonuclear 
leukocytes (PMNLs) was noted in association with necrosis in the lung and liver as well as an 
apoptotic cellular appearance in the LPS group. In addition, LPS stimulates the production of many 
cellular substances, such as cytokines, NO, vasoactive peptides, pro-coagulant factors, and 
prostaglandins, both in vitro and in vivo [15]. Earlier reports indicate that LPS and cytokines, such as 
TNF-α and IL-1β, induce apoptotic necrosis in cells and tissues [20,21]. Furthermore, LPS activates 
NF-κB, which activates many mediators including pro- and anti-inflammatory cytokines such as  
TNF-α ,IL-1β, IL6 and IL-10 [22]. These cytokines enhance vascular permeability, stimulate the 
expression of adhesion molecules on endothelial cells, and induce infiltration of cells from the blood to 
tissues [23]. Sepsis-induced acute lung injury is a major clinical problem with significant morbidity 
and mortality [24–26]. PMNLs are thought to contribute significantly to the pathophysiologic features 
of acute lung injury [27–31]. A pathological hallmark of acute lung injury is subsequent tissue 
infiltration of neutrophils and pulmonary microvascular sequestration [32,33]. Enhanced pulmonary 
neutrophil sequestration and infiltration during sepsis changes the neutrophil profile by increasing 
neutrophil surface expression and activating cell-cell adhesion molecules, and enhancing the release of 
soluble mediators, production of cytokines, and generation of reactive oxygen species, NO, and 
ONOO
−
 [34–38]. Acute lung injury is characterized by increased MPO activity, a marker of neutrophil 
infiltration, increased expression and activity of cytokines and iNOS, high-protein pulmonary edema, 
and oxidant stress [31,39]. Pulmonary microvascular neutrophil sequestration and tissue infiltration are 
hallmarks of the pathogenesis of acute lung injury [33,40,41]. The present study is in agreement with 
previous studies showing that sepsis induces changes in pulmonary microvascular neutrophil 
sequestration and alveolar neutrophil infiltration, [34–36,42] as clearly shown in the untreated group 
but not in the honey-treated group (Figures 1 and 2). In addition, honey treatment decreased lung 
injury by inhibiting MPO activity. Therefore, as reported in our previous studies, honey may decrease 
lung injury through systemic inhibition of cytokines such as PGE2 and NO [9,10].  
In this study, the reductions in RBC, WBC, and platelet counts observed in the untreated group 
confirm those seen in earlier reports [43,44]. Treatment with honey significantly attenuated the severe 
reductions in blood counts (WBC and RBC) and thrombocytopenia, suggesting that honey has a 
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protective role against sepsis-induced disseminated intravascular coagulation. LPS causes disseminated 
intravascular coagulation, which is associated with coagulation disorders and loss of platelets. In the 
liver, LPS causes increases in AST, ALT, γ-GT, and lipid profiles [43,45–49], which are all markers of 
hepatic damage [44,49,50]. Our results confirm that sepsis caused liver failure, as shown by 
significantly elevated serum levels of AST, ALP, and γ-GT in the untreated group; honey inhibited 
these increases. Improved liver function tests after honey treatment indicate that honey may potentially 
protect liver cells from sepsis. Lipid profiles showed that cholesterol, triglycerides, and LDL levels 
were significantly increased in the LPS-induced untreated sepsis group but not in the honey-treated 
group. However, the HDL levels were significantly lower in the untreated group. Injection of LPS into 
animals induces renal dysfunction characterized by increased blood urea nitrogen and plasma 
creatinine levels [45,51]. Urea nitrogen and plasma creatinine levels were increased by LPS injection, 
but were lower in the honey-treated group than in the untreated group. Both our previous studies and 
the above results show that LPS increased the levels of hepatic damage markers, modified lipid 
metabolism, and increased lipid profiles, hematological values, and renal dysfunction [52]. Our results 
also show that Gelam honey protects organs from immune responses induced by lethal doses of LPS. 
Our previous study showed that Gelam honey contains many phenolic compounds with antioxidant and 
anti-inflammatory activity. In addition, its inhibitory effect on cytokines (TNF-α, IL-1β, and IL-10), 
high-mobility group protein 1 (HMG-1), and NO both in vitro and in vivo were studied [9,10,53]. 
Gelam honey also showed potent induction of HO-1, a molecule related to oxidative stress [53]. These 
activities, including the inhibition of cytokines and NO during severe sepsis, suggest that honey may 
be useful for the treatment of sepsis. The phenolic compounds in Gelam honey play a role in protecting 
tissues from LPS and free radicals due to their antioxidant activity, such as scavenging oxygen radicals, 
NO, and lipid radicals [54], and preventing cancer and various inflammatory disorders, such as 
arthritis and septic shock induced by endotoxemia [55–58]. The beneficial effects of honey, which 
include preventing histological changes and hypoxia in the organs of rabbits treated with LPS, may be 
directly related to its antioxidant activity, or indirectly related to the inhibition of PMNL chemotaxis, 
thereby preventing the production of the chemotactic agents implicated in tissue damage. We showed 
previously that Gelam honey has potent antioxidant activity and inhibits mediators of inflammation, 
such as cytokines, NO and PGE2 [9,10,53]. Allergic reactions constitute a potentially serious 
contraindication for injecting people with honey because honey contains bee-secreted and plant pollen-
derived proteins that are known to induce allergic reactions [59].  
4. Experimental Section 
4.1. Preparation of Honey  
Malaysian Gelam honey (Melaleuca spp.) was purchased from the department of Agriculture, Batu 
Pahat, Johor, Malaysia, and sent to Malaysian Nuclear Agency for sterilization using a Cobalt-60 
source (Model JS10000). Honey was mixed with saline and filtered through a 0.20 µm syringe filter 
before injection. 
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4.2. Animals 
Mice Balb/c mice (6–7 weeks of age) and New Zealand white male rabbits weighing 25 g and 2 kg, 
respectively, were kept in individual cages under standard conditions (12 h light and 12 h dark 
conditions); water and chow diet were available ad libitum. The study was carried out in accordance 
with the University of Malaya Animal Ethics Committee guidelines for animal experimentation and 
followed the approved protocols outlined in the project license (ANES/14/07/2010/MKAK (R)). 
4.3. Toxicity Tests  
The toxicity of Gelam honey was evaluated in mice (n = 8) for 1 month prior to the study. Four 
different doses of honey (10, 60, 300, and 600 mg/kg diluted in saline) were administered daily by 
injection into the tail vein (final volume, 100 µL). The control group received a similar volume of 
saline. Mice were observed for 3 h after injection. Symptoms and mortality were recorded for all 
groups. At the end of the study, all mice were sacrificed, and blood and organs were collected. 
Compared with the control group, the treated groups showed no abnormalities on biochemical and 
histopathological analysis of the liver, lungs, and kidneys (data not shown). 
4.4. Induction of an Immune Response in Rabbits by LPS Stimulation and Treatment with Honey  
New Zealand white male rabbits were divided into six groups (N = 6) of six animals (n = 6) and 
each group was treated as described below. An immune response was induced in four groups by 
intravenous injection of 0.5 mg/kg LPS (B: 0111; Sigma, St. Louis, MO, USA) diluted in saline. One 
hour before LPS injection, honey (500 mg/kg diluted in saline) was injected into the rabbits from two 
groups (treated group), while saline was injected into the rabbits from another two groups (untreated 
groups). The two remaining groups acted as negative controls and were given saline only and no LPS. 
All doses were administered in a final volume of 1 mL and were mixed immediately prior to injection. 
Three groups, one from each treatment stream, were used for biochemical and histopathological 
studies and assessment of myeloperoxidase (MPO) activity as described below, while the remaining 
three groups were used to assess survival rates. Survival was monitored every 12 h for 15 days. 
4.5. Biochemical Analysis 
Blood samples were collected from the ears of rabbits after 8 h of LPS injection. Serum was 
separated by centrifugation at 3000 × g at 23 °C, and hematological and biochemistry analysis were 
performed using an automated hematology cell counter analyzer (Sysmex XE-2100, Sysmex America, Inc.) 
and Advia 2400 Chemistry System (Siemen, Eschborn, Germany), respectively, in the clinical 
diagnostic laboratory at University of Malaya Medical Center. Biochemical analyses included 
measurement of glucose, liver, and kidney functions. The parameters used for hematological analysis 
were red blood cell count (RBC), white blood cell count (WBC), and platelet counts. Arterial blood 
samples were collected to measure pH, pO2, pCO2, and HCO3 using a blood gas analyser at the same 
time as the other biomedical tests were performed.  
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4.6. Myeloperoxidase Assay 
Neutrophil infiltration into the lungs was monitored by measuring MPO activity as previously 
reported [60]. Briefly, tissue specimens were homogenized at 50 mg/mL in PBS (50 mM, pH 6.0) 
containing 0.5% exadecyltrimethylammonium bromide (Sigma-Aldrich). Samples were freeze-thawed 
three times and centrifuged at 13,000 rpm for 20 min. The supernatants were diluted 1:30 in assay 
buffer (50 mM PBS pH 6.0 containing 0.167 mg/mL o-dianisidine; (Sigma-Aldrich) and 0.0005% 
H2O2), and the colorimetric reaction was measured at 450 nm for between 1 and 3 min in a 
spectrophotometer (Microplate reader, Model 680, Life Science Research, Bio-Rad). MPO activity/g 
of wet tissue was calculated as follows: MPO activity (U/g wet tissue) = (A450) (13.5)/tissue weight (g), 
where A450 is the change in the absorbance of 450 nm light between 1 and 3 min after the initiation of 
the reaction. The coefficient 13.5 was empirically determined such that 1 U MPO activity 
corresponded to the amount of enzyme that reduced 1 μmol peroxide/min. 
4.7. Histopathology 
Liver, lung, heart, and kidney tissues were fixed in 10% formalin after the organs were dehydrated 
using graded ethanol solutions, cleared with xylene, paraffin embedded, sectioned, and stained with 
hematoxylin and eosin. Pathological changes were evaluated under a light microscope by a pathologist. 
4.8. Statistical Analysis 
All data are expressed as the mean ± confidence interval. Data were analysed using GraphPad prism 
statistical software (San Diego, CA, USA) for non-parametric analysis of variance. Kaplan–Meier 
analysis was used to compare survival rates. Differences were considered statistically significant at  
P < 0.05. 
5. Conclusions  
In summary, Gelam honey protects organs from lethal doses of LPS by improving organ functions, 
reducing infiltration by PMNs that cause tissue damage, reducing MPO activity and increasing the 
survival rate. 
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Abstract: Monocytes and macrophages are part of the first-line defense against bacterial, 
fungal, and viral infections during host immune responses; they express high levels of 
proinflammatory cytokines and cytotoxic molecules, including nitric oxide, reactive 
oxygen species, and their reaction product peroxynitrite. Peroxynitrite is a short-lived 
oxidant and a potent inducer of cell death. Honey, in addition to its well-known sweetening 
properties, is a natural antioxidant that has been used since ancient times in traditional 
medicine. We examined the ability of Gelam honey, derived from the Gelam tree 
(Melaleuca spp.), to scavenge peroxynitrite during immune responses mounted in the 
murine macrophage cell line RAW 264.7 when stimulated with lipopolysaccharide/ 
interferon-γ (LPS/IFN-γ) and in LPS-treated rats. Gelam honey significantly improved  
the viability of LPS/IFN-γ-treated RAW 264.7 cells and inhibited nitric oxide  
production—similar to the effects observed with an inhibitor of inducible nitric oxide 
synthase (1400W). Furthermore, honey, but not 1400W, inhibited peroxynitrite production 
from the synthetic substrate 3-morpholinosydnonimine (SIN-1) and prevented the 
peroxynitrite-mediated conversion of dihydrorhodamine 123 to its fluorescent oxidation 
product rhodamine 123. Honey inhibited peroxynitrite synthesis in LPS-treated rats. Thus, 
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honey may attenuate inflammatory responses that lead to cell damage and death, 
suggesting its therapeutic uses for several inflammatory disorders. 
Keywords: inflammation; honey; nitric oxide; peroxynitrite; macrophage 
 
1. Introduction 
Monocytes and macrophages play critical roles in innate immunity. Specifically, these cells act as a 
part of the first-line defense against bacterial, fungal, and viral infections during host immune 
responses [1] by expressing high levels of proinflammatory cytokines such as tumor necrosis factor 
(TNF)-α, interferon (IFN)-γ, and interleukin (IL)-1β, and cytotoxic molecules such as nitric oxide (NO) 
and reactive oxygen species (ROS) [2,3]. The inflammatory response is accompanied by the 
upregulation of a lipopolysaccharide (LPS)-inducible isoform of NO synthase (iNOS) [4], the 
expression of which is correlated with the degree of inflammation [5] as well as the presence of NO. 
However, in addition to their defensive roles, proinflammatory responses can damage DNA and other 
cellular structures, activating necrosis, apoptosis, and potentially, tumorigenesis [6,7]. 
Of the inflammatory modulators produced in response to LPS, NO is implicated in both acute and 
chronic models of inflammation, including septic shock [8], where there is extensive damage to host 
tissues. The damage is, in part, due to the reaction of NO with superoxide radicals, resulting in the 
formation of peroxynitrite (ONOO
−
). This short-lived oxidant species profoundly influences the 
inflammatory response at multiple cellular levels and is a potent inducer of cell death [9]. The 
biological targets of peroxynitrite include membrane, cytosolic, and nuclear receptors [9]. During 
inflammation, peroxynitrite also reacts with inflammatory mediators such as interleukins, and  
with iNOS, either triggering or enhancing proinflammatory pathways mediated by nuclear factor  
(NF)-κB [10]. Furthermore, the reaction products of peroxynitrite are detected in several pathological 
conditions, including vascular diseases, ischemia-reperfusion injury, circulatory shock, inflammation, 
pain, and neurodegeneration. Conversely, studies in animal models of inflammation and reperfusion 
injury have shown a protective effect for compounds that either inhibit peroxynitrite formation or 
accelerate its decomposition [9,11–16]. 
Honey is a well-known natural sweetener; this property is conferred by its complex mixture of 
carbohydrates, which are the main constituents of honey and are produced by honeybees from nectar 
sucrose. Monosaccharides, including fructose and glucose, are the major carbohydrates in honey; 
disaccharides (such as maltose and sucrose), trisaccharides (such as maltotriose and panose), and 
oligosaccharides are also present in honey [17–22]. In addition, honey also contains minerals, vitamins, 
enzymes, flavonoids, and phenolic compounds, making it a natural antioxidant [23]. Indeed, honey has 
been used in traditional medicine since ancient times [24]. It has potential effects in high oxidative 
stress conditions, and its ability to modulate antioxidant enzymes as well as its antioxidative properties 
provide protective effects against oxidative stress [25,26]. Recent studies demonstrated a strong 
correlation between the content of phenolic compounds in honeys from various floral sources and their 
antioxidant capacity and beneficial effects in human health [27–31]. One of the potential benefits of 
phenolic compounds is that they stabilize cell membranes by reducing lipid peroxidation and 
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scavenging free radicals, [32] and they simultaneously enhance membrane integrity against several 
chemical and physical stress conditions [33]. Various studies investigated the potential protective 
effects of phenolic compounds against oxidative damage to red blood cells [34,35]. Honey 
demonstrated strong reducing activity against free radicals, with significant suppression/prevention of 
cell damage, complete inhibition of cell membrane oxidation and intracellular ROS production, and 
recovery of intracellular glutathione in cultured endothelial cells. This protective effect is mainly 
attributed to phenolic acids and flavonoids [36]. The phenolic compounds in honey were found to 
scavenge free radicals and prevent the production of malondialdehyde, a biomarker of oxidative 
damage, in a concentration-dependent manner [36,37]. 
Gelam honey is derived from the nectar of the Gelam tree (Melaleuca spp.), which grows in the 
forests of Malaysia. [38,39]. Gelam honey is reported to have a high phenolic content, with many 
phenolic compounds isolated from it, such as gallic acid, chlorogenic acid, caffeic acid, p-coumaric 
acid, ferulic acid, ellagic acid, quercetin, hesperetin, luteolin, kaempferol, and chrysin [40]. A previous 
study showed that Gelam honey exhibited antibacterial activity and free radical scavenging activity 
because of its phenolic compounds; furthermore, Gelam honey inhibited inflammation in vitro and  
in vivo [38–42]. It is also a potent inducer of heme oxygenase-1 (HO-1) and significantly reduces 
DNA damage and plasma malondialdehyde levels [41,43]. In this study, we tested the ability of Gelam 
honey to scavenge peroxynitrites in LPS/IFN-γ-stimulated murine macrophages (RAW 264.7) in vitro, 
and in a rat model of inflammation in vivo. Therefore, in this study, we carefully examined the 
cytoprotective effects of Gelam honey under the cellular damage conditions induced by two doses of 
LPS. In parallel, the effect of NO on murine macrophage (RAW 264.7) cell viability was  
also examined. 
2. Results  
2.1. Effect of Gelam Honey on Untreated and LPS/IFN-γ-Stimulated Cells 
In RAW 264.7 cells, none of the doses of honey resulted in cytotoxicity, and the concentrations of 
honey did not affect cell viability (Figure 1). However, the viability of cells stimulated with 1 µg/mL 
LPS and 35 ng/mL IFN-γ was <68% of the control (untreated) value. 
In contrast, as shown in Figure 2A, pretreatment with honey had a protective effect on  
LPS/IFN-γ-stimulated cells, significantly increasing their viability to >76% (p < 0.03), whereas the 
viability of cells pretreated with 1400W was >90% (p < 0.001). Increasing the LPS concentration to  
3 µg/mL significantly reduced the viability of the untreated cells to <50% of the control value, whereas 
the addition of honey increased viability to >69% (p < 0.001), and the addition of 1400W resulted 
in >79% viability (p < 0.001) (Figure 2B). 
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Figure 1. Effect of honey and the iNOS inhibitor 1400W on the viability of RAW 264.7 
macrophages. Cells were treated or not treated (control) with the indicated concentrations 
of honey or 100 µM 1400W. Cell viability was determined by the mitochondrial reduction 
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Data are expressed 
as the mean ± SEM of five independent experiments performed in triplicate. The viability 
of untreated cells was defined as 100%. 
 
Figure 2. Cytoprotective effect of honey against LPS/IFN-γ-induced cytotoxicity. RAW 
264.7 cells were incubated with either 1 µg/mL LPS and 35 ng/mL IFN-γ (A) or 3 μg/mL 
LPS and 35 ng/mL IFN-γ (B), and with various concentrations of honey or 100 µM of the 
iNOS inhibitor 1400W. The negative control was completely untreated (control), and the 
positive control was treated only with LPS/IFN-γ (LPS). After 24 h incubation, cell 
viability was determined using an MTT assay. *** p < 0.001 and ** p < 0.003 indicate 
significant differences compared with the LPS/IFN-γ group. 
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Honey also significantly inhibited NO formation in cells that were stimulated with the indicated 
concentration of LPS (1 μg/mL or 3 μg/mL). A dose-dependent effect was observed at higher 
concentrations of honey (Figure 3). 
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Figure 3. Effect of honey on NO production. NO production was estimated in RAW 264.7 
macrophages pretreated for 1 h with the indicated concentrations of honey or the iNOS 
inhibitor 1400W (100 µM) and then exposed to 1 μg/mL LPS and 35 ng/mL IFN-γ (A) or  
3 μg/mL LPS and 35 ng/mL IFN-γ (B) for 24 h. Nitrite accumulation in the supernatant 
was measured by the Griess reaction. All results are expressed as a percentage of the  
LPS/IFN-γ control (mean ± SEM of 5 independent experiments performed in duplicate). 
*** p < 0.001, ** p < 0.003, and * p < 0.05 indicate significant differences compared with 
the LPS/IFN-γ group. 
 
2.2. Effect of Gelam Honey on Peroxynitrite in vitro and in vivo 
An increase in the oxidation of dihydrorhodamine 123 (DHR-123) is indicative of the presence of 
peroxynitrite. In the 3-morpholinosydnonimine (SIN-1) model, honey was found to be a potent 
scavenger of peroxynitrite, inhibiting the SIN-1–induced oxidation of DHR-123 to rhodamine 123 
with a half-maximal inhibitory concentration (IC50) of 0.148 mg/mL. Highly significant levels of 
oxidation were recorded in the presence of the iNOS inhibitor 1400W and in the (untreated) positive 
control (Figure 4A). To directly confirm the peroxynitrite scavenging activity of honey, peroxynitrite 
was incubated with or without different concentrations of honey (Figure 4B). In these experiments, 
honey also inhibited DHR-123 oxidation, presumably by scavenging peroxynitrite, with an IC50 of 
0.68 mg/mL. However, oxidation was not inhibited by 1400W because the level of rhodamine 123 
fluorescence was the same as that in the untreated control (Figure 4B). The addition of Gelam honey to 
RAW 264.7 cells that were induced with LPS/IFN-γ for 24 h also completely attenuated peroxynitrite 
activity and had an IC50 of 0.254 mg/mL (Figure 4C). In this experiment (unlike the previous  
2 experiments), peroxynitrite synthesis was inhibited, and DHR-123 was not converted to its 
fluorescent product because cellular iNOS was blocked by 1400W (100 µM) (Figure 4C). 
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Figure 4. Effect of honey on the peroxynitrite-induced oxidation of DHR-123. (A) SIN-1, 
a peroxynitrite donor, was incubated for 2 h with different dilutions of honey (in PBS), 
1400W (100 µM), and DHR-123, and the formation of rhodamine 123 was measured;  
(B) Honey (different dilutions in PBS) or 1400W (100 µM) were incubated for 15 min 
with DHR-123 and peroxynitrite, and the formation of rhodamine 123 was measured;  
(C) RAW 264.7 cells were incubated with honey (different dilutions in PBS), 1400W  
(100 µM), and DHR-123 for 60 min. Then, LPS/IFN-γ was added, and the cultures were 
incubated for an additional 24 h, after which the formation of rhodamine 123 was 
measured. Results are expressed as a percentage of the control (mean ± SEM of  
3 independent experiments performed in triplicate). *** p < 0.001 and ** p < 0.003. 
Rhodamine 123 formation in the untreated control was defined as 100%. 
 
 
Pretreatment with 50 mg/kg or 500 mg/kg of honey also significantly inhibited peroxynitrite 
formation in rats, albeit not in a dose-dependent manner. Inhibition was determined by a reduction in 
3-nitrotyrosine, which is an in vitro marker of peroxynitrite (Figure 5). 
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Figure 5. Effect of honey on the concentration of 3-nitrotyrosine in rat serum. Treated 
groups of animals were intravenously injected with either honey (50 or 500 mg/kg diluted 
in saline) or saline alone. One hour later, the treated animals were injected with LPS  
(5 mg/kg), and 4 h later, the treated and untreated rats were killed. The sera were collected 
and assayed for the presence of 3-nitrotyrosine. Data are expressed as the mean ± SEM. 
*** p < 0.001 and * p < 0.05 compared with the positive (LPS alone) control. 
 
3. Discussion 
This study investigated the ability of honey to modulate peroxynitrite-induced cell damage in 
LPS/IFN-γ-stimulated cultured macrophages and in a rat model of LPS-induced inflammation. The 
data presented here suggest that honey, through its antioxidant properties, is able to protect host 
immune cells from the inflammation-mediated cytotoxicity that develops in response to LPS 
stimulation. Gelam honey prevented the LPS-mediated decrease in RAW 264.7 cell viability caused by 
the high production of cytotoxic molecules such as cytokines, ROS, NO, and peroxynitrite [1]. Honey 
apparently scavenged peroxynitrite
 
in RAW 264.7 cells induced with LPS/IFN-γ in vitro. Inhibitory 
effects were also observed upon incubation with the substrate SIN-1, a peroxynitrite donor, and with 
peroxynitrite itself. The ability of honey to scavenge peroxynitrite in tissues in vivo was demonstrated 
by the absence of 3-nitrotyrosine, a peroxynitrite marker, from rat serum. 
Excess NO production is cytotoxic and has a broad spectrum of cellular effects. In RAW 264.7 
macrophages, there was a pronounced increase in NO production and a significant decrease in cell 
viability after stimulation with LPS/IFN-γ, which is known to induce iNOS and thus increase cellular 
NO concentrations. This decrease in viability was much less pronounced in the presence of 1400W, 
suggesting that cytotoxicity was induced by iNOS and NO. In fact, NO production, measured as nitrite 
in the Griess reaction, was almost completely inhibited by iNOS inhibition. 
The mechanism by which NO mediates toxicity includes the generation of reactive nitrogen 
derivatives such as peroxynitrite, which acts upon multiple cellular targets, including DNA and various 
proteins [44]. Thus, cellular exposure to high concentrations of peroxynitrite often leads to rapid, 
necrotic-type cell death due to acute and severe cellular energetic derangements [11,45,46]. In contrast, 
lower concentrations of peroxynitrite trigger delayed apoptosis that is mainly dependent on the activation 
of caspases 3, 2, 8, and 9, similar to other forms of oxidant/free radical-mediated apoptosis [47–50]. 
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The effects of NO on cell viability are proportional to the cellular non-heme iron content. Thus, NO 
induces apoptosis in cells with a low non-heme iron level, such as RAW 264.7 macrophages, whereas 
it induces necrosis in cells with a high non-heme iron level, such as hepatocytes [51]. For example, NO 
induces both caspase-3 activation and cytochrome c release in apoptotic RAW 264.7 cells, and a 
caspase-3 inhibitor prevents NO-mediated RAW 264.7 apoptotic cell death [51]. NO readily reacts 
with non-heme iron to form iron-nitrosyl complexes [52,53], which are thought to protect cells from 
NO-induced toxicity by a scavenging mechanism [53]. Alternatively, NO may be converted to  
S-nitrosylating species, which act as potent regulatory molecules in a variety of cell types and cellular 
functions [54,55]. 
Recent studies show that peroxynitrite stimulates the release of the mitochondrial apoptosis-inducing 
factor, which subsequently triggers DNA fragmentation [56], release of mitochondrial pro-apoptotic 
factors, and cytochrome c-dependent apoptosis in the cytosol, through peroxynitrite-dependent 
oxidation of the mitochondrial permeability transition pore. The key role of peroxynitrite in promoting 
mitochondrial dysfunction is clearly exemplified in experimental sepsis, in which peroxynitrite 
production results in the inhibition of mitochondrial respiration in the diaphragm in a process 
associated with mitochondrial protein nitration. The latter is prevented by NO synthase inhibitors and 
Mn-porphyrin therapy [57]. Peroxynitrite-induced activation of the MLK/p38/JNK pathway also plays 
a crucial role in apoptosis [58–60]. This study shows that honey can inhibit NO production, and thus 
peroxynitrite formation, thereby reducing the effects of these cytotoxic compounds both in vitro and  
in vivo. Moreover, scavengers of peroxynitrite are known to be protective against tissue damage [9]. 
Some scavengers of peroxynitrite, such as uric acid, ebselen, mercaptoalkylguanidines, N-acetylcysteine, 
and dihydrolipoic acid, and some chemicals that work as decomposition catalysts of peroxynitrite, 
such as metalloporphyrins of iron and manganese, can attenuate the toxic effects of peroxynitrite  
in vitro and in vivo [11,16,61–68]. These compounds can reduce 3-nitrotyrosine immunoreactivity in 
various pathophysiological conditions and have beneficial effects in animal models of inflammation, 
sepsis, and reperfusion injury [57,68–77]. Many phenolic compounds, such as gallic acid, caffeic acid, 
kaempferol, ferulic acid, p-coumaric, and quercetin have been shown to inhibit peroxynitrite. 
Monohydroxylated phenolic compounds, such as ferulic acid and p-coumaric acid, act as peroxynitrite 
scavengers by nitration. On the other hand, compounds with a catechol moiety, such as caffeic acid 
and chlorogenic acid, reduce peroxynitrite by electron donation [66,78]. Interestingly, all of the above 
phenolic compounds were identified in Gelam honey [40]. Data from this study was in agreement with 
that of previous studies as described earlier. Moreover, a direct interaction through nitration and 
electron donation between honey and peroxynitrite is suggested by the results of the experiments 
involving SIN-1 and the direct incubation of honey and peroxynitrite. In addition, the presence of 
phenolic compounds in Gelam honey that act as potent scavengers of peroxynitrite, as described above, 
supports this hypothesis. In our previous studies, we demonstrated the anti-inflammatory activity of 
Gelam honey and its methanol and ethyl acetate extracts, on the basis of their abilities to suppress NO 
production in macrophages and rat inflammation models, inhibit the release of NO-induced cytokines 
(such as TNF-α, IL-1β, and IL-10) and high mobility group protein 1 (HMGB1), induces HO-1 in 
animal models, and protects organs from lethal doses of LPS that induce sepsis [39–41,79]. Gelam 
honey also inhibited iNOS protein expression in an animal model [80]. The results of this study 
support these previous findings, confirming the protective effects of honey mediated through the 
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inhibition of NO and its derivatives (ONOO
−
) and, thus, its ability to prevent inflammatory-type 
cytotoxicity both in cultured macrophages and in animals. 
The antioxidant and radical-scavenging abilities of Gelam honey are attributable to its phenolic 
compounds, which were also identified and quantified in previous studies [38]. The potential of Gelam 
honey to reduce LPS-induced inflammation is also mediated by its ability to reduce the release of 
proinflammatory cytokines and prostaglandin (PG) E2, both of which play a central role in 
inflammation [39,79]. In these studies, the reduced release of cytokines such as TNF-α, IL-1β, and IL-10 
was quite dramatic in an endotoxemia model. This finding is particularly relevant to macrophages, 
where these mediators play a fundamental role in cell activation because they are released during the 
early stages of the inflammatory cascade [81]. In addition, honey may suppress NF-κB activation 
through other biologically active components, and consequently, inhibit iNOS induction [82,83]. 
Taken together, our work supports further investigations into the use of honey as a natural antioxidant, 
based on its ability to protect cells by inhibiting NO production, scavenging peroxynitrite, and 
modulating other inflammatory mediators such as PGE2, HMGB1, HO-1, and cytokines. The 
involvement of mechanisms other than iNOS inhibition, NO production, and peroxynitrite scavenging 
in these processes is suggested because low doses of honey had no effect on NO synthesis but did 
increase the viability of cells treated with LPS. 
4. Experimental Section 
4.1. Preparation of Gelam Honey 
Fresh Malaysian honey, Apis mellifera (Gelam), was obtained from the National Apiary 
(Department of Agriculture, Parit Botak, Johor, Malaysia) and sent to the Malaysian Nuclear Agency 
for sterilization using a cobalt-60 source (model JS10000). Before its use in the in vitro and in vivo 
experiments described below, the sterilized honey was passed through a 0.20-µm filter syringe. The 
following concentrations were tested: 0.039, 0.078, 0.15, 0.31, 0.62, 1.25, 2.5, and 5 mg/mL. 
4.2. Animals 
Male Sprague–Dawley rats weighing 300–350 g were housed in individual cages under standard 
conditions (12 h light and 12 h dark). The animals were fed a diet of Purina lab chow and given water 
ad libitum. The study was carried out in accordance with the guidelines for animal experimentation of 
the University of Malaya Animal Ethics Committee and the protocols were approved under the terms 
set out: project license ANES/14/07/2010/MKAK (R). 
4.3. Cell Culture and Reagents 
The murine macrophage cell line RAW 264.7 was maintained in Dulbecco’s Modified Eagle 
Medium (DMEM), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 100 U/mL 
penicillin, and 100 U/mL streptomycin in a humidified 37 °C, 5% CO2 incubator. DMEM without 
phenol red, FBS, and antibiotics (penicillin, streptomycin) were purchased from Nacalai Tesque 
(Kyoto, Japan). LPS (Escherichia coli 0111 B4), iNOS inhibitor (1400W), and IFN-γ were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). 
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4.4. LPS/IFN-γ Stimulation of RAW 264.7 Cells 
RAW 264.7 cells were grown in 10% FBS-DMEM and seeded at a density of 2 × 10
6
 in a 24-well 
plate, followed by incubation for 24 h at 37 °C. The cells were then washed with PBS and resuspended 
in fresh medium containing different concentrations of Gelam honey (0.039–5 mg/mL) or 100 µM of 
1400W. Untreated cells were included as positive or negative controls in each experiment. One hour 
later, 1 or 3 µg/mL of LPS and 35 ng/mL of IFN-γ were added to the cultures, followed by incubation 
for 24 h at 37 °C and 5% CO2 [84]. The cells were then processed for viability or NO or peroxynitrite 
detection as described below. 
4.5. Measurement of Mitochondrial Respiration 
The viability of RAW 264.7 macrophages was determined in cultures treated or not treated with 
LPS/IFN-γ and different concentrations of Gelam honey or 1400W. The viability was measured in 
terms of cellular respiration as assessed by the mitochondrial-dependent reduction of MTT to 
formazan. Cells were cultured, stimulated with LPS, and treated with honey or 1400W as described 
above, after which 100 µL of MTT (5 mg/mL) was added to each well, followed by 1 h incubation 
under the same conditions. The MTT solution was then removed and the cells were solubilized in  
200 µL DMSO with shaking for 5 min. The absorbance was measured at 550 nm using a microplate 
reader (GloMax
®
-Multi Microplate detection; Promega, Madison, WI, USA) [85]. All experiments 
were repeated 5 times in triplicate. 
4.6. Nitric Oxide Assay 
Nitric oxide has a half-life of only a few seconds before it is quickly converted to nitrate and nitrite. 
These products can be measured using the colorimetric Griess reaction to indirectly determine the NO 
concentration. Therefore, RAW 264.7 cells were cultured and treated as described in Subsection 4.4 
(LPS/IFN-γ stimulation of RAW 264.7 cells), after which 100 µL of the culture was placed in a  
96-well plate, together with an equal amount of Griess reagent (50 µL of 1% sulfanilamide in 5% 
concentrated H3PO4 and 50 µL of 0.1% naphthylethylenediamine dihydrochloride in distilled water). 
The reaction between the Griess reagent and the nitrite present in the supernatant yields a pink 
derivative that can be spectrophotometrically quantified from a concentration curve prepared from a 
nitrite standard [40]. 
4.7. DHR-123 Oxidation Assay 
4.7.1. DHR-123 Oxidation Using SIN-1 
SIN-1 spontaneously releases NO and superoxide under physiological conditions. At pH 7.4, SIN-1 
is converted to SIN-1A via base-catalyzed ring opening. During ring opening, the oxygen undergoes 
univalent reduction to O2
−
. SIN-1A then releases NO and is converted to the stable metabolite SIN-1C, 
whereas the O2
−
 radical reacts with NO to form peroxynitrite (ONOO
−
). The oxidation of DHR-123 by 
ONOO
−
 results in the formation of fluorescent rhodamine 123, the amount of which can be measured 
by fluorometric analysis (GloMax
®
-Multi Microplate) at an excitation wavelength of 460–530 nm and 
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an emission wavelength of 530–590 nm. In experiments examining the effects of honey on 
peroxynitrite scavenging, 100 µM of SIN-1 was used and the reactions were carried out in PBS, with 
the incubation of the samples for 2 h at 37 °C [84]. 
4.7.2. DHR-123 Oxidation Using Peroxynitrite 
The ability of peroxynitrite to oxidize DHR-123, thus converting it to rhodamine 123, was also 
measured directly as previously described [9]. Briefly, 10 µM peroxynitrite was mixed in PBS 
containing 20 µM DHR-123, in the absence or presence of either honey (0–5 mg/mL) or 100 µM of 
1400W. After a 15-min incubation period at room temperature, the fluorescence of the rhodamine  
123 reaction product was measured (GloMax
®
-Multi Microplate) at an excitation wavelength of  
460–530 nm and an emission wavelength of 530–590 nm. 
4.7.3. DHR-123 Oxidation by LPS/IFN-γ-Treated RAW 264.7 Cells 
Cells were cultured, stimulated with LPS, and treated with honey or 1400W as described in 
subsection 4.4 (LPS/IFN-γ stimulation of RAW 264.7 cells) in the presence of 10 µM DHR-123. After 
24 h, 100 µL of the culture suspension was removed, and the amount of rhodamine 123 was 
determined fluorometrically. 
4.8. Induction of an Immune Response in LPS-Stimulated Rats and the Effects of Honey 
Rats were divided into four groups of six animals each. An immune response was induced in the 
animals in three of the four groups by intravenous injection of 5 mg/kg LPS (0111B4; Sigma) diluted 
in saline. One of these groups served as the positive control (LPS only), whereas the other two groups 
were intravenously injected with 50 or 500 mg/kg honey diluted in saline. The fourth (negative control) 
group was given saline only. All doses of LPS and honey were prepared immediately before injection, 
and 0.5 mL of the preparations were injected. The blood was collected (by cardiac puncture) from rats 
4 h after the immune response was induced. The levels of 3-nitrotyrosine in the sera were measured 
using an ELISA kit according to the manufacturer’s protocol (Cell Biolabs Inc., San Diego, CA, USA). 
4.9. Statistical Analysis 
Student’s t-test and a non-parametric one-way ANOVA were used to determine the statistical 
significance of differences between the experimental and control groups, with p ≤ 0.05 considered to 
be statistically significant. 
5. Conclusion 
In conclusion, our data showed that honey is a potent peroxynitrite scavenger in vitro and in vivo 
that has cytoprotective effects against peroxynitrite-mediated cellular injury and death. Moreover, the 
preservation of cellular viability from peroxynitrite-mediated damage is critical to any consideration of 
the potential therapeutic value of peroxynitrite scavengers in many diseases, including inflammation 
and sepsis. This finding suggests that honey has therapeutic applications for a wide range of 
inflammatory disorders. 
Int. J. Mol. Sci. 2012, 13 12 
 
 
Acknowledgments 
This work was supported in part by grants (No. PV009/2011B, RG031/09HTM, FP036/2010B, and 
RG225/10HTM) from the University of Malaya. 
Conflict of Interest 
The authors declare no conflict of interest. 
References 
1. Sampath, V.; Radish, A.C.; Eis, A.L.; Broniowska, K.; Hogg, N.; Konduri, G.G. Attenuation of 
lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelial 
cells by hypoxia. Free Radical Biol. Med. 2009, 46, 663–671. 
2. Kedzierska, K.; Crowe, S.M. Cytokines and hiv-1: Interactions and clinical implications. Antiviral 
Chem. Chemother. 2001, 12, 133–150. 
3. Hanna, M.G., Jr. Immunologic aspects of bcg-mediated regression of established tumors and 
metastases in guinea pigs. Semin. Oncol. 1974, 1, 319–335. 
4. Sawa, T.; Ohshima, H. Nitrative DNA damage in inflammation and its possible role in 
carcinogenesis. Nitric Oxide 2006, 14, 91–100. 
5. Kimura, H.; Hokari, R.; Miura, S.; Shigematsu, T.; Hirokawa, M.; Akiba, Y.; Kurose, I.;  
Higuchi, H.; Fujimori, H.; Tsuzuki, Y.; et al. Increased expression of an inducible isoform of 
nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active 
ulcerative colitis. Gut 1998, 42, 180–187. 
6. Han, K.Y.; Kwon, T.H.; Lee, T.H.; Lee, S.J.; Kim, S.H.; Kim, J. Suppressive effects of 
lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of ap-1 and  
nf-kappab via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep. 
2008, 41, 328–333. 
7. Dannenberg, A.J.; Altorki, N.K.; Boyle, J.O.; Dang, C.; Howe, L.R.; Weksler, B.B.; 
Subbaramaiah, K. Cyclo-oxygenase 2: A pharmacological target for the prevention of cancer. 
Lancet Oncol. 2001, 2, 544–551. 
8. Petros, A.; Bennett, D.; Vallance, P. Effect of nitric oxide synthase inhibitors on hypotension in 
patients with septic shock. Lancet 1991, 338, 1557–1558. 
9. Szabo, C.; Ischiropoulos, H.; Radi, R. Peroxynitrite: Biochemistry, pathophysiology and 
development of therapeutics. Nat. Rev. Drug Discov. 2007, 6, 662–680. 
10. Zouki, C.; Jozsef, L.; Ouellet, S.; Paquette, Y.; Filep, J.G. Peroxynitrite mediates  
cytokine-induced il-8 gene expression and production by human leukocytes. J. Leukoc. Biol.  
2001, 69, 815–824. 
11. Szabo, C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 2003, 140–141, 105–112. 
12. Lanone, S.; Manivet, P.; Callebert, J.; Launay, J.M.; Payen, D.; Aubier, M.; Boczkowski, J.; 
Mebazaa, A. Inducible nitric oxide synthase (nos2) expressed in septic patients is nitrated on 
selected tyrosine residues: Implications for enzymic activity. Biochem. J. 2002, 366, 399–404. 
Int. J. Mol. Sci. 2012, 13 13 
 
 
13. Whiteman, M.; Ketsawatsakul, U.; Halliwell, B. A reassessment of the peroxynitrite scavenging 
activity of uric acid. Ann. N. Y. Acad. Sci. 2002, 962, 242–259. 
14. Scott, G.S.; Spitsin, S.V.; Kean, R.B.; Mikheeva, T.; Koprowski, H.; Hooper, D.C. Therapeutic 
intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. 
Proc. Natl. Acad. Sci. USA 2002, 99, 16303–16308. 
15. Robinson, K.M.; Morre, J.T.; Beckman, J.S. Triuret: A novel product of peroxynitrite-mediated 
oxidation of urate. Arch. Biochem. Biophys. 2004, 423, 213–217. 
16. Scott, G.S.; Cuzzocrea, S.; Genovese, T.; Koprowski, H.; Hooper, D.C. Uric acid protects against 
secondary damage after spinal cord injury. Proc. Natl. Acad. Sci. USA 2005, 102, 3483–3488. 
17. Sanz, M.L.; Sanz, J.; Martinez-Castro, I. Gas chromatographic-mass spectrometric method for  
the qualitative and quantitative determination of disaccharides and trisaccharides in honey.  
J. Chromatogr. A 2004, 1059, 143–148. 
18. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S. Honey—A novel antidiabetic agent. Int. J. Biol. Sci. 
2012, 8, 913–934. 
19. Munstedt, K.; Bohme, M.; Hauenschild, A.; Hrgovic, I. Consumption of rapeseed honey leads to 
higher serum fructose levels compared with analogue glucose/fructose solutions. Eur. J. Clin. Nutr. 
2011, 65, 77–80. 
20. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S. Fructose might contribute to the hypoglycemic 
effect of honey. Molecules 2012, 17, 1900–1915. 
21. Munstedt, K.; Sheybani, B.; Hauenschild, A.; Bruggmann, D.; Bretzel, R.G.; Winter, D. Effects of 
basswood honey, honey-comparable glucose-fructose solution, and oral glucose tolerance test 
solution on serum insulin, glucose, and c-peptide concentrations in healthy subjects. J. Med. Food 
2008, 11, 424–428. 
22. Gomes, T.; Feas, X.; Iglesias, A.; Estevinho, L.M. Study of organic honey from the northeast 
portugal. Molecules 2011, 16, 5374–5386. 
23. Martos, I.; Ferreres, F.; Yao, L.; D’Arcy, B.; Caffin, N.; Tomas-Barberan, F.A. Flavonoids in 
monospecific eucalyptus honeys from australia. J. Agric. Food Chem. 2000, 48, 4744–4748. 
24. Bertoncelj, J.; Dobersek, U.; Jamnik, M.; Golob, T. Evaluation of the phenolic content, 
antioxidant activity and colour of slovenian honey. Food Chem. 2007, 105, 822–828. 
25. Mohamed, M.; Sulaiman, S.A.; Jaafar, H.; Sirajudeen, K.N. Antioxidant protective effect of 
honey in cigarette smoke-induced testicular damage in rats. Int. J. Mol. Sci. 2011, 12, 5508–5521. 
26. Moskaug, J.O.; Carlsen, H.; Myhrstad, M.C.; Blomhoff, R. Polyphenols and glutathione synthesis 
regulation. Am. J. Clin. Nutr. 2005, 81, 277S–283S. 
27. Morais, M.; Moreira, L.; Feas, X.; Estevinho, L.M. Honeybee-collected pollen from five 
portuguese natural parks: Palynological origin, phenolic content, antioxidant properties and 
antimicrobial activity. Food Chem. Toxicol. 2011, 49, 1096–1101. 
28. Hung, H.C.; Joshipura, K.J.; Jiang, R.; Hu, F.B.; Hunter, D.; Smith-Warner, S.A.; Colditz, G.A.; 
Rosner, B.; Spiegelman, D.; Willett, W.C. Fruit and vegetable intake and risk of major chronic 
disease. J. Natl. Cancer Inst. 2004, 96, 1577–1584. 
29. Schramm, D.D.; Karim, M.; Schrader, H.R.; Holt, R.R.; Cardetti, M.; Keen, C.L. Honey with high 
levels of antioxidants can provide protection to healthy human subjects. J. Agric. Food Chem. 
2003, 51, 1732–1735. 
Int. J. Mol. Sci. 2012, 13 14 
 
 
30. Tartibian, B.; Maleki, B.H. The effects of honey supplementation on seminal plasma cytokines, 
oxidative stress biomarkers, and antioxidants during 8 weeks of intensive cycling training.  
J. Androl. 2012, 33, 449–461. 
31. Estevinho, L.; Pereira, A.P.; Moreira, L.; Dias, L.G.; Pereira, E. Antioxidant and antimicrobial 
effects of phenolic compounds extracts of northeast portugal honey. Food Chem. Toxicol. 2008, 
46, 3774–3779. 
32. Chaudhuri, S.; Banerjee, A.; Basu, K.; Sengupta, B.; Sengupta, P.K. Interaction of flavonoids 
with red blood cell membrane lipids and proteins: Antioxidant and antihemolytic effects.  
Int. J. Biol. Macromol. 2007, 41, 42–48. 
33. Pawlikowska-Pawlega, B.; Gruszecki, W.I.; Misiak, L.E.; Gawron, A. The study of the quercetin 
action on human erythrocyte membranes. Biochem. Pharmacol. 2003, 66, 605–612. 
34. Mendes, L.; de Freitas, V.; Baptista, P.; Carvalho, M. Comparative antihemolytic and radical 
scavenging activities of strawberry tree (arbutus unedo l.) leaf and fruit. Food Chem. Toxicol. 
2011, 49, 2285–2291. 
35. Valente, M.J.; Baltazar, A.F.; Henrique, R.; Estevinho, L.; Carvalho, M. Biological activities of 
portuguese propolis: Protection against free radical-induced erythrocyte damage and inhibition of 
human renal cancer cell growth in vitro. Food Chem. Toxicol. 2011, 49, 86–92. 
36. Beretta, G.; Orioli, M.; Facino, R.M. Antioxidant and radical scavenging activity of honey in 
endothelial cell cultures (ea.Hy926). Planta Med. 2007, 73, 1182–1189. 
37. Blasa, M.; Candiracci, M.; Accorsi, A.; Piacentini, M.P.; Albertini, M.C.; Piatti, E. Raw millefiori 
honey is packed full of antioxidants. Food Chem. 2006, 97, 217–222. 
38. Aljadi, A.M.; Kamaruddin, M.Y. Evaluation of the phenolic contents and antioxidant capacities of 
two malaysian floral honeys. Food Chem. 2004, 85, 513–518. 
39. Kassim, M.; Achoui, M.; Mansor, M.; Yusoff, K.M. The inhibitory effects of gelam honey and its 
extracts on nitric oxide and prostaglandin e(2) in inflammatory tissues. Fitoterapia 2010, 81, 
1196–1201. 
40. Kassim, M.; Achoui, M.; Mustafa, M.R.; Mohd, M.A.; Yusoff, K.M. Ellagic acid, phenolic acids, 
and flavonoids in malaysian honey extracts demonstrate in vitro anti-inflammatory activity.  
Nutr. Res. 2010, 30, 650–659. 
41. Kassim, M.; Yusoff, K.M.; Ong, G.; Sekaran, S.; Yusof, M.Y.; Mansor, M. Gelam honey inhibits 
lipopolysaccharide-induced endotoxemia in rats through the induction of heme oxygenase-1 and 
the inhibition of cytokines, nitric oxide, and high-mobility group protein b1. Fitoterapia 2012, 83, 
1054–1059. 
42. Kassim, M.; Mansor, M.; Al-Abd, N.; Yusoff, K.M. Gelam honey has a protective effect against 
lipopolysaccharide (lps)-induced organ failure. Int. J. Mol. Sci. 2012, 13, 6370–6381. 
43. Yao, L.K.; Abdul Razak, S.L.; Nazhirah, I.; Ng, C.F.; Asyraf, M.H.; Asgar, M.; Nursyahirah, M.S.; 
Aan, G.J.; Jubri, Z. Malaysian gelam honey reduces oxidative damage and modulates antioxidant 
enzyme activities in young and middle aged rats. J. Med. Plant Res. 2011, 5, 5618–5625. 
44. Fang, F.C. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related 
antimicrobial activity. J. Clin. Investig. 1997, 99, 2818–2825. 
45. Jagtap, P.; Szabo, C. Poly(adp-ribose) polymerase and the therapeutic effects of its inhibitors.  
Nat. Rev. Drug Discov. 2005, 4, 421–440. 
Int. J. Mol. Sci. 2012, 13 15 
 
 
46. Virag, L.; Szabo, E.; Gergely, P.; Szabo, C. Peroxynitrite-induced cytotoxicity: Mechanism and 
opportunities for intervention. Toxicol. Lett. 2003, 140–141, 113–124. 
47. Shacka, J.J.; Sahawneh, M.A.; Gonzalez, J.D.; Ye, Y.Z.; D’Alessandro, T.L.; Estevez, A.G. Two 
distinct signaling pathways regulate peroxynitrite-induced apoptosis in pc12 cells. Cell Death Diff. 
2006, 13, 1506–1514. 
48. Virag, L.; Marmer, D.J.; Szabo, C. Crucial role of apopain in the peroxynitrite-induced apoptotic 
DNA fragmentation. Free Radic Biol. Med. 1998, 25, 1075–1082. 
49. Zhuang, S.; Simon, G. Peroxynitrite-induced apoptosis involves activation of multiple caspases in 
hl-60 cells. Am. J. Physiol. Cell Physiol. 2000, 279, C341–C351. 
50. Vicente, S.; Perez-Rodriguez, R.; Olivan, A.M.; Martinez Palacian, A.; Gonzalez, M.P.;  
Oset-Gasque, M.J. Nitric oxide and peroxynitrite induce cellular death in bovine chromaffin cells: 
Evidence for a mixed necrotic and apoptotic mechanism with caspases activation. J. Neurosci. 
Res. 2006, 84, 78–96. 
51. Kim, Y.M.; Chung, H.T.; Simmons, R.L.; Billiar, T.R. Cellular non-heme iron content is a 
determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J. Biol. Chem. 
2000, 275, 10954–10961. 
52. Stadler, J.; Bergonia, H.A.; Di Silvio, M.; Sweetland, M.A.; Billiar, T.R.; Simmons, R.L.; 
Lancaster, J.R., Jr. Nonheme iron-nitrosyl complex formation in rat hepatocytes: Detection by 
electron paramagnetic resonance spectroscopy. Arch. Biochem. Biophys. 1993, 302, 4–11. 
53. Kazmierski, W.M.; Wolberg, G.; Wilson, J.G.; Smith, S.R.; Williams, D.S.; Thorp, H.H.; Molina, L. 
Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. 
Proc. Natl. Acad. Sci. USA 1996, 93, 9138–9141. 
54. Kim, Y.M.; Chung, H.T.; Kim, S.S.; Han, J.A.; Yoo, Y.M.; Kim, K.M.; Lee, G.H.; Yun, H.Y.; 
Green, A.; Li, J.; et al. Nitric oxide protects pc12 cells from serum deprivation-induced apoptosis 
by cgmp-dependent inhibition of caspase signaling. J. Neurosci. 1999, 19, 6740–6747. 
55. Boese, M.; Mordvintcev, P.I.; Vanin, A.F.; Busse, R.; Mulsch, A. S-nitrosation of serum albumin 
by dinitrosyl-iron complex. J. Biol. Chem. 1995, 270, 29244–29249. 
56. Zhang, X.; Chen, J.; Graham, S.H.; Du, L.; Kochanek, P.M.; Draviam, R.; Guo, F.;  
Nathaniel, P.D.; Szabo, C.; Watkins, S.C.; et al. Intranuclear localization of apoptosis-inducing 
factor (aif) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal 
cultures exposed to peroxynitrite. J. Neurochem. 2002, 82, 181–191. 
57. Nin, N.; Cassina, A.; Boggia, J.; Alfonso, E.; Botti, H.; Peluffo, G.; Trostchansky, A.; Batthyany, C.; 
Radi, R.; Rubbo, H.; et al. Septic diaphragmatic dysfunction is prevented by mn(iii)porphyrin 
therapy and inducible nitric oxide synthase inhibition. Intensive Care Med. 2004, 30, 2271–2278. 
58. Trujillo, M.; Budde, H.; Pineyro, M.D.; Stehr, M.; Robello, C.; Flohe, L.; Radi, R. Trypanosoma 
brucei and trypanosoma cruzi tryparedoxin peroxidases catalytically detoxify peroxynitrite via 
oxidation of fast reacting thiols. J. Biol. Chem. 2004, 279, 34175–34182. 
59. Dubuisson, M.; Vander Stricht, D.; Clippe, A.; Etienne, F.; Nauser, T.; Kissner, R.;  
Koppenol, W.H.; Rees, J.F.; Knoops, B. Human peroxiredoxin 5 is a peroxynitrite reductase. 
FEBS Lett. 2004, 571, 161–165. 
Int. J. Mol. Sci. 2012, 13 16 
 
 
60. Rhee, S.G.; Chae, H.Z.; Kim, K. Peroxiredoxins: A historical overview and speculative preview 
of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol. Med. 2005, 38, 
1543–1552. 
61. Spitsin, S.V.; Scott, G.S.; Kean, R.B.; Mikheeva, T.; Hooper, D.C. Protection of myelin basic 
protein immunized mice from free-radical mediated inflammatory cell invasion of the central 
nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 2000, 292, 137–141. 
62. Hooper, D.C.; Spitsin, S.; Kean, R.B.; Champion, J.M.; Dickson, G.M.; Chaudhry, I.; Koprowski, H. 
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and 
multiple sclerosis. Proc. Natl. Acad. Sci. USA 1998, 95, 675–680. 
63. Szabo, C.; Ferrer-Sueta, G.; Zingarelli, B.; Southan, G.J.; Salzman, A.L.; Radi, R. 
Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite 
and protect against peroxynitrite-induced oxidative damage. J. Biol. Chem. 1997, 272, 9030–9036. 
64. Ploner, F.; Radermacher, P.; Theisen, M.; Tugtekin, I.F.; Matejovic, M.; Stehr, A.; Szabo, C.; 
Southan, G.J.; Georgieff, M.; Bruckner, U.B.; et al. Effects of combined selective inos inhibition 
and peroxynitrite blockade during endotoxemia in pigs. Shock 2001, 16, 130–136. 
65. Lancel, S.; Tissier, S.; Mordon, S.; Marechal, X.; Depontieu, F.; Scherpereel, A.; Chopin, C.; 
Neviere, R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and 
inflammation in endotoxemic rats. J. Am. Coll. Cardiol. 2004, 43, 2348–2358. 
66. Klotz, L.O.; Sies, H. Defenses against peroxynitrite: Selenocompounds and flavonoids.  
Toxicol. Lett. 2003, 140–141, 125–132. 
67. Daiber, A.; Zou, M.H.; Bachschmid, M.; Ullrich, V. Ebselen as a peroxynitrite scavenger in vitro 
and ex vivo. Biochem. Pharmacol. 2000, 59, 153–160. 
68. Noiri, E.; Nakao, A.; Uchida, K.; Tsukahara, H.; Ohno, M.; Fujita, T.; Brodsky, S.; Goligorsky, M.S. 
Oxidative and nitrosative stress in acute renal ischemia. Am. J. Physiol. Renal Physiol. 2001, 281, 
F948–F957. 
69. Crow, J.P. Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic Biol. Med. 
2000, 28, 1487–1494. 
70. Briviba, K.; Roussyn, I.; Sharov, V.S.; Sies, H. Attenuation of oxidation and nitration reactions of 
peroxynitrite by selenomethionine, selenocystine and ebselen. Biochem. J. 1996, 319, 13–15. 
71. Tabuchi, Y.; Sugiyama, N.; Horiuchi, T.; Furusawa, M.; Furuhama, K. Ebselen, a seleno-organic 
compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and  
in vitro systems. Eur. J. Pharmacol. 1995, 272, 195–201. 
72. Batinic-Haberle, I.; Spasojevic, I.; Stevens, R.D.; Hambright, P.; Neta, P.; Okado-Matsumoto, A.; 
Fridovich, I. New class of potent catalysts of O2.-dismutation. Mn(iii) ortho-methoxyethylpyridyl- 
and di-ortho-methoxyethylimidazolylporphyrins. Dalton Trans. 2004, 1696–1702. 
73. Wang, W.; Jittikanont, S.; Falk, S.A.; Li, P.; Feng, L.; Gengaro, P.E.; Poole, B.D.; Bowler, R.P.; 
Day, B.J.; Crapo, J.D.; et al. Interaction among nitric oxide, reactive oxygen species, and 
antioxidants during endotoxemia-related acute renal failure. Am. J. Physiol. Renal Physiol. 2003, 
284, F532–F537. 
74. Brodsky, S.V.; Gealekman, O.; Chen, J.; Zhang, F.; Togashi, N.; Crabtree, M.; Gross, S.S.; 
Nasjletti, A.; Goligorsky, M.S. Prevention and reversal of premature endothelial cell senescence 
and vasculopathy in obesity-induced diabetes by ebselen. Circ. Res. 2004, 94, 377–384. 
Int. J. Mol. Sci. 2012, 13 17 
 
 
75. Gealekman, O.; Brodsky, S.V.; Zhang, F.; Chander, P.N.; Friedli, C.; Nasjletti, A.; Goligorsky, M.S. 
Endothelial dysfunction as a modifier of angiogenic response in zucker diabetic fat rat: 
Amelioration with ebselen. Kidney Int. 2004, 66, 2337–2347. 
76. Crow, J.P. Catalytic antioxidants to treat amyotropic lateral sclerosis. Expert Opin. Investig. 
Drugs 2006, 15, 1383–1393. 
77. Beckman, J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 
1996, 9, 836–844. 
78. Pannala, A.S.; Razaq, R.; Halliwell, B.; Singh, S.; Rice-Evans, C.A. Inhibition of peroxynitrite 
dependent tyrosine nitration by hydroxycinnamates: Nitration or electron donation? Free Radic 
Biol. Med. 1998, 24, 594–606. 
79. Kassim, M.; Mansor, M.; Achoui, M.; Ong, G.S.Y.; Sekaran, S.D.; Yusoff, K.M. Honey as an 
immunomodulator during sepsis in animal models. Crit. Care J. 2009, 13, P40. 
80. Hussein, S.Z.; Mohd Yusoff, K.; Makpol, S.; Mohd Yusof, Y.A. Gelam honey inhibits the 
production of proinflammatory, mediators no, pge2, tnf-&#x3b1;, and il-6 in carrageenan-induced 
acute paw edema in rats. Evid.-Based Complement. Altern. Med. 2012, 2012, 13. 
81. Laskin, D.L.; Pendino, K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. 
Pharmacol. Toxicol. 1995, 35, 655–677. 
82. Cheng, Y.W.; Chang, C.Y.; Lin, K.L.; Hu, C.M.; Lin, C.H.; Kang, J.J. Shikonin derivatives 
inhibited lps-induced nos in raw 264.7 cells via downregulation of mapk/nf-kappab signaling.  
J. Ethnopharmacol. 2008, 120, 264–271. 
83. Sandur, S.K.; Ichikawa, H.; Sethi, G.; Ahn, K.S.; Aggarwal, B.B. Plumbagin (5-hydroxy-2-
methyl-1,4-naphthoquinone) suppresses nf-kappab activation and nf-kappab-regulated gene 
products through modulation of p65 and ikappabalpha kinase activation, leading to potentiation of 
apoptosis induced by cytokine and chemotherapeutic agents. J. Biol. Chem. 2006, 281, 17023–17033. 
84. Muijsers, R.B.; van Den Worm, E.; Folkerts, G.; Beukelman, C.J.; Koster, A.S.; Postma, D.S.; 
Nijkamp, F.P. Apocynin inhibits peroxynitrite formation by murine macrophages. Br. J. 
Pharmacol. 2000, 130, 932–936. 
85. Achoui, M.; Appleton, D.; Abdulla, M.A.; Awang, K.; Mohd, M.A.; Mustafa, M.R. In vitro and  
in vivo anti-inflammatory activity of 17-O-acetylacuminolide through the inhibition of cytokines,  
nf-kappab translocation and ikkbeta activity. PLoS One 2010, 5, e15105. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
82 
 
CHAPTER 4. GENERAL DISCUSION AND CONCLUSION 
 
4.1 Discussion 
Although HPLC did not provide information about some compounds and their 
derivatives and conjugates, the identification of some phenolic compounds and their 
derivatives, such as ellagic acid and ellagitannin and their conjugates was possible with 
LC-MS. The inhibition of inflammatory mediators, such as TNF and NO, which were 
explored in this study, is one of the important steps in controlling inflammation. 
Reactive oxygen species (ROS) play a critical role in mediating TNF-α-induced 
cytotoxicity (Kunnumakkara et al., 2008). It was shown that such cytotoxicity can be 
blocked by specific free radical scavengers (Goossens et al., 1995). Our findings show 
that both types of the honey extracts had a dose-dependent protective effect in TNF-α-
mediated cytotoxicity. Previous research has reported that Malaysian honey has free 
radical scavenging activity. Although the concentrations of the phenolics identified 
were higher in HME, the in vitro anti-inflammatory activity seemed to be better for 
HEAE. This could be explained by the fact that the concentrations were reported for 
every 100 g of honey extracted. The dry extract yield ratio of the HEAE to the HME 
had been 1:5 for every 100 g of honey, hence over-representing the concentrations of 
the phenolic compounds in the methanol extract. Phenolic compounds in Gelam honey 
and its extracts do appear to have anti-inflammatory effects against the inflammatory 
mediators NO and PGE2 in tissues. Effects on NO and PGE2 correspond with the 
reduction in paw edema volume and the inhibition of pain. Honey and its extracts are, 
therefore, potentially useful for treating inflammatory conditions. The immune model 
(LPS) showed a faster development of edema, with the largest edema volume being 
recorded at 3 hrs. On the other hand, the non-immune model (carrageenan) induced a 
larger edema volume, and the development of edema occurred over a longer period with 
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the largest edema volume being recorded at 6 hrs. The effects of honey and its extracts 
were significant in both models but were more pronounced in the carrageenan model. 
This may be attributed to the fact that carrageenan is known to destroy macrophages 
(Ogata et al., 1999). In this model, a decrease in paw withdrawal latency to radiant heat 
and withdrawal threshold was observed throughout the 30 min - 7 hrs time period after 
induction of the paws by carrageenan. The results depict that honey and its extracts 
showed potent anti-nociceptive activity which is caused by the inhibition of PGE2 and 
NO. The extracts were more significant supporting the above suggestion for the 
involvement of phenolic compounds in this activity. 
Nitric oxide (NO) is known to be an important mediator of acute and chronic 
inflammation. The results show that honey and it extracts inhibited NO in inflammatory 
tissues in both models. In the carrageenan model, the inhibition was more pronounced 
than that of the LPS model. The major phenolic compounds in the methanol and ethyl 
acetate extracts were gallic acid, ellagic acid, caffeic acid, luteolin, chrysin and 
quercetin. The anti-inflammatory activity correlates positively with the radical-
scavenging activity and total phenolic content (Terra et al., 2007). Prostaglandin is a 
very important mediator of all types of inflammation. Previous studies have shown that 
COX-2 is responsible for increased prostaglandin production in inflamed tissue 
(DeWitt, 1991). The results indicate that honey and its extracts inhibit the PGE2 in 
inflammatory tissues of both inflammation models. Specific inhibition of COX-2 
expression at the transcriptional level is a potent mechanism in the treatment of 
inflammatory disease (O'Banion et al., 1992). It is possible that honey and its extracts 
are selective inhibitors of COX-2 because honey has no side effects on the 
gastrointestinal system. Different extraction methods and solvents yield different 
concentrations of phenolic compounds in honey. In addition the study’s findings 
resulted in Malaysian honey displaying varying anti-inflammatory activities in the two 
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in vitro models of inflammation used. This bioactivity may be attributed, at least in part, 
to the phenolic compounds within the extracts, thus, highlighting the nutritional value of 
this food. In addition to its well-known properties as a natural sweetener, honey has 
many anti-inflammatory properties. These include the ability to stimulate HO-1 
production and to inhibit the release of both pro- and anti-inflammatory cytokines 
(TNF-α, IL-1, IL-10), HMGB1, and NO. Together, these effects suggest a mechanism 
by which honey is able to protect animals from the lethal effects of LPS-induced 
endotoxemia. Therefore, honey should be further explored with respect to its anti-
inflammatory and immunomodulatory properties for use in the treatment of 
inflammatory diseases. Intravenous injection of honey into LPS-treated rats inhibited 
cytokine production, including that of TNF-α, IL-1, and IL-10, as well as HMGB1 and 
NO release, while at the same time inducing HO-1. Thus, consistent with in vitro 
studies demonstrating the immunomodulatory effects of gelam honey on cytokines and 
NO released in L929 and RAW 264.7(Kassim et al., 2010), our results show that Gelam 
honey inhibits cytokines, NO and  protects rats from endotoxemia. Upregulation of HO-
1 inhibits the release of cytokines, HMGB1 and NO. The enzyme HO-1 protects 
animals from severe inflammation, and a clear relationship has been determined 
between HO-1 activation and decreased HMGB1 levels which, in turn, protects animals 
from endotoxemia. Our results have been shown that honey inhibited HMGB1 while 
inducing HO-1 and increasing the survival of LPS-treated rats. Gelam honey protects 
organs from lethal doses of LPS by improving organ functions, reducing infiltration by 
PMNs that cause tissue damage, reducing MPO activity and increasing the survival rate. 
When immune responses are insufficient, infections can lead to sepsis (Molan, 2001). 
Sepsis-induced acute lung injury is a major clinical problem with significant morbidity 
and mortality (Luce, 1998; Vincent et al., 2003; Bernard et al., 1994). The present study 
is in agreement with previous studies showing that sepsis induces changes in pulmonary 
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microvascular neutrophil sequestration and alveolar neutrophil infiltration, (Doerschuk, 
2001; Brown et al., 1995; Skoutelis et al., 2000; Razavi et al., 2004) as clearly shown in 
the untreated group but not in the honey-treated group. The reductions in RBC, WBC, 
and platelet counts observed in the untreated group confirm those seen in earlier reports 
(Aoki et al., 2000; Chiou et al., 2002). Treatment with honey significantly attenuated 
the severe reductions in blood counts (WBC and RBC) and thrombocytopenia, 
suggesting that honey has a protective role against sepsis-induced disseminated 
intravascular coagulation. Our results confirm that sepsis caused liver failure, as shown 
by significantly elevated serum levels of AST, ALP, and γ-GT in the untreated group; 
honey inhibited these increases. Improved liver function tests after honey treatment 
indicate that honey may potentially protect liver cells from sepsis. Lipid profiles showed 
that cholesterol, triglycerides, and LDL levels were significantly increased in the LPS-
induced untreated sepsis group but not in the honey-treated group. However, the HDL 
levels were significantly lower in the untreated group. Injection of LPS into animals 
induces renal dysfunction characterized by increased blood urea nitrogen and plasma 
creatinine levels (Chen et al., 1999; Wellings et al., 1995). Urea nitrogen and plasma 
creatinine levels were increased by LPS injection, but were lower in the honey-treated 
group than in the untreated group. Both our previous studies and the above results show 
that LPS increased the levels of hepatic damage markers, modified lipid metabolism, 
and increased lipid profiles, hematological values, and renal dysfunction (Memon et al., 
1993). Our data showed that honey is a potent peroxynitrite scavenger in vitro and in 
vivo that has cytoprotective effects against peroxynitrite-mediated cellular injury and 
death. Moreover, the preservation of cellular viability from peroxynitrite-mediated 
damage is critical to any consideration of the potential therapeutic value of peroxynitrite 
scavengers in many diseases, including inflammation and sepsis. This finding suggests 
that honey has therapeutic applications for a wide range of inflammatory disorders. The 
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data presented here suggest that honey, through its antioxidant properties, is able to 
protect host immune cells from the inflammation-mediated cytotoxicity that develops in 
response to LPS stimulation. Excess NO production is cytotoxic and has a broad 
spectrum of cellular effects. In RAW 264.7 macrophages, there was a pronounced 
increase in NO production and a significant decrease in cell viability after stimulation 
with LPS/IFN-γ, which is known to induce iNOS and thus increase cellular NO 
concentrations. This decrease in viability was much less pronounced in the presence of 
1400W, suggesting that cytotoxicity was induced by iNOS and NO. In fact, NO 
production, measured as nitritein the Griess reaction, was almost completely inhibited 
by iNOS inhibition. Earlier studies show that peroxynitrite stimulates the release of the 
mitochondrial apoptosis-inducing factor, which subsequently triggers DNA 
fragmentation (Zhang et al., 2002), release of mitochondrial pro-apoptotic factors, and 
cytochrome c-dependent apoptosis in the cytosol through peroxynitrite-dependent 
oxidation of the mitochondrial permeability transition pore. This study shows that 
honey can inhibit NO production, and thus peroxynitrite formation, thereby reducing the 
effects of these cytotoxic compounds both in vitro and in vivo. Moreover, scavengers of 
peroxynitrite are known to be protective against tissue damage (Szabo et al., 2007). 
These compounds can reduce 3-nitrotyrosine immune reactivity in various 
pathophysiological conditions and have beneficial effects in animal models of 
inflammation, sepsis, and reperfusion injury (Crow, 2000Crow, 2000; Briviba et al., 
1996; Tabuchi et al., 1995; Batinic-Haberle et al., 2004; Noiri et al., 2001; Wang et al., 
2003; Brodsky et al., 2004; Gealekman et al., 2004; Nin et al., 2004; Crow, 2006; 
Beckman, 1996).  
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4.2 Conclusion 
In conclusion, this study indicated that different extraction methods and solvents 
will yield different concentrations of phenolic compounds in honey. Additionally, this 
study's findings also supported our hypothesis that Gelam honey extracts would display 
varying anti-inflammatory activities in the two in vitro models of inflammation utilized. 
This bioactivity may be attributed, at least in part, to the phenolic compounds within the 
extracts. As such, this study has made a contribution to the elucidation of the potential 
therapeutic value of honey and its extracts in inflammatory conditions, thus highlighting 
the nutritional value of this food. Phenolic compounds in Gelam honey and its extracts 
do appear to have anti-inflammatory effects against the inflammatory mediators NO and 
PGE2 in tissues. Effects on NO and PGE2 correspond with the reduction in paw edema 
volume and the inhibition of pain. In addition to its well-known properties as a natural 
sweetener, honey has many anti-inflammatory properties. These include the ability to 
stimulate HO-1 production and to inhibit the release of both pro- and anti-inflammatory 
cytokines (TNF-α, IL-1, IL-10), HMGB1, and NO. Together, these effects suggest a 
mechanism by which honey is able to protect animals from the lethal effects of LPS-
induced endotoxemia. Gelam honey protects organs from lethal doses of LPS by 
improving organ functions, reducing infiltration by PMNs that cause tissue damage, 
reducing MPO activity and increasing the survival rate. Honey inhibited peroxynitrite 
synthesis in vitro and vivo (endotoxemia). Thus, by suppressing the production of 
cytotoxic molecules such as NO and peroxynitrite, honey may attenuate the 
inflammatory responses that lead to cell damage and, potentially, to cell death, 
suggesting it has therapeutic applications for a wide range of inflammatory disorders. 
Suggestion, honey should be further explored with respect to its anti-inflammatory and 
immunomodulatory properties for use in the treatment of inflammatory diseases. 
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APPENDIX: 
Appendix A: Supplementary of 3.3 
  
Figure S1:  Chromatograms for the phenolic compounds of gelam honey using electrospray ionisation-mass spectra (ESI-MS), the based 
peaks (black colour), positive ionisation [+ESI-MS] (red colour) and negative ionisation [-ESI-MS] (green colour). gellic acid at 2.02 min , 
ferulic  acid at 11.53 min , quercetin at23.64 min , ellagic acid at 24,58 min, Hesperetin at 27.23 min , and chrysin at 33.26 min.
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Figure S2: Electrospray ionisation-mass spectra negative ionisation (-ESI-MS) for 
ferulic acid , MW =Molecular weight (MW= 194 g/mol), ESI-MS [M-H-H2O] = 193. 
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Figure S3: Electrospray ionisation-mass spectra (ESI-MS) negative ionisation for 
quercetin, MW =Molecular weight (MW=302 g/mol), ESI-MS [M-H] = 301 
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Figure S4: Electrospray ionisation-mass spectra (ESI-MS) negative ionisation for 
ellagic acid, MW =Molecular weight (MW=302 g/mol), ESI-MS [M-H] = 301. 
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Figure S5: Electrospray ionisation-mass spectra (ESI-MS) posittive ionisation for 
Hesperetin, MW =Molecular weight (MW=302 g/mol), ESI-MS [M+H] = 303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
Figure S6: Electrospray ionisation-mass spectra (ESI-MS) negative ionisation for 
chrysin, MW =Molecular weight (MW=254.242g/mol), ESI-MS [M-H] = 
253.28.A, P. S. (2002). procedure to identify a honey type. Food Chemistry, 79, 401-
406.  
 
 
